# ::snt Diabetes Insipidus in Mice with a Mutation in Aquaporin-2 .
# ::tok Diabetes Insipidus in Mice with a Mutation in Aquaporin-2 .
# ::alignments 8-9|0.0.2.0+0.0.2+0.0 6-7|0.0.0.0.0+0.0.0.0+0.0.0 3-4|0.0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:07.002
(d / diabet 
      :name (c / country 
            :location-of (o / organization 
                  :name (n2 / name 
                        :op1 "Mutation")) 
            :mod-of (m / mouse) 
            :name (n / name 
                  :op1 "Aquaporin-2")))

# ::snt Congenital nephrogenic diabetes insipidus ( NDI ) is a disease characterized by failure of the kidney to concentrate urine in response to vasopressin .
# ::tok Congenital nephrogenic diabetes insipidus ( NDI ) is a disease characterized by failure of the kidney to concentrate urine in response to vasopressin .
# ::alignments 22-23|0.0 20-21|0 18-19|0.1.1 17-18|0.1 15-16|0.1.0 12-13|0.1.0.0 10-11|0.1.0.0.0 9-10|0.1.0.0.0.0 3-4|0.1.0.0.0.0.0 2-3|0.1.0.0.0.0.0.0 0-1|0.1.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:07.450
(r / respond-01 
      :ARG1 (v / vasopressin) 
      :ARG2 (c / concentrate-01 
            :ARG0 (k / kidney 
                  :ARG1-of (f / fail-01 
                        :ARG0-of (c2 / characterize-01 
                              :ARG1 (d / disease 
                                    :domain (i / insipidu 
                                          :mod (d2 / diabetes) 
                                          :mod (c3 / congenital)))))) 
            :ARG1 (u / urine)))

# ::snt Human kindreds with nephrogenic diabetes insipidus have been found to harbor mutations in the vasopressin receptor 2 ( Avpr2 ) gene or the vasopressin-sensitive water channel aquaporin-2 ( Aqp2 ) gene .
# ::tok Human kindreds with nephrogenic diabetes insipidus have been found to harbor mutations in the vasopressin receptor 2 ( Avpr2 ) gene or the vasopressin-sensitive water channel aquaporin-2 ( Aqp2 ) gene .
# ::alignments 30-31|0.0.0.2.1 25-26|0.0.0.1.1 24-25|0.0.0.1.3 21-22|0.0.0.2 20-21|0.0.0.2.0 16-17|0.0.0.1.2 15-16|0.0.0.1.0.1 14-15|0.0.0.1.0.2 11-12|0.0.0 10-11|0.0.0.0 8-9|0.0.0.1 5-6|0.0 4-5|0 1-2|0.0.0.1.0 0-1|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:08.193
(d / diabetes 
      :mod-of (i / insipidu 
            :ARG0-of (m / mutate-01 
                  :ARG1 (h / harbor) 
                  :ARG2-of (f / find-01 
                        :ARG1 (k / kindred 
                              :mod (h2 / human) 
                              :name-of (r / receptor) 
                              :name-of (v / vasopressin)) 
                        :op1-of (c / channel) 
                        :op1-of 2 
                        :op1-of (w / water)) 
                  :op1-of (o / or 
                        :op2 (g2 / gene) 
                        :op3 (g / gene)))))

# ::snt Development of a treatment is rendered difficult due to the lack of a viable animal model .
# ::tok Development of a treatment is rendered difficult due to the lack of a viable animal model .
# ::alignments 15-16|0.0.0.0 14-15|0.0.0 13-14|0.0.0.0.1 10-11|0.0.0.0.0 6-7|0.1 5-6|0 3-4|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:08.577
(r / render-01 
      :ARG1 (t / treat-03 
            :ARG1 (a / animal 
                  :mod-of (m / model 
                        :ARG1-of (l / lack-01) 
                        :mod (v / viable)))) 
      :ARG2 (d / difficult))

# ::snt Through forward genetic screening of ethylnitrosourea-mutagenized mice , we report the identification and characterization of a mouse model of NDI , with an F204V mutation in the Aqp2 gene .
# ::tok Through forward genetic screening of ethylnitrosourea-mutagenized mice , we report the identification and characterization of a mouse model of NDI , with an F204V mutation in the Aqp2 gene .
# ::alignments 28-29|0.1.0.2 24-25|0.0.0.1 23-24|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 17-18|0.1.0.1 16-17|0.1.0.1.0 13-14|0.1.1 12-13|0.1 11-12|0.1.0 9-10|0 8-9|0.0 6-7|0.0.0.0 5-6|0.0.0.0.0 3-4|0.0.0 2-3|0.0.0.2 1-2|0.1.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:08.945
(r / report-01 
      :ARG0 (w / we 
            :ARG0-of (s / screen-01 
                  :ARG1 (m4 / mouse 
                        :mod (e / ethylnitrosourea-mutageniz)) 
                  :ARG2 (m / mutation 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "F204V"))) 
                  :mod (g2 / gene))) 
      :ARG1 (a / and 
            :op1 (i / identify-02 
                  :ARG0 (f / forward) 
                  :ARG1 (m2 / model 
                        :mod (m3 / mouse)) 
                  :location (g / gene)) 
            :op2 (c / characterization)) 
      :time (t2 / through))

# ::snt Unlike previously attempted murine models of NDI , our mice survive to adulthood and more exactly recapitulate the human disorder .
# ::tok Unlike previously attempted murine models of NDI , our mice survive to adulthood and more exactly recapitulate the human disorder .
# ::alignments 19-20|0.1.0 18-19|0.1.0.0 16-17|0.1 15-16|0.1.1 14-15|0.1.1.0 13-14|0 10-11|0.0 9-10|0.0.0 8-9|0.0.0.0 4-5|0.0.1 3-4|0.0.1.1 2-3|0.0.1.0 1-2|0.0.1.0.0 0-1|0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:09.785
(a / and 
      :ARG1-of (s / survive-01 
            :ARG0 (m2 / mouse 
                  :poss (w / we)) 
            :ARG2 (m3 / model 
                  :ARG1-of (a2 / attempt-01 
                        :mod (p / previous)) 
                  :mod (m4 / murine) 
                  :op1-of (u / unlike))) 
      :op1 (r / recapitulate-01 
            :ARG1 (d / disord 
                  :mod (h / human)) 
            :manner (e / exact 
                  :degree (m / more))))

# ::snt Previous in vitro experiments using renal cell lines suggest recessive Aqp2 mutations result in improper trafficking of the mutant water pore .
# ::tok Previous in vitro experiments using renal cell lines suggest recessive Aqp2 mutations result in improper trafficking of the mutant water pore .
# ::alignments 20-21|0.1.0.0 19-20|0.1.0.0.0 18-19|0.1.0.0.1 15-16|0.1.0 14-15|0.0.1 12-13|0.1 11-12|0.1.1 9-10|0.1.2 8-9|0 7-8|0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0.1 4-5|0.0.0 3-4|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:10.210
(s / suggest-01 
      :ARG0-of (e / experiment-01 
            :ARG0-of (u / use-01 
                  :ARG1 (l / line 
                        :mod (c / cell) 
                        :mod (r3 / renal))) 
            :ARG1 (i / improper) 
            :beneficiary-of (p2 / previou)) 
      :ARG1 (r / result-01 
            :ARG1 (t / traffic-01 
                  :ARG1 (p / pore-01 
                        :ARG1 (w / water) 
                        :mod (m / mutant))) 
            :mod (m2 / mutate-01) 
            :mod (r2 / recessive)))

# ::snt Using these animals , we have directly proven this hypothesis of improper AQP2 translocation as the molecular defect in nephrogenic diabetes insipidus in the intact organism .
# ::tok Using these animals , we have directly proven this hypothesis of improper AQP2 translocation as the molecular defect in nephrogenic diabetes insipidus in the intact organism .
# ::alignments 25-26|0.0.1.1 24-25|0.0.1.1.0 21-22|0.0.1.0 20-21|0.0.1.0.0 17-18|0.0.1 16-17|0.0.1.2 13-14|0.1.1 12-13|0.1.1.0 11-12|0.1.1.1 9-10|0.1 8-9|0.1.0 7-8|0 6-7|0.2 4-5|0.0 2-3|0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:10.859
(p / prove-01 
      :ARG0 (w / we 
            :ARG0-of (u / use-01 
                  :ARG1 (a2 / animal 
                        :mod (t3 / this))) 
            :ARG0-of (d2 / defect-01 
                  :ARG1 (i2 / insipidu 
                        :mod (d / diabetes)) 
                  :location (o / organism 
                        :mod (i / intact)) 
                  :mod (m / molecule))) 
      :ARG1 (h / hypothesi 
            :mod (t2 / this) 
            :mod (t / translocation 
                  :mod (a / AQP2) 
                  :mod (i3 / improper))) 
      :ARG1-of (d3 / direct-02))

# ::snt Additionally , using a renal cell line we show that the mutated protein , AQP2-F204V , is retained in the endoplasmic reticulum and that this abnormal localization can be rescued by wild-type protein .
# ::tok Additionally , using a renal cell line we show that the mutated protein , AQP2-F204V , is retained in the endoplasmic reticulum and that this abnormal localization can be rescued by wild-type protein .
# ::alignments 32-33|0.1.2.0.0 29-30|0.1.2.0 27-28|0.1.2.0.2 26-27|0.1.2.0.1 25-26|0.1.2.0.1.0 24-25|0.1.2.0.1.1 22-23|0.1.2 21-22|0.1.1 17-18|0.1 12-13|0.1.0 11-12|0.1.0.0 8-9|0 7-8|0.0 6-7|0.0.0.0 5-6|0.0.0.0.0 4-5|0.1.2.0.2.0 2-3|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:12.503
(s / show-01 
      :ARG0 (w / we 
            :ARG0-of (u / use-01 
                  :ARG1 (l2 / line 
                        :mod (c / cell)) 
                  :mod (a3 / additional))) 
      :ARG1 (r3 / retain-01 
            :ARG1 (p3 / protein 
                  :ARG1-of (m / mutate-01)) 
            :ARG2 (r2 / reticulum) 
            :op1-of (a2 / and 
                  :op2 (r / rescue-01 
                        :ARG0 (p / protein) 
                        :ARG1 (l / localization 
                              :mod (a / abnormal) 
                              :mod (t / this)) 
                        :ARG1-of (p2 / possible-01 
                              :ARG0 (r4 / renal))))))

# ::snt This novel mouse model allows for further mechanistic studies as well as testing of pharmacological and gene therapies for NDI .
# ::tok This novel mouse model allows for further mechanistic studies as well as testing of pharmacological and gene therapies for NDI .
# ::alignments 17-18|0.3 16-17|0.3.0 15-16|0 14-15|0.2 12-13|0.1 8-9|0.0.2 7-8|0.0.2.0 6-7|0.0.2.1 4-5|0.0 3-4|0.0.0 2-3|0.0.0.1 1-2|0.0.1 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:13.078
(a / and 
      :op1 (a2 / allow-01 
            :ARG0 (m2 / model 
                  :mod (t3 / this) 
                  :mod (m3 / mouse)) 
            :ARG1 (n / novel) 
            :ARG2 (s / study-01 
                  :ARG1 (m / mechanistic) 
                  :mod (f / further))) 
      :op2 (t2 / test-01) 
      :op3 (p / pharmacological) 
      :op4 (t / therapi 
            :mod (g / gene)))

# ::snt Nephrogenic diabetes insipidus ( NDI ) is a disease marked by excessive urination and thirst .
# ::tok Nephrogenic diabetes insipidus ( NDI ) is a disease marked by excessive urination and thirst .
# ::alignments 14-15|0 13-14|0.0 12-13|0.0.1 11-12|0.0.1.0 9-10|0.0.0 8-9|0.0.0.0 2-3|0.0.0.0.0 1-2|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:13.300
(t / thirst-01 
      :op2-of (a / and 
            :ARG0-of (m / mark-01 
                  :ARG1 (d / disease 
                        :domain (i / insipidu 
                              :mod (d2 / diabetes)))) 
            :op1 (u / urination 
                  :ARG1-of (e / excessive-02))))

# ::snt Normally , the hypothalamus senses situations where water is limited and signals to the kidney to increase water reabsorption from urine .
# ::tok Normally , the hypothalamus senses situations where water is limited and signals to the kidney to increase water reabsorption from urine .
# ::alignments 20-21|0.2.0.1.1 18-19|0.2.0.1 17-18|0.2.0.1.0 16-17|0.2.0 14-15|0.2.0.0 11-12|0.2 10-11|0 9-10|0.1.1.0 7-8|0.1.1.0.0 5-6|0.1.1 4-5|0.1 3-4|0.1.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:14.116
(a / and 
      :ARG1-of (n / normal-02) 
      :op1 (s3 / sense-01 
            :ARG0 (h / hypothalamu) 
            :ARG1 (s2 / situation 
                  :ARG0-of (l / limit-01 
                        :ARG1 (w2 / water)))) 
      :op2 (s / signal 
            :purpose (i / increase-01 
                  :ARG0 (k / kidney) 
                  :ARG1 (r / reabsorption 
                        :mod (w / water) 
                        :source (u / urine)))))

# ::snt The signaling molecule secreted by the hypothalamus is arginine vasopressin ( AVP ) , which binds to a specific protein on the surface of kidney cells , AVP receptor ( AVPR2 ) .
# ::tok The signaling molecule secreted by the hypothalamus is arginine vasopressin ( AVP ) , which binds to a specific protein on the surface of kidney cells , AVP receptor ( AVPR2 ) .
# ::alignments 28-29|0 25-26|0.0.1.0.0.1.0 24-25|0.0.1.0.0.1.0.0 22-23|0.0.1.0.0.1 19-20|0.0.1.0 18-19|0.0.1 15-16|0.0.1.0.0 9-10|0.0.1.0.0.0.0 8-9|0.0.1.0.0.0 6-7|0.0.0.0.0 3-4|0.0.0.0 2-3|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:14.700
(r / receptor 
      :ARG0-of (s4 / signal-01 
            :ARG1 (m / molecule 
                  :ARG1-of (s3 / secrete-01 
                        :ARG0 (h / hypothalamu))) 
            :ARG2-of (s2 / specific-02 
                  :ARG1 (p / protein 
                        :ARG2-of (b / bind-01 
                              :ARG0 (a / arginine 
                                    :mod-of (v / vasopressin)) 
                              :ARG1 (s / surface 
                                    :domain (c / cell 
                                          :mod (k / kidney))))))))

# ::snt AVP binding to its receptor on kidney cells begins a series of biochemical events that ultimately results in the insertion of a protein , aquaporin 2 ( AQP2 ) , into the outer surface of the kidney cell .
# ::tok AVP binding to its receptor on kidney cells begins a series of biochemical events that ultimately results in the insertion of a protein , aquaporin 2 ( AQP2 ) , into the outer surface of the kidney cell .
# ::alignments 37-38|0.0.0.1 36-37|0.0.0.1.0 33-34|0.0.0 32-33|0.0.0.0 25-26|0.0.1.1.1.0.0.0.0.0 24-25|0.0.1.0 22-23|0 19-20|0.0 16-17|0.0.1 15-16|0.0.1.2 13-14|0.0.1.1 12-13|0.0.1.1.0 10-11|0.0.1.1.1 8-9|0.0.1.1.1.0 7-8|0.0.1.1.1.0.0 6-7|0.0.1.1.1.0.0.1 4-5|0.0.1.1.1.0.0.0 1-2|0.0.1.1.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:15.286
(p / protein 
      :ARG1-of (i / insert-01 
            :ARG2 (s / surface 
                  :mod (o / outer) 
                  :poss (c / cell 
                        :mod (k / kidney))) 
            :ARG2-of (r / result-01 
                  :ARG0 (a / aquaporin) 
                  :ARG1 (e / event 
                        :mod (b / biochemical) 
                        :quant (s2 / series 
                              :ARG1-of (b2 / begin-01 
                                    :ARG0 (c2 / cell 
                                          :location-of (r2 / receptor 
                                                :ARG2-of (b3 / binding-07 
                                                      :ARG1 2)) 
                                          :mod (k2 / kidney))))) 
                  :time (u / ultimate))))

# ::snt As its name suggests , AQP2 facilitates the reuptake of water from the urinary space into the cell , thus concentrating the urine and conserving water .
# ::tok As its name suggests , AQP2 facilitates the reuptake of water from the urinary space into the cell , thus concentrating the urine and conserving water .
# ::alignments 25-26|0.2.0 24-25|0.2 23-24|0 22-23|0.1.0 20-21|0.1 19-20|0.1.1 17-18|0.0.1 14-15|0.0.0.1 13-14|0.0.0.1.0 10-11|0.0.0.0 8-9|0.0.0 6-7|0.0 3-4|0.0.2 2-3|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:16.236
(a / and 
      :ARG1-of (f / facilitate-01 
            :ARG2 (r / reuptake 
                  :quant-of (w2 / water) 
                  :source (s / space 
                        :mod (u2 / urinary))) 
            :ARG4 (c3 / cell) 
            :condition (s2 / suggest-01 
                  :ARG0 (n / name))) 
      :op1 (c2 / concentrate-01 
            :ARG1 (u / urine) 
            :time (t / thus-far)) 
      :op2 (c / conserve-01 
            :ARG1 (w / water)))

# ::snt Congenital NDI is caused by mutations in either the water channel , AQP2 , or in the receptor , AVPR2 .
# ::tok Congenital NDI is caused by mutations in either the water channel , AQP2 , or in the receptor , AVPR2 .
# ::alignments 17-18|0.0.0.2 14-15|0.0.0 10-11|0.0.0.1 9-10|0.0.0.1.0 7-8|0.0.0.0 5-6|0.0 3-4|0 0-2|0.1.0.1+0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:16.360
(c2 / cause-01 
      :ARG0 (m / mutate-01 
            :ARG1 (o / or 
                  :mod (e / either) 
                  :op1 (c / channel 
                        :mod (w / water)) 
                  :op2 (r / receptor))) 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 (c3 / Congenital) 
                  :op2 (n2 / NDI))))

# ::snt While these mutations have been studied extensively in the lab , work in live animals has been very limited .
# ::tok While these mutations have been studied extensively in the lab , work in live animals has been very limited .
# ::alignments 18-19|0 17-18|0.2 14-15|0.0.0.0 13-14|0.0.0 11-12|0.1 9-10|0.1.0.2 6-7|0.1.0.1 5-6|0.1.0 2-3|0.1.0.0 1-2|0.1.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:17.076
(l / limit-01 
      :ARG0-of (w2 / while-01 
            :ARG1-of (l2 / live-01 
                  :ARG0 (a / animal))) 
      :ARG1 (w / work-01 
            :ARG0-of (s / study-01 
                  :ARG1 (m / mutate-01 
                        :mod (t / this)) 
                  :degree (e / extensive) 
                  :location (l3 / lab))) 
      :degree (v / very))

# ::snt This report describes the first viable mouse model of NDI .
# ::tok This report describes the first viable mouse model of NDI .
# ::alignments 7-8|0.1 6-7|0.1.0 5-6|0.1.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:17.117
(d / describe-01 
      :ARG0 (r / report 
            :mod (t / this)) 
      :ARG1 (m / model 
            :mod (m2 / mouse) 
            :mod (v / viable)))

# ::snt Previous models have been attempted by targeted mutation , i.e. , genes known to be involved in the disease have been altered in the mouse , a so-called reverse genetic approach .
# ::tok Previous models have been attempted by targeted mutation , i.e. , genes known to be involved in the disease have been altered in the mouse , a so-called reverse genetic approach .
# ::alignments 30-31|0 29-30|0.0.0 28-29|0.2 27-28|0.1 24-25|0.0.1.1.0.0.0 21-22|0.0.1.1.0.0 18-19|0.0.1.1.2 15-16|0.0.1.1 12-13|0.0.1.1.1 11-12|0.0.1.1.0 9-10|0.0.1.0.1 7-8|0.0.1 6-7|0.0 4-5|0.0.1.0 1-2|0.0.1.0.0 0-1|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:17.970
(a / approach-02 
      :ARG1 (t / target-01 
            :ARG0 (g / gene) 
            :ARG1 (m2 / mutation 
                  :ARG0-of (a3 / attempt-01 
                        :ARG1 (m3 / model 
                              :mod (p / previou)) 
                        :manner (i2 / i.e.)) 
                  :ARG0-of (i / involve-01 
                        :ARG1 (g2 / gene 
                              :ARG1-of (a2 / alter-01 
                                    :location (m / mouse))) 
                        :ARG1-of (k / know-02) 
                        :ARG2 (d / disease)))) 
      :ARG1-of (s / so-call) 
      :ARG1-of (r / reverse-01))

# ::snt Reverse genetic approaches have so far failed to produce a viable mouse model of NDI .
# ::tok Reverse genetic approaches have so far failed to produce a viable mouse model of NDI .
# ::alignments 12-13|0.1.0 11-12|0.1.0.0 10-11|0.1.0.1 8-9|0.1 6-7|0 5-6|0.2 2-3|0.0 1-2|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:18.042
(f / fail-01 
      :ARG1 (a / approach-02 
            :ARG1-of (r / reverse-01) 
            :manner (g / gene)) 
      :ARG2 (p / produce-01 
            :ARG1 (m / model 
                  :mod (m2 / mouse) 
                  :mod (v / viable))) 
      :degree (f2 / far))

# ::snt Here the authors take a forward genetic approach in which genes are mutated at random and animals are screened for disease-like properties .
# ::tok Here the authors take a forward genetic approach in which genes are mutated at random and animals are screened for disease-like properties .
# ::alignments 21-22|0.2 18-19|0 16-17|0.1 15-16|0.3 14-15|0.0.0.1 12-13|0.0.0 10-11|0.0 7-8|0.0.0.0 6-7|0.0.0.0.2 5-6|0.0.0.0.3 3-4|0.0.0.0.1 2-3|0.0.0.0.0 0-1|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:18.838
(s / screen-01 
      :ARG0 (g / gene 
            :ARG1-of (m / mutate-01 
                  :location (a3 / approach-02 
                        :ARG0 (a4 / author-01) 
                        :ARG1-of (t / take-01 
                              :ARG0 (h / here)) 
                        :extent-of (g2 / gene) 
                        :mod (f / forward)) 
                  :mod (r / random))) 
      :ARG1 (a / animal) 
      :ARG2 (p / property) 
      :op1-of (a2 / and))

# ::snt As well as proving hypotheses that come from lab studies , this model opens the door to the testing of gene therapy or other therapies for treatment of NDI .
# ::tok As well as proving hypotheses that come from lab studies , this model opens the door to the testing of gene therapy or other therapies for treatment of NDI .
# ::alignments 26-27|0.2 24-25|0.0.0.0.0.0.0.1.1 23-24|0.0.0.0.0.0.0.1.1.0 22-23|0.0.0.0.0.0.0.1 21-22|0.0.0.0.0.0.0 20-21|0.0.0.0.0.0.0.0 18-19|0.0.0.0.0.0.0.1.0 15-16|0.1 13-14|0 12-13|0.0 11-12|0.0.1 9-10|0.0.0.0.0.0 8-9|0.0.0.0.0.0.1 6-7|0.0.0.0.0 4-5|0.0.0.0.1+0.0.0.0 3-4|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:19.519
(o3 / open-01 
      :ARG0 (m / model 
            :ARG0-of (p / prove-01 
                  :ARG1 (t6 / thing 
                        :ARG1-of (c / come-01 
                              :ARG3 (s / study-01 
                                    :ARG0 (t3 / therapy 
                                          :mod (g / gene) 
                                          :op1-of (o2 / or 
                                                :ARG1-of (t4 / test-01) 
                                                :op2 (t2 / therapi 
                                                      :mod (o / other)))) 
                                    :ARG1 (l / lab))) 
                        :ARG1-of (h / hypothesize-01))) 
            :mod (t5 / this)) 
      :ARG1 (d / door) 
      :purpose (t / treat-03))

# ::snt Nephrogenic diabetes insipidus ( NDI ) is a disease characterized by excessive urination and thirst , despite normal production of the antidiuretic hormone arginine vasopressin ( AVP ) [ 1 ] .
# ::tok Nephrogenic diabetes insipidus ( NDI ) is a disease characterized by excessive urination and thirst , despite normal production of the antidiuretic hormone arginine vasopressin ( AVP ) [ 1 ] .
# ::alignments 29-30|0.2.1.0.0 24-25|0.1.0 23-24|0.1.0.0 22-23|0.1.0.0.0 21-22|0.0 18-19|0.1 17-18|0.1.1 14-15|0 13-14|0.2 12-13|0.2.1 11-12|0.2.1.0 9-10|0.2.0 8-9|0.2.0.0 2-3|0.2.0.0.0 1-2|0.2.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:20.458
(t / thirst-01 
      :ARG1 (a2 / antidiuretic) 
      :ARG1-of (p / produce-01 
            :ARG0 (v / vasopressin 
                  :mod (a / arginine 
                        :mod (h / hormone))) 
            :ARG1-of (n / normal-02)) 
      :op2-of (a3 / and 
            :ARG0-of (c / characterize-01 
                  :ARG1 (d / disease 
                        :domain (i / insipidu 
                              :mod (d2 / diabetes)))) 
            :op1 (u / urination 
                  :ARG1-of (e / excessive-02 
                        :ARG0 1))))

# ::snt The inherited forms are either X-linked as a consequence of mutation of the Avpr2 gene [ 2 ] , or autosomal due to mutation of the Aqp2 gene [ 3 ] .
# ::tok The inherited forms are either X-linked as a consequence of mutation of the Avpr2 gene [ 2 ] , or autosomal due to mutation of the Aqp2 gene [ 3 ] .
# ::alignments 29-30|0.0.0.1.0.1 27-28|0.0.0.1.0.3.0 23-24|0.0.0.1.0.3 20-21|0.0.0.1.0.0 19-20|0 16-17|0.0.0.1.0.2 14-15|0.1 10-11|0.1.0 8-9|0.0.0.0 5-6|0.0.0 4-5|0.0 2-3|0.0.0.1 1-2|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:20.634
(o / or 
      :mod (e / either 
            :mod-of (x / x-link 
                  :compared-to (c / consequence) 
                  :domain (f / form 
                        :ARG1-of (i / inherit-01 
                              :op1-of (a / autosomal) 
                              :op1-of 3 
                              :op1-of 2 
                              :op1-of (m / mutation 
                                    :poss (g / gene)))))) 
      :op1 (g2 / gene 
            :poss-of (m2 / mutation)))

# ::snt Aquaporin-2 ( AQP2 ) is a pore-forming protein belonging to a family of water channels [ 4 ] , and it is expressed in collecting-duct principal cells in the kidney [ 5 ] .
# ::tok Aquaporin-2 ( AQP2 ) is a pore-forming protein belonging to a family of water channels [ 4 ] , and it is expressed in collecting-duct principal cells in the kidney [ 5 ] .
# ::alignments 31-32|0.0.2 29-30|0.1.0.0.0 26-27|0.1.0.0 25-26|0.1.0.0.1 22-23|0.1.0 19-20|0.1.0.2 16-17|0.1.0.1 14-15|0.1.0.2.0 13-14|0.0.1 11-12|0.0.0 8-9|0.0 7-8|0 6-7|0.2 0-1|0.1.1.0+0.1.1+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:20.945
(p2 / protein 
      :ARG0-of (b / belong-01 
            :ARG1 (f / family) 
            :ARG2 (w / water) 
            :op1-of 5) 
      :domain (p4 / person 
            :ARG0-of (e / express-01 
                  :ARG1 (c / cell 
                        :location (k / kidney) 
                        :mod (p / principal)) 
                  :ARG2 4 
                  :op2-of (a / and 
                        :op1 (c2 / channel))) 
            :name (n / name 
                  :op1 "Aquaporin-2")) 
      :mod (p3 / pore-form))

# ::snt Generally these proteins permit the passage of water through the plasma membrane ( PM ) of cells , several of which carry out this role specifically in the process of water reabsorption from urine in the kidney .
# ::tok Generally these proteins permit the passage of water through the plasma membrane ( PM ) of cells , several of which carry out this role specifically in the process of water reabsorption from urine in the kidney .
# ::alignments 36-37|0.1.0.0.0.1.0.0 33-34|0.1.0.0.0.1.0 31-32|0.1.0.0.0.1.1 30-31|0.1.0.0.0.1.1.0 28-29|0.1.0.0.0.1 25-26|0.1.0.0.0.1.2 24-25|0.1.0.0.0.0 23-24|0.1.0.0.0.0.0 21-22|0.1.0.0.0 18-19|0.2.0 16-17|0.1.0.0 13-14|0.1.0.0.0.1.2.0 11-12|0.1.0 10-11|0.1.0.1 7-8|0.1.1 5-6|0.1 3-4|0 2-3|0.0 1-2|0.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:21.809
(p5 / permit-01 
      :ARG0 (p6 / protein 
            :mod (t2 / this)) 
      :ARG1 (p4 / pass-01 
            :ARG0 (m / membrane 
                  :domain (c2 / cell 
                        :ARG0-of (c / carry-01 
                              :ARG1 (r2 / role 
                                    :mod (t / this)) 
                              :prep-in (p / process-02 
                                    :ARG0 (u / urine 
                                          :location (k / kidney)) 
                                    :ARG1 (r / reabsorption 
                                          :mod (w / water)) 
                                    :ARG2-of (s / specific-02 
                                          :ARG1 (p2 / pm))))) 
                  :mod (p3 / plasma)) 
            :ARG1 (w2 / water)) 
      :manner (g / general-02 
            :ARG1 (s2 / several)))

# ::snt It has been established that aquaporins , although functional as a monomer , tetramerize before their insertion into the plasma membrane [ 4,6 ] .
# ::tok It has been established that aquaporins , although functional as a monomer , tetramerize before their insertion into the plasma membrane [ 4,6 ] .
# ::alignments 20-21|0.0 19-20|0.1.0.1 16-17|0.1.0 14-15|0.1.0.2 11-12|0.1.0.0 8-9|0.1.0.0.0 5-6|0.2 3-4|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:22.019
(e / establish-01 
      :ARG0 (m / membrane) 
      :ARG1 (i2 / it 
            :ARG0-of (i / insert-01 
                  :ARG1 (m2 / monom 
                        :compared-to-of (f / functional)) 
                  :ARG2 (p / plasma) 
                  :op1-of (b / before))) 
      :ARG2 (a / aquaporin))

# ::snt Furthermore these proteins can also be differentially targeted to distinct regions of the PM ; for example , AQP2 is routed to the apical membrane of cells surrounding the collecting duct , whereas other aquaporins ( AQP3 or 4 ) are inserted into the basolateral face .
# ::tok Furthermore these proteins can also be differentially targeted to distinct regions of the PM ; for example , AQP2 is routed to the apical membrane of cells surrounding the collecting duct , whereas other aquaporins ( AQP3 or 4 ) are inserted into the basolateral face .
# ::alignments 45-46|0.0.0.1.0.0.0.2 44-45|0.0.0.1.0.0.0.2.0 41-42|0.0.0.1.0.0.0 38-39|0.0.0.1.0.0.2.0.1 37-38|0.0.0.1.0.0.2.0 34-35|0.0.0.1.0.0.0.1 33-34|0.0.0.1.0.0.0.1.0 32-33|0.0.0.1.0.0.0.3 30-31|0.0 29-30|0 27-28|0.0.0 26-27|0.0.0.1 24-25|0.0.0.1.0 23-24|0.0.0.1.0.1 20-21|0.0.0.1.0.0 16-17|0.0.0.1.0.0.0.0 14-15|0.0.0.1.0.0.2 13-14|0.0.0.1.0.0.1 10-11|0.0.0.1.0.0.2.0.0.2 9-10|0.0.0.1.0.0.2.0.0.2.0 7-8|0.0.0.1.0.0.2.0.0 6-7|0.0.0.1.0.0.2.0.0.4 4-5|0.0.0.1.0.0.2.0.0.3 3-4|0.0.0.1.0.0.2.0.0.1 2-3|0.0.0.1.0.0.2.0.0.0 1-2|0.0.0.1.0.0.2.0.0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:23.547
(c / collect-01 
      :ARG1 (d / duct 
            :ARG2-of (s / surround-01 
                  :ARG0 (f2 / furthermore) 
                  :ARG1 (c2 / cell 
                        :domain-of (m / membrane 
                              :ARG2-of (r / route-01 
                                    :ARG0 (i / insert-01 
                                          :ARG0 (e / example) 
                                          :ARG1 (a / aquaporin 
                                                :mod (o2 / other)) 
                                          :location (f / face 
                                                :mod (b / basolateral)) 
                                          :op1-of (w / whereas)) 
                                    :ARG1 (p / pm) 
                                    :op1-of (a3 / and 
                                          :op1-of (o / or 
                                                :ARG0-of (t / target-01 
                                                      :ARG1 (p3 / protein 
                                                            :mod (t2 / this)) 
                                                      :ARG1-of (p2 / possible-01) 
                                                      :ARG2 (r2 / region 
                                                            :mod (d2 / distinct)) 
                                                      :mod (a4 / also) 
                                                      :mod (d3 / differentially)) 
                                                :op2 4))) 
                              :mod (a2 / apical))))))

# ::snt Unlike all other family members , AQP2 is not constitutively inserted into the plasma membrane .
# ::tok Unlike all other family members , AQP2 is not constitutively inserted into the plasma membrane .
# ::alignments 14-15|0.0.1 13-14|0.0.1.0 10-11|0.0 9-10|0 8-9|0.0.2 4-5|0.0.0.0.0.1+0.0.0.0.0+0.0.0.0 3-4|0.0.0.0.0.0 2-3|0.0.0.0.1 1-2|0.0.0 0-1|0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:24.000
(c / constitutively 
      :ARG1-of (i / insert-01 
            :ARG0 (a / all 
                  :quant-of (p2 / person 
                        :ARG0-of (h / have-org-role-91 
                              :ARG1 (f / family) 
                              :ARG2 (m2 / member)) 
                        :mod (o / other) 
                        :op1-of (u / unlike))) 
            :location (m / membrane 
                  :mod (p / plasma)) 
            :polarity -))

# ::snt Under basal conditions , the protein resides in subapical intracellular vesicles ; however , under conditions requiring water retention AQP2 translocates to the apical membrane , permitting water reabsorption [ 7,8 ] .
# ::tok Under basal conditions , the protein resides in subapical intracellular vesicles ; however , under conditions requiring water retention AQP2 translocates to the apical membrane , permitting water reabsorption [ 7,8 ] .
# ::alignments 28-29|0.3.1 27-28|0.3.1.0 26-27|0.3 24-25|0.2 23-24|0.2.0 20-21|0.1 19-20|0.1.1 18-19|0.1.0 17-18|0.3.0 16-17|0 15-16|0.0 11-12|0.3.1.1 10-11|0.3.1.1.0.1 9-10|0.3.1.1.0.1.0 6-7|0.3.1.1.0 5-6|0.3.1.1.0.0 2-3|0.3.1.1.0.2.0 1-2|0.3.1.1.0.2.0.0 0-1|0.3.1.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:24.726
(r3 / require-01 
      :ARG0 (c / condition) 
      :ARG1 (t / translocate 
            :mod (r2 / retention) 
            :mod (a2 / AQP2)) 
      :ARG2 (m / membrane 
            :mod (a / apical)) 
      :ARG2-of (p / permit-01 
            :ARG0 (w2 / water) 
            :ARG1 (r / reabsorption 
                  :mod (w / water) 
                  :op2-of (a3 / and 
                        :op1 (r4 / reside-01 
                              :ARG0 (p2 / protein) 
                              :ARG1 (v / vesicl 
                                    :mod (i / intracellular)) 
                              :location (u / under 
                                    :op1 (c2 / condition 
                                          :mod (b / basal))))))))

# ::snt For this process to occur , AVP binds its receptor , AVPR2 , on the basolateral face of the collecting duct cells , leading to a rise in intracellular cAMP , ultimately resulting in phosphorylation of AQP2 at serine 256 by cAMP-dependent protein kinase [ 9 ] and its redistribution to the plasma membrane .
# ::tok For this process to occur , AVP binds its receptor , AVPR2 , on the basolateral face of the collecting duct cells , leading to a rise in intracellular cAMP , ultimately resulting in phosphorylation of AQP2 at serine 256 by cAMP-dependent protein kinase [ 9 ] and its redistribution to the plasma membrane .
# ::alignments 53-54|0.0.1.0.1.1.1 52-53|0.0.1.0.1.1.1.0 49-50|0.1 47-48|0 45-46|0.0.0 43-44|0.0.1.0.1.1.0 42-43|0.0.1.0.1.1.0.0 38-39|0.0.1.0.1.0 34-35|0.0.1.0.1 32-33|0.0.1.0.1.1 31-32|0.0.1.0.1.1.2 29-30|0.0.1.0 28-29|0.0.1.0.0 26-27|0.0.1 23-24|0.0 21-22|0.0.2.0 20-21|0.0.2.0.1 19-20|0.0.2 16-17|0.0.2.0.0 9-10|0.0.2.0.0.0.0 7-8|0.0.2.0.0.0 4-5|0.0.2.0.0.0.1.0 2-3|0.0.2.0.0.0.1 1-2|0.0.2.0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:26.525
(a / and 
      :ARG0-of (l / lead-01 
            :ARG1 9 
            :ARG2 (r3 / rise-01 
                  :ARG1 (c / camp-01 
                        :ARG1 (i / intracellular) 
                        :manner (p3 / phosphorylate-01 
                              :ARG1 (s / serine) 
                              :ARG2-of (r2 / result-01 
                                    :ARG0 (k / kinase 
                                          :mod (p2 / protein)) 
                                    :ARG1 (m / membrane 
                                          :mod (p / plasma)) 
                                    :time (u / ultimate))))) 
            :condition-of (c3 / collect-01 
                  :ARG1 (c2 / cell 
                        :domain-of (f / face 
                              :location-of (b / bind-01 
                                    :ARG1 (r4 / receptor) 
                                    :purpose (p4 / process-02 
                                          :ARG1 (o / occur-01) 
                                          :mod (t / this)))) 
                        :mod (d / duct)))) 
      :op1 (r / redistribution))

# ::snt The importance of AQP2 redistribution has been highlighted by functional characterization of Aqp2 mutations resulting in severe NDI in humans [ 3,10 ] .
# ::tok The importance of AQP2 redistribution has been highlighted by functional characterization of Aqp2 mutations resulting in severe NDI in humans [ 3,10 ] .
# ::alignments 19-20|0.2.1 16-17|0.3 14-15|0.2 13-14|0.2.0 10-11|0.0 9-10|0.0.0 7-8|0 4-5|0.1.0 3-4|0.1.0.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:26.684
(h2 / highlight-01 
      :ARG0 (c / characterization 
            :mod (f / functional)) 
      :ARG1 (i / important 
            :mod (r2 / redistribution 
                  :mod (a / AQP2))) 
      :purpose (r / result-01 
            :ARG1 (m / mutate-01) 
            :ARG2 (h / human)) 
      :time (s / severe))

# ::snt Recessive Aqp2 mutations are generally thought to produce an abnormally localized and , in most instances , misfolded water pore that responds abnormally to an increase in cAMP [ 6,11 ] .
# ::tok Recessive Aqp2 mutations are generally thought to produce an abnormally localized and , in most instances , misfolded water pore that responds abnormally to an increase in cAMP [ 6,11 ] .
# ::alignments 27-28|0.2 25-26|0.0.1.0.0 21-22|0.0.1.0 19-20|0.0.1 18-19|0.0.1.1 17-18|0.0.1.1.0.1.0 15-16|0.0.1.1.0.2 14-15|0.0.1.1.0.2.0 11-12|0.0.1.1.0.1 10-11|0.0.1.1.0 9-10|0.0.1.1.0.0 7-8|0.0 5-6|0 4-5|0.1 2-3|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:27.607
(t / think-01 
      :ARG1 (p2 / produce-01 
            :ARG0 (m3 / mutate-01 
                  :mod (r2 / recessive)) 
            :ARG1 (p / pore-01 
                  :ARG0-of (r / respond-01 
                        :ARG1 (i / increase-01)) 
                  :ARG1 (w / water 
                        :ARG1-of (l / localize-01 
                              :degree (a2 / abnormally) 
                              :op1-of (a / and 
                                    :op2 (m / misfold)) 
                              :time (i2 / instance 
                                    :quant (m2 / most)))))) 
      :ARG1-of (g / general-02) 
      :ARG1-of (c / camp-01))

# ::snt Furthermore , dominant mutations have been described and found to misroute both the mutant and the wild-type protein to the basolateral membrane [ 6,12 ] .
# ::tok Furthermore , dominant mutations have been described and found to misroute both the mutant and the wild-type protein to the basolateral membrane [ 6,12 ] .
# ::alignments 21-22|0.0.0.0.0.1 17-18|0 14-15|0.0 13-14|0.0.1 11-12|0.0.0.1.0 8-9|0.0.0.1 7-8|0.0.0 6-7|0.0.0.0 3-4|0.0.0.0.0 2-3|0.0.0.0.0.2 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:28.150
(p / protein 
      :op3-of (a / and 
            :op1 (a2 / and 
                  :op1 (d / describe-01 
                        :ARG1 (m3 / mutate-01 
                              :ARG0 (f2 / furthermore) 
                              :ARG1 (m / membrane) 
                              :ARG1-of (d2 / dominate-01))) 
                  :op2 (f / find-01 
                        :ARG1 (b / both))) 
            :op2 (m2 / mutant)))

# ::snt Several mouse models of diabetes insipidus have been generated [ 13 -- 17 ] .
# ::tok Several mouse models of diabetes insipidus have been generated [ 13 -- 17 ] .
# ::alignments 12-13|0.0 10-11|0.1.2.1 8-9|0 5-6|0.1.2 4-5|0.1.2.0 2-3|0.1 1-2|0.1.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:28.231
(g / generate-01 
      :ARG0 17 
      :ARG1 (m / model 
            :ARG1-of (s / several) 
            :mod (m2 / mouse) 
            :topic (i / insipidu 
                  :mod (d / diabetes) 
                  :op1-of 13)))

# ::snt In an attempt to recapitulate human NDI , mice have been generated with mutations in Aqp2 and Avpr2 [ 15,18 ] .
# ::tok In an attempt to recapitulate human NDI , mice have been generated with mutations in Aqp2 and Avpr2 [ 15,18 ] .
# ::alignments 17-18|0.3 16-17|0 15-16|0.2 13-14|0.0 11-12|0.1 8-9|0.1.0 5-6|0.0.0 4-5|0.1.1.0 2-3|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:28.349
(a2 / and 
      :ARG1-of (m / mutate-01 
            :ARG0 (h / human)) 
      :op1 (g / generate-01 
            :ARG1 (m2 / mouse) 
            :ARG2 (a4 / attempt-01 
                  :ARG1 (r / recapitulate-01))) 
      :op2 (a3 / Aqp2) 
      :op3 (a / Avpr2))

# ::snt Yang and colleagues created a mouse with a T126M knock-in mutation in the Aqp2 gene .
# ::tok Yang and colleagues created a mouse with a T126M knock-in mutation in the Aqp2 gene .
# ::alignments 14-15|0.2 10-11|0.2.0 5-6|0.1 3-4|0 2-3|0.0.0 1-2|0.0 0-1|0.2.1.0+0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:28.480
(c / create-01 
      :ARG0 (a / and 
            :op1 (c2 / colleagu)) 
      :ARG1 (m2 / mouse) 
      :ARG2 (g / gene 
            :location-of (m / mutation) 
            :mod (n / name 
                  :op1 "Yang")))

# ::snt Unexpectedly , homozygous mutant mice died within 6 d after birth .
# ::tok Unexpectedly , homozygous mutant mice died within 6 d after birth .
# ::alignments 10-11|0.3.0 9-10|0.3 8-9|0.3.1 7-8|0.3.1.0 5-6|0 4-5|0.1 3-4|0.0 2-3|0.1.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:28.593
(d2 / die-01 
      :ARG0 (m2 / mutant) 
      :ARG1 (m / mouse 
            :mod (h / homozygou)) 
      :op1-of (u / unexpectedly) 
      :time (a / after 
            :op1 (b / birth-01) 
            :time-of (d / d 
                  :quant 6)))

# ::snt Interestingly , AVPR2-deficient male pups also die within the first week after birth .
# ::tok Interestingly , AVPR2-deficient male pups also die within the first week after birth .
# ::alignments 12-13|0.3.0 11-12|0.3 10-11|0.3.1 6-7|0 5-6|0.2 4-5|0.0 3-4|0.3.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:28.632
(d / die-01 
      :ARG1 (p / pup-01) 
      :manner (i / interesting) 
      :mod (a2 / also) 
      :time (a / after 
            :op1 (b / birth-01 
                  :ARG2 (m / male)) 
            :time-of (w / week)))

# ::snt Together these models suggest that the mouse may be a highly sensitive organism with regard to water homeostasis , and is unable to survive with polyuria .
# ::tok Together these models suggest that the mouse may be a highly sensitive organism with regard to water homeostasis , and is unable to survive with polyuria .
# ::alignments 25-26|0.0.0.0.0 23-24|0.0.0.0 19-20|0.1 17-18|0.1.0.0.0.0 16-17|0.1.0.0.0.0.0 14-15|0.1.0.0.0 12-13|0.1.0.0 11-12|0.1.0.0.1 10-11|0.1.0.0.1.0 7-8|0.1.0 6-7|0.1.0.0.2 3-4|0 2-3|0.0 1-2|0.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:29.148
(s3 / suggest-01 
      :ARG0 (m2 / model 
            :mod (t / this 
                  :ARG0-of (s / survive-01 
                        :ARG1 (p / polyuria)))) 
      :ARG1 (a / and 
            :op1 (p2 / possible-01 
                  :ARG1 (o / organism 
                        :ARG0-of (r / regard-01 
                              :ARG1 (h / homeostasi 
                                    :mod (w / water))) 
                        :ARG1-of (s2 / sensitive-03 
                              :degree (h2 / high)) 
                        :domain (m / mouse)))) 
      :mod (t2 / together))

# ::snt In a forward genetic screen , a mouse with an Aqp2 mutation was identified .
# ::tok In a forward genetic screen , a mouse with an Aqp2 mutation was identified .
# ::alignments 13-14|0 11-12|0.0.0 7-8|0.0 4-5|0.1 3-4|0.1.0 2-3|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:29.263
(i / identify-01 
      :ARG1 (m2 / mouse 
            :accompanier (m / mutation)) 
      :time (s / screen 
            :consist-of (g / gene) 
            :mod (f / forward)))

# ::snt The purpose of this study was to characterize this murine model of recessive nephrogenic DI .
# ::tok The purpose of this study was to characterize this murine model of recessive nephrogenic DI .
# ::alignments 12-13|0.0.1 10-11|0.0.0.0 9-10|0.0.0.0.1 8-9|0.0.0.0.0 7-8|0.0.0 4-5|0.0 3-4|0.0.2 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:29.305
(p / purpose 
      :mod (s / study-01 
            :ARG0-of (c / characterize-01 
                  :ARG1 (m / model 
                        :mod (t / this) 
                        :mod (m2 / murine))) 
            :ARG1 (r / recessive) 
            :mod (t2 / this)))

# ::snt We now report a novel F204V mutation in the Aqp2 gene .
# ::tok We now report a novel F204V mutation in the Aqp2 gene .
# ::alignments 10-11|0.1.0 6-7|0.1 5-6|0.1.2.0.0+0.1.2.0+0.1.2 4-5|0.1.1 2-3|0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:29.366
(r / report-01 
      :ARG0 (w / we) 
      :ARG1 (m / mutation 
            :location (g / gene) 
            :mod (n2 / novel) 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "F204V"))) 
      :time (n3 / now))

# ::snt This allele of Aqp2 was found to cause the first mouse model of NDI to survive past the first week of life .
# ::tok This allele of Aqp2 was found to cause the first mouse model of NDI to survive past the first week of life .
# ::alignments 21-22|0.3 19-20|0.1.0.0 16-17|0.1.0.1 15-16|0.1.0 11-12|0.1 10-11|0.1.1 7-8|0 5-6|0.2 3-4|0.2.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:29.535
(c / cause-01 
      :ARG0 (a2 / allele 
            :mod (t / this)) 
      :ARG1 (m / model 
            :ARG0-of (s / survive-01 
                  :ARG1 (w / week) 
                  :ARG2 (p / past)) 
            :mod (m2 / mouse)) 
      :ARG2-of (f / find-01 
            :ARG1 (a / Aqp2)) 
      :purpose (l / life))

# ::snt Molecular analyses concluded that mutant AQP2 adopts a different subcellular localization in renal collecting-duct cells , and was resistant to translocation induced by desmopressin , an agonist of AVP .
# ::tok Molecular analyses concluded that mutant AQP2 adopts a different subcellular localization in renal collecting-duct cells , and was resistant to translocation induced by desmopressin , an agonist of AVP .
# ::alignments 26-27|0.1.0.0.0 23-24|0.1.1.0.0.0 21-22|0.1.1.0.0 20-21|0.1.1.0 18-19|0.1.1 16-17|0.1 14-15|0.1.0.1.1 12-13|0.1.0.1.1.0 10-11|0.1.0.1 9-10|0.1.0.1.2 8-9|0.1.0.1.0 6-7|0.1.0 4-6|0.1.0.0.1.1+0.1.0.0.1.0+0.1.0.0.1+0.1.0.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:29.764
(c2 / conclude-01 
      :ARG0 (a5 / analysis 
            :mod (m2 / molecular)) 
      :ARG1 (a2 / and 
            :op1 (a3 / adopt-01 
                  :ARG0 (t2 / thing 
                        :mod-of (a / agonist) 
                        :name (n / name 
                              :op1 (m / mutant) 
                              :op2 (a4 / AQP2))) 
                  :ARG1 (l / localization 
                        :ARG1-of (d2 / differ-02) 
                        :location (c / cell 
                              :mod (r2 / renal)) 
                        :mod (s / subcellular))) 
            :op2 (r / resist-01 
                  :ARG1 (t / translocation 
                        :ARG1-of (i / induce-01 
                              :ARG0 (d / desmopressin))))))

# ::snt In vitro studies using the Madin-Darby canine kidney ( MDCK ) cell line demonstrated an endoplasmic reticulum pattern for the mutant protein , and apparent resistance to translocation .
# ::tok In vitro studies using the Madin-Darby canine kidney ( MDCK ) cell line demonstrated an endoplasmic reticulum pattern for the mutant protein , and apparent resistance to translocation .
# ::alignments 27-28|0.1.1.0.2 25-26|0.1.1.0 24-25|0.1.1.0.3 23-24|0.1.1 21-22|0.1.1.0.1 20-21|0.1.1.0.1.0 17-18|0.1 16-17|0.1.0 13-14|0 12-13|0.0 11-12|0.0.0 7-8|0.2.1 6-7|0.2.1.0 5-6|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 3-4|0.2 2-3|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:30.145
(d / demonstrate-01 
      :ARG0 (l / line 
            :mod (c / cell)) 
      :ARG1 (p2 / pattern 
            :mod (r2 / reticulum) 
            :op1-of (a2 / and 
                  :op2 (r / resist-01 
                        :ARG0 (t2 / thing 
                              :name (n / name 
                                    :op1 "Madin-Darby")) 
                        :ARG1 (p / protein 
                              :mod (m / mutant)) 
                        :ARG2 (t / translocation) 
                        :mod (a / apparent)))) 
      :manner (u / use-01 
            :ARG0 (s / study-01) 
            :ARG1 (k / kidney 
                  :mod (c2 / canine))))

# ::snt These data conclusively prove that autosomal recessive NDI is a consequence of improper AQP2 routing in the intact mammal .
# ::tok These data conclusively prove that autosomal recessive NDI is a consequence of improper AQP2 routing in the intact mammal .
# ::alignments 18-19|0.2.2 17-18|0.2.0.0 14-15|0.2 13-14|0.2.1 12-13|0.2.1.0 10-11|0.1 6-7|0.2.0 5-6|0.2.3 3-4|0 2-3|0.3 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:30.358
(p / prove-01 
      :ARG0 (d / data 
            :mod (t / this)) 
      :ARG1 (c / consequence) 
      :ARG2 (r / route-01 
            :ARG0 (r2 / recessive 
                  :part (i / intact)) 
            :ARG1 (a / AQP2 
                  :mod (i2 / improper)) 
            :ARG2 (m / mammal) 
            :op1-of (a2 / autosomal)) 
      :manner (c2 / conclusively))

# ::snt In a forward genetic screen that used ethylnitrosourea ( ENU ) to induce mutations in a founder animal whose offspring were then screened for abnormal whole body metabolism [ 19,20 ] , we found a family of mice that urinated and drank excessively .
# ::tok In a forward genetic screen that used ethylnitrosourea ( ENU ) to induce mutations in a founder animal whose offspring were then screened for abnormal whole body metabolism [ 19,20 ] , we found a family of mice that urinated and drank excessively .
# ::alignments 42-43|0.2.1.1.0.0.1.0.1 41-42|0.2.1.1.0.0.1.0.1.1 40-41|0.2.1.1.0.0.1 39-40|0.2.1.1.0.0.1.0 37-38|0.2.1.1.0.0.1.0.1.1.0 35-36|0.2.1.1.0.0.0 33-34|0.2.1.1.0.0 32-33|0.2.1.1.0 27-28|0.2.1.0.0.0 26-27|0.2.1.0.0 25-26|0.2.1.1.0.0.1.0.0 24-25|0.2.1.1.0.0.1.0.1.0 22-23|0 21-22|0.3 19-20|0.1 17-18|0.2 16-17|0.2.0 13-14|0.2.1.0 12-13|0.2.1 7-8|0.2.1.1.1 6-7|0.2.1.1 4-5|0.2.1.1.2 3-4|0.0 2-3|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:33.324
(s / screen-01 
      :ARG0 (g / gene) 
      :ARG1 (o / offspr) 
      :ARG2 (a3 / animal 
            :ARG1-of (f3 / found-01 
                  :ARG0 (f4 / forward)) 
            :ARG1-of (i / induce-01 
                  :ARG2 (m3 / mutate-01 
                        :ARG1 (b / body 
                              :mod-of (m2 / metabolism))) 
                  :ARG2-of (u2 / use-01 
                        :ARG0 (w / we 
                              :ARG0-of (f2 / find-01 
                                    :ARG1 (f / family) 
                                    :op1-of (a / and 
                                          :op2 (u / urinate-01 
                                                :ARG0 (w2 / whole) 
                                                :ARG1 (e / excessive-02 
                                                      :ARG1 (a2 / abnormal) 
                                                      :ARG1-of (d / drink-01 
                                                            :ARG0 (m / mouse))))))) 
                        :ARG1 (e2 / ethylnitrosourea) 
                        :ARG3 (s2 / screen)))) 
      :time (t / then))

# ::snt Serum and urine analysis showed that plasma glucose levels were normal and there was no glucose in the urine ( unpublished data ) .
# ::tok Serum and urine analysis showed that plasma glucose levels were normal and there was no glucose in the urine ( unpublished data ) .
# ::alignments 21-22|0.2.1 20-21|0.2.1.0 18-19|0.1.2.1 15-16|0.1.2.0 14-15|0.2.0 11-12|0.1.2 10-11|0.1 8-9|0.1.1 7-8|0.1.1.0 6-7|0.1.0 4-5|0 3-4|0.2 2-3|0.0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:34.500
(s / show-01 
      :ARG0 (a3 / and 
            :op1 (s2 / serum) 
            :op2 (u3 / urine)) 
      :ARG1 (n / normal-02 
            :ARG0 (p / plasma) 
            :ARG1 (l / level 
                  :mod (g2 / glucose)) 
            :op1-of (a / and 
                  :op2 (g / glucose) 
                  :op3 (u2 / urine))) 
      :ARG2 (a2 / analyze-01 
            :ARG0 - 
            :ARG1 (d / data 
                  :mod (u / unpublish))))

# ::snt Hence , this was an example of diabetes insipidus .
# ::tok Hence , this was an example of diabetes insipidus .
# ::alignments 8-9|0.0.1.0 7-8|0.0.1 5-6|0.0 2-3|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:34.519
(h / hence 
      :mod-of (e / example 
            :domain (t / this) 
            :mod (d / diabetes 
                  :mod (i / insipidu))))

# ::snt The disorder in these mice segregated in a monogenic , autosomal recessive manner , making Aqp2 a candidate gene .
# ::tok The disorder in these mice segregated in a monogenic , autosomal recessive manner , making Aqp2 a candidate gene .
# ::alignments 18-19|0.0 17-18|0.0.1 15-16|0 12-13|0.0.0.1 11-12|0.0.0.1.0 10-11|0.0.0.1.1 8-9|0.0.0.1.2 5-6|0.0.0 4-5|0.0.0.0.0 3-4|0.0.0.0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:34.659
(a / Aqp2 
      :domain-of (g / gene 
            :ARG1-of (s / segregate-01 
                  :ARG0 (d / disord 
                        :location (m3 / mouse 
                              :mod (t / this))) 
                  :ARG2 (m / manner 
                        :mod (r / recessive) 
                        :mod (a2 / autosomal) 
                        :mod (m2 / monogenic))) 
            :mod (c / candidate)))

# ::snt Sequencing of Aqp2 coding region of affected mice identified a thymine to guanine ( T to G ) transversion ( Figure 1A ) , which is predicted to lead to a valine for phenylalanine substitution at amino acid 204 of the protein ( F204V ) .
# ::tok Sequencing of Aqp2 coding region of affected mice identified a thymine to guanine ( T to G ) transversion ( Figure 1A ) , which is predicted to lead to a valine for phenylalanine substitution at amino acid 204 of the protein ( F204V ) .
# ::alignments 43-44|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 41-42|0 37-38|0.0.0.0.0.1.2.0.2 36-37|0.0.0.0.0.1.2.0.2.0 34-35|0.0.0.0.0.1.2.0 33-34|0.0.0.0.0.1.2.0.1 31-32|0.0.0.0.0.1.2 28-29|0.0.0.0.0.1 26-27|0.0.0.0.0.1.1 20-21|0.0.0.0.0.1.0 18-19|0.0.0.0.0.1.1.0 16-17|0.0.1.0.0.1+0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 14-15|0.0.0.0.0.1.2.0.0.1+0.0.0.0.0.1.2.0.0.0.0+0.0.0.0.0.1.2.0.0.0+0.0.0.0.0.1.2.0.0 12-13|0.0.1 10-11|0.0.1.0.1 8-9|0.0.1.0 7-8|0.0.0.0 6-7|0.0.0.0.0 4-5|0.0.0 3-4|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:35.615
(p / protein 
      :ARG0-of (c / code-01 
            :ARG1 (r / region 
                  :mod (m / mouse 
                        :ARG1-of (a4 / affect-01 
                              :ARG0 (t / thing 
                                    :name (n / name 
                                          :op1 "F204V")) 
                              :ARG1-of (l / lead-03 
                                    :ARG0 (f / figure) 
                                    :ARG1-of (p3 / predict-01 
                                          :ARG0 (t2 / transversion)) 
                                    :ARG2 (v / valine 
                                          :purpose (s / substitute-01 
                                                :ARG0 (a3 / aircraft-type 
                                                      :name (n3 / name 
                                                            :op1 "T50") 
                                                      :wiki "Sukhoi_PAK_FA") 
                                                :ARG1 (p2 / phenylalanine) 
                                                :ARG2 (a / acid 
                                                      :mod (a2 / amino)))))))) 
            :ARG2 (g / guanine 
                  :ARG2-of (i / identify-01 
                        :ARG0 (o / organization 
                              :name (n2 / name 
                                    :op1 "G-8") 
                              :wiki "G8") 
                        :ARG1 (t3 / thymine)))))

# ::snt AQP2 is a six-transmembrane water channel , and F204 lies near the extracellular face of the sixth membrane spanning domain , a region rich in hydrophobic amino acids .
# ::tok AQP2 is a six-transmembrane water channel , and F204 lies near the extracellular face of the sixth membrane spanning domain , a region rich in hydrophobic amino acids .
# ::alignments 27-28|0.1.1.0.1.0.0 26-27|0.1.1.0.1.0.0.0 25-26|0.1.1.0.1.0.0.1 23-24|0.1.1.0.1.0.0.2 22-23|0.1.1.0.1.0.0.2.0 19-20|0.1.1.0.1 18-19|0.1.1.0.1.0 17-18|0.1.1.0.1.2 16-17|0.1.1.0.1.1 13-14|0.1.1.0 12-13|0.1.1.0.0 10-11|0.1.1 9-10|0.1 8-9|0.1.0.0.0+0.1.0.0+0.1.0 7-8|0 5-6|0.0 4-5|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:36.175
(a3 / and 
      :op1 (c / channel 
            :mod (w / water)) 
      :op2 (l / lie-07 
            :ARG1 (t / thing 
                  :name (n2 / name 
                        :op1 "F204")) 
            :ARG1-of (n / near-02 
                  :ARG2 (f / face 
                        :mod (e / extracellular) 
                        :part-of (d / domain 
                              :ARG1-of (s / span-01 
                                    :ARG0 (a / acid 
                                          :mod (a2 / amino) 
                                          :mod (h / hydrophobic) 
                                          :mod-of (r / rich 
                                                :mod-of (r2 / region)))) 
                              :mod (s2 / sixth) 
                              :mod (m / membrane))))))

# ::snt This and the other membrane-spanning domains are conserved among vertebrate species .
# ::tok This and the other membrane-spanning domains are conserved among vertebrate species .
# ::alignments 10-11|0.1.0.0 9-10|0.1.0.0.0 7-8|0.1.0 5-6|0.1 4-5|0.1.1 3-4|0.1.2 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:36.238
(a / and 
      :op1 (t / this) 
      :op2 (d / domain 
            :ARG1-of (c / conserve-01 
                  :ARG0 (s / species 
                        :mod (v / vertebrate))) 
            :mod (m / membrane-spann) 
            :mod (o / other)))

# ::snt The phenylalanine at position 204 is particularly well conserved ( Figure 1B ) , not only among vertebrate AQP2 proteins , but also among others members of this family .
# ::tok The phenylalanine at position 204 is particularly well conserved ( Figure 1B ) , not only among vertebrate AQP2 proteins , but also among others members of this family .
# ::alignments 28-29|0.3.0.0.0 27-28|0.3.0.0.0.0 25-26|0.3.0.0.1+0.3.0.0+0.3.0 24-25|0.3.0.1 22-23|0.2 21-22|0 19-20|0.0.0 17-18|0.0 15-16|0.1 14-15|0.1.0 10-11|0.3.0.2.0.0 8-9|0.3.0.2.0 6-7|0.3.0.2 3-4|0.3 1-2|0.3.0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:37.100
(c / contrast-01 
      :ARG0 (v / vertebrate 
            :mod-of (p2 / protein)) 
      :ARG1 (o2 / only 
            :polarity -) 
      :ARG2 (a / also) 
      :op1-of (p4 / position 
            :poss (p / person 
                  :ARG0-of (h / have-org-role-91 
                        :ARG1 (f / family 
                              :mod (t / this)) 
                        :ARG2 (m / member)) 
                  :mod (o / other) 
                  :mod (p3 / particular 
                        :mod-of (c2 / conserve-01 
                              :ARG0 (f2 / figure) 
                              :ARG1 (p5 / phenylalanine))))))

# ::snt Aqp2F204V/F204V mice have dramatically increased urine production , in some cases producing an amount of urine in 24 h that exceeds their body weight , compared to their heterozygous or wild-type littermates .
# ::tok Aqp2F204V/F204V mice have dramatically increased urine production , in some cases producing an amount of urine in 24 h that exceeds their body weight , compared to their heterozygous or wild-type littermates .
# ::alignments 31-32|0.2.0.1 29-30|0.2.0 28-29|0.2.0.0 25-26|0.2 23-24|0.4.1.0.1 22-23|0.4.1.0.1.0 20-21|0.4.1.0 18-19|0.4.1.0.0 17-18|0.4.1.0.0.0 15-16|0.4.0.0 13-14|0.4.1 11-12|0.4.0 10-11|0.4 9-10|0.4.2 6-7|0.1 5-6|0.1.0 4-5|0 3-4|0.3 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:37.972
(i / increase-01 
      :ARG0 (m / mouse) 
      :ARG1 (p2 / produce-01 
            :ARG1 (u2 / urine)) 
      :ARG1-of (c / compare-01 
            :ARG2 (o / or 
                  :op1 (h / heterozygou) 
                  :op2 (l / littermat))) 
      :manner (d / dramatic) 
      :time (c2 / case-03 
            :ARG0-of (p / produce-01 
                  :ARG1 (u / urine)) 
            :ARG1 (a / amount 
                  :ARG1-of (e / exceed-01 
                        :ARG0 (h2 / h 
                              :quant 24) 
                        :ARG2 (w / weight 
                              :part-of (b / body)))) 
            :mod (s / some)))

# ::snt Such loss of water would rapidly lead to dehydration were it not compensated by increased water intake .
# ::tok Such loss of water would rapidly lead to dehydration were it not compensated by increased water intake .
# ::alignments 16-17|0.0 15-16|0.0.1 14-15|0 12-13|0.0.0 11-12|0.0.0.1 8-9|0.0.0.0 6-7|0.0.0.0.1 5-6|0.0.0.0.1.1 3-4|0.0.0.0.0 1-2|0.0.0.0.1.0 0-1|0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:38.043
(i / increase-01 
      :ARG1 (t / take-01 
            :ARG0-of (c / compensate-01 
                  :condition-of (d / dehydrate-01 
                        :ARG1 (w2 / water) 
                        :ARG2-of (l / lead-03 
                              :ARG0 (l2 / loss 
                                    :mod (s / such)) 
                              :manner (r / rapid))) 
                  :polarity -) 
            :ARG1 (w / water)))

# ::snt Indeed , mutant mice also dramatically increase their water intake ( Figure 1C ) compared to their heterozygous or wild-type littermates .
# ::tok Indeed , mutant mice also dramatically increase their water intake ( Figure 1C ) compared to their heterozygous or wild-type littermates .
# ::alignments 20-21|0.1.0.1.1 18-19|0.1.0.1 17-18|0.1.0.1.0 14-15|0.1.0 11-12|0.1.0.0 9-10|0.1 8-9|0.1.1 6-7|0 5-6|0.2 4-5|0.3 3-4|0.0 2-3|0.0.0 0-1|0.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:38.340
(i / increase-01 
      :ARG0 (m / mouse 
            :mod (m2 / mutant)) 
      :ARG1 (t / take-01 
            :ARG0 (c / compare-01 
                  :ARG1 (f / figure) 
                  :ARG2 (o / or 
                        :op1 (h / heterozygou) 
                        :op2 (l / littermat))) 
            :ARG1 (w / water)) 
      :manner (d / dramatic) 
      :mod (a / also) 
      :mod (i2 / indeed))

# ::snt This phenotype -- increased urinary output and water intake -- showed complete concordance with homozygosity of the F204V mutation in the 58 animals tested .
# ::tok This phenotype -- increased urinary output and water intake -- showed complete concordance with homozygosity of the F204V mutation in the 58 animals tested .
# ::alignments 23-24|0.2.3 22-23|0.2.3.1 21-22|0.2.1.0 18-19|0.2.3.0.0 17-18|0.2.3.0.0.0.0.0+0.2.3.0.0.0.0+0.2.3.0.0.0 14-15|0.2.3.0 12-13|0.1 11-12|0.1.0 10-11|0 8-9|0.2.2 7-8|0.2.2.0 6-7|0.2 5-6|0.2.1.1 4-5|0.2.0 3-4|0.2.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:38.590
(s / show-01 
      :ARG0 (p / phenotype 
            :mod (t4 / this)) 
      :ARG1 (c / concordance 
            :ARG1-of (c2 / complete-02)) 
      :op3-of (a2 / and 
            :mod (u / urinary) 
            :op1 (i / increase-01 
                  :ARG0 58 
                  :ARG1 (o / output)) 
            :op2 (t3 / take-01 
                  :ARG1 (w / water)) 
            :op4 (t / test-01 
                  :ARG0 (h / homozygosity 
                        :poss (m / mutation 
                              :mod (t2 / thing 
                                    :name (n / name 
                                          :op1 "F204V")))) 
                  :ARG1 (a / animal))))

# ::snt Diabetes insipidus can be defined as an inability to concentrate urine where appropriate .
# ::tok Diabetes insipidus can be defined as an inability to concentrate urine where appropriate .
# ::alignments 12-13|0.0.0.0.1 10-11|0.0.0.0.0 9-10|0.0.0.0 7-8|0.0.0.0.2.0+0.0.0.0.2 4-5|0.0 2-3|0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:38.667
(p / possible-01 
      :ARG1 (d / define-01 
            :ARG1 (i / insipidu 
                  :ARG0-of (c / concentrate-01 
                        :ARG1 (u / urine) 
                        :ARG1-of (a / appropriate-02) 
                        :domain-of (a2 / ability 
                              :polarity -)) 
                  :mod (d2 / diabet))))

# ::snt Compared to wild-type or heterozygous littermates , Aqp2F204V/F204V mice produce very dilute urine ( Figure 1D ) .
# ::tok Compared to wild-type or heterozygous littermates , Aqp2F204V/F204V mice produce very dilute urine ( Figure 1D ) .
# ::alignments 14-15|0.2.1.0.0 12-13|0.2.1 11-12|0.2.1.0 10-11|0.2.1.0.1 9-10|0.2 8-9|0.2.0 5-6|0.1 4-5|0.0 3-4|0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:38.788
(o / or 
      :op1 (h / heterozygou) 
      :op2 (l / littermat 
            :ARG1-of (c / compare-01)) 
      :op3 (p / produce-01 
            :ARG0 (m / mouse) 
            :ARG1 (u / urine 
                  :ARG1-of (d / dilute-01 
                        :ARG0 (f / figure) 
                        :degree (v / very)))))

# ::snt Basal urine concentration in mutant mice is about 161 mOsm , compared to about 1,293 mOsm in wild-type mice ( p < 0.001 ) .
# ::tok Basal urine concentration in mutant mice is about 161 mOsm , compared to about 1,293 mOsm in wild-type mice ( p < 0.001 ) .
# ::alignments 20-21|0.0.0.1 18-19|0 11-12|0.0 9-10|0.0.0.2 7-8|0.0.0.2.0 5-6|0.0.0.4 4-5|0.0.0.4.0 2-3|0.0.0 1-2|0.0.0.0 0-1|0.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:38.939
(m / mouse 
      :ARG0-of (c / compare-01 
            :ARG1 (c2 / concentrate-02 
                  :ARG1 (u / urine) 
                  :ARG2 (p / p) 
                  :domain-of (m2 / mOsm 
                        :quant (a / about)) 
                  :mod (b / basal) 
                  :prep-in (m3 / mouse 
                        :mod (m4 / mutant)))))

# ::snt Normally , urine concentration is under the control of the hypothalamus , which , in response to hypovolemia or hypernatremia [ 21 ] , secretes AVP .
# ::tok Normally , urine concentration is under the control of the hypothalamus , which , in response to hypovolemia or hypernatremia [ 21 ] , secretes AVP .
# ::alignments 24-25|0.0.0.0 21-22|0.0.0.0.0.0.1.0 19-20|0.1 18-19|0 17-18|0.0 15-16|0.0.0 10-11|0.0.0.0.0 7-8|0.0.0.0.0.0 3-4|0.0.0.0.0.0.0 2-3|0.0.0.0.0.0.0.0 0-1|0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:39.068
(o / or 
      :op1 (h2 / hypovolemia 
            :ARG1-of (r / respond-01 
                  :ARG2 (s / secrete-01 
                        :ARG1 (h3 / hypothalamu 
                              :ARG1-of (c / control-01 
                                    :ARG0 (c2 / concentrate-02 
                                          :ARG1 (u / urine)) 
                                    :ARG1-of (n / normal-02 
                                          :ARG0 21)))))) 
      :op2 (h / hypernatremia))

# ::snt The synthetic AVP analog , 1-deamino-8-D-arginine vasopressin ( dDAVP ; also called desmopressin ) , is a potent agonist of AVPR2 .
# ::tok The synthetic AVP analog , 1-deamino-8-D-arginine vasopressin ( dDAVP ; also called desmopressin ) , is a potent agonist of AVPR2 .
# ::alignments 18-19|0.1.0.1 17-18|0.1.0.1.1 12-13|0.1 11-12|0.1.0 10-11|0.1.0.2 9-10|0 8-9|0.0 6-7|0.1.0.0 3-4|0.1.0.1.0 1-2|0.1.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:39.208
(a3 / and 
      :op1 (d2 / dDAVP) 
      :op2 (d / desmopressin 
            :ARG1-of (c / call-01 
                  :ARG0 (v / vasopressin) 
                  :ARG2 (a / agonist 
                        :domain (a4 / analog) 
                        :mod (p / potent)) 
                  :manner (a2 / also) 
                  :op1-of (s / synthetic))))

# ::snt When administered to wild-type mice , dDAVP leads to a dramatic increase in urine concentration , from 1,293 to 5,885 mOsm ( 4.6-fold ; Figure 1D ) .
# ::tok When administered to wild-type mice , dDAVP leads to a dramatic increase in urine concentration , from 1,293 to 5,885 mOsm ( 4.6-fold ; Figure 1D ) .
# ::alignments 24-25|0.1 23-24|0 20-21|0.0.1.0 14-15|0.0.2.0 13-14|0.0.2 11-12|0.0.2.0.0 10-11|0.0.2.0.0.0 7-8|0.0 6-7|0.0.0 4-5|0.0.1.1 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:39.356
(a / and 
      :ARG2-of (l / lead-03 
            :ARG0 (d2 / dDAVP) 
            :ARG1 (a2 / administer-01 
                  :ARG0 (m / mOsm) 
                  :ARG2 (m2 / mouse)) 
            :manner (u / urine 
                  :ARG1-of (c / concentrate-02 
                        :ARG1-of (i / increase-01 
                              :manner (d / dramatic))))) 
      :op1 (f / figure))

# ::snt With similar treatment , mutant mice concentrate their urine to a lesser but still significant extent , from 161 to 470 mOsm ( 2.9-fold ) , indicating that these animals are not only unable to concentrate their urine properly but are also defective in their response to dDAVP .
# ::tok With similar treatment , mutant mice concentrate their urine to a lesser but still significant extent , from 161 to 470 mOsm ( 2.9-fold ) , indicating that these animals are not only unable to concentrate their urine properly but are also defective in their response to dDAVP .
# ::alignments 47-48|0.0.0.0.0.0.1.0.0.0.0 45-46|0.0.0.0.0.0.1.0.0.0 42-43|0.0.0.0.0.0.1.0.0 41-42|0.0.0.0.0.0.1.0.0.2 39-40|0.0.0.0.0.0.1.0 38-39|0.0.0.0.0.0.1.0.0.1.0.1 37-38|0.0.0.0.0.0.1.0.0.1.0.0 35-36|0.0.0.0.0.0.1.0.0.1.0 32-33|0.2.0 31-32|0.0.0.0.0.0.0 29-30|0.0.0.0.0.0.1.0.0.1 28-29|0.0.0.0.0.0.1.0.0.1.1 26-27|0.0.0.0.0 21-22|0.0.0.2 15-16|0.0 14-15|0.2 13-14|0.2.1 12-13|0 11-12|0.1 8-9|0.0.0.1 6-7|0.0.0 5-6|0.0.0.0 4-5|0.0.0.0.1 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:40.089
(c3 / contrast-01 
      :ARG1 (e / extent 
            :degree-of (c4 / concentrate-01 
                  :ARG0 (m2 / mouse 
                        :ARG0-of (i / indicate-01 
                              :ARG1-of (t2 / treat-03 
                                    :ARG0 - 
                                    :ARG1-of (r2 / resemble-01 
                                          :ARG1-of (c / contrast-01 
                                                :ARG2 (d2 / defective 
                                                      :compared-to (r / respond-01 
                                                            :ARG1 (d / dDAVP)) 
                                                      :domain (a2 / animal 
                                                            :ARG0-of (c2 / concentrate-01 
                                                                  :ARG1 (u / urine) 
                                                                  :manner (p / proper)) 
                                                            :mod (t / this)) 
                                                      :mod (a / also)))))) 
                        :mod (m3 / mutant)) 
                  :ARG1 (u2 / urine) 
                  :ARG2 (m / mOsm))) 
      :ARG2 (l / less) 
      :op1 (s / significant-02 
            :ARG0 (o / only) 
            :mod (s2 / still)))

# ::snt The smaller response to dDAVP indicates some residual activity of the mutant AQP2 channel , which must be sufficient to allow survival of the individual , in contrast to the T126M knock-in mouse [ 18 ] .
# ::tok The smaller response to dDAVP indicates some residual activity of the mutant AQP2 channel , which must be sufficient to allow survival of the individual , in contrast to the T126M knock-in mouse [ 18 ] .
# ::alignments 34-35|0.1.1.0.0.1 32-33|0.1.0 30-31|0.1.1.0.1.0.0.0+0.1.1.0.1.0.0+0.1.1.0.1.0 27-28|0.1.1.0.0.0.0 24-25|0.1.1.0.0.0 21-22|0.1.1.0.0 20-21|0.1.1.0 18-19|0.1.1.0.1 13-14|0.1.1 12-13|0.1.1.1 11-12|0.1.1.0.0.0.0.0 8-9|0.1 7-8|0.1.3 6-7|0.1.2 5-6|0 4-5|0.0.0 2-3|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:40.532
(i2 / indicate-01 
      :ARG0 (r2 / respond-01 
            :ARG1 (d / dDAVP) 
            :ARG2 (s4 / small)) 
      :ARG1 (a3 / activity-06 
            :ARG0 (m / mouse) 
            :ARG1 (c2 / channel 
                  :ARG0-of (a / allow-01 
                        :ARG1 (s / survive-01 
                              :ARG0 (i / individual 
                                    :ARG1-of (c / contrast-01 
                                          :ARG0 (m2 / mutant))) 
                              :ARG1 18) 
                        :ARG1-of (s2 / suffice-01 
                              :ARG0 (t / thing 
                                    :name (n / name 
                                          :op1 "T126M")))) 
                  :mod (a2 / AQP2)) 
            :mod (s3 / some) 
            :mod (r / residual)))

# ::snt Multiple heterozygous matings yielded 101 animals , which appeared at a ratio of 26:49:26 , near the expected Mendelian wild type , heterozygote , and mutant frequencies , respectively , indicating that there is no reduced viability associated with this mutation .
# ::tok Multiple heterozygous matings yielded 101 animals , which appeared at a ratio of 26:49:26 , near the expected Mendelian wild type , heterozygote , and mutant frequencies , respectively , indicating that there is no reduced viability associated with this mutation .
# ::alignments 40-41|0 39-40|0.1 37-38|0.0 36-37|0.0.0 35-36|0.0.0.1 34-35|0.0.0.0.2 30-31|0.0.0.0 28-29|0.0.0.0.1 26-27|0.0.0.0.0.0.0.0.0.1.2 25-26|0.0.0.0.0.0.0.0.0.1.2.0 24-25|0.0.0.0.0.0.0.0.0.1 22-23|0.0.0.0.0.0.0.0.0.1.1 20-21|0.0.0.0.0.0.0.0.0.1.0 19-20|0.0.0.0.0.0.0.0.0.1.0.1 18-19|0.0.0.0.0.0.0.0.0.1.0.2.0.0+0.0.0.0.0.0.0.0.0.1.0.2.0+0.0.0.0.0.0.0.0.0.1.0.2 17-18|0.0.0.0.0.0.0.0.0.1.0.0 15-16|0.0.0.0.0.0.0.0.0 11-12|0.0.0.0.0.0.0.0.1 8-9|0.0.0.0.0.0.0.0 5-6|0.0.0.0.0.0.0 4-5|0.0.0.1.0 3-4|0.0.0.0.0.0 2-3|0.0.0.0.0 1-2|0.0.0.0.0.1 0-1|0.0.0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:41.669
(m / mutation 
      :ARG2-of (a / associate-01 
            :ARG1 (v / viability 
                  :ARG1-of (i / indicate-01 
                        :ARG0 (m3 / mating 
                              :ARG0-of (y / yield-01 
                                    :ARG1 (a4 / animal 
                                          :ARG1-of (a3 / appear-01 
                                                :ARG1-of (n2 / near-02 
                                                      :ARG0 (m4 / multiple) 
                                                      :ARG2 (a2 / and 
                                                            :op1 (t2 / type 
                                                                  :ARG1-of (e / expect-01) 
                                                                  :mod (w / wild) 
                                                                  :mod (t3 / thing 
                                                                        :name (n / name 
                                                                              :op1 "Mendelian"))) 
                                                            :op2 (h / heterozygote) 
                                                            :op3 (f / frequenci 
                                                                  :mod (m2 / mutant)))) 
                                                :location (r3 / ratio)))) 
                              :mod (h2 / heterozygou)) 
                        :manner (r2 / respective) 
                        :polarity -) 
                  :ARG1-of (r / reduce-01 
                        :ARG0 101))) 
      :mod (t / this))

# ::snt Other than the increased urine production and water intake , there was no overt phenotype in mutant mice , save distended kidneys , which appeared variably in adult animals ( Figure 2A ) .
# ::tok Other than the increased urine production and water intake , there was no overt phenotype in mutant mice , save distended kidneys , which appeared variably in adult animals ( Figure 2A ) .
# ::alignments 30-31|0.1.0 28-29|0.0.1.0.0.1.1 27-28|0.0.1.0.0.1.1.0 25-26|0.0.1.0.0.1.0 24-25|0.0.1.0.0.1 21-22|0.0.1.0.0 20-21|0.0.1.0.0.0 19-20|0.0.1.0 17-18|0.0.0 16-17|0.0.0.0 14-15|0.0.0.1 13-14|0.0.1.0.0.0.0 12-13|0.0.1.2 8-9|0.1 7-8|0.1.1 6-7|0 5-6|0.0.1 4-5|0.0.1.1 3-4|0.0 0-1|0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:42.250
(a4 / and 
      :op1 (i / increase-01 
            :ARG0 (m / mouse 
                  :mod (m2 / mutant) 
                  :mod-of (p / phenotype)) 
            :ARG1 (p2 / produce-01 
                  :ARG0-of (s / save-02 
                        :ARG1 (k / kidney 
                              :ARG1-of (d / distend-01 
                                    :ARG2 (o / overt)) 
                              :ARG1-of (a3 / appear-01 
                                    :manner (v / variably) 
                                    :medium (a / animal 
                                          :mod (a2 / adult))))) 
                  :ARG1 (u / urine 
                        :compared-to-of (o2 / other)) 
                  :ARG2 -)) 
      :op2 (t / take-01 
            :ARG0 (f / figure) 
            :ARG1 (w / water)))

# ::snt Although not specifically measured , mutant mice seem to have a normal lifespan .
# ::tok Although not specifically measured , mutant mice seem to have a normal lifespan .
# ::alignments 12-13|0.0 11-12|0.0.0 7-8|0 6-7|0.1.0 5-6|0.1.0.0 3-4|0.1 2-3|0.1.1 1-2|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:42.393
(s / seem-01 
      :ARG1 (l / lifespan 
            :ARG1-of (n / normal-02)) 
      :purpose (m3 / measure-01 
            :ARG1 (m / mouse 
                  :mod (m2 / mutant)) 
            :manner (s2 / specific-02 
                  :polarity -)))

# ::snt The one animal that was followed lived to 18 mo , typical for animals in our colony .
# ::tok The one animal that was followed lived to 18 mo , typical for animals in our colony .
# ::alignments 16-17|0.1 15-16|0.1.0 13-14|0 11-12|0.0 9-10|0.0.0 8-9|0.0.0.0.0 6-7|0.0.0.0.1.0 5-6|0.0.0.0 2-3|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:42.565
(a / animal 
      :ARG2-of (t / typical-02 
            :ARG1 (m / mo 
                  :ARG2-of (f / follow-01 
                        :ARG0 18 
                        :ARG1 (a2 / animal 
                              :ARG0-of (l / live-01))))) 
      :location (c / colony 
            :poss (w / we)))

# ::snt Aqp2F204V/F204V mice suffer from severe hydronephrosis ( Figure 2A and 2B ) , presumably as a consequence of an inability to cope with the extreme polyuria .
# ::tok Aqp2F204V/F204V mice suffer from severe hydronephrosis ( Figure 2A and 2B ) , presumably as a consequence of an inability to cope with the extreme polyuria .
# ::alignments 25-26|0.0.0 24-25|0.0.0.0 21-22|0.0 19-20|0.0.1.0+0.0.1 16-17|0.0.2.2 13-14|0.0.2 9-10|0 7-8|0.0.2.0 5-6|0.0.2.1.1 4-5|0.0.2.1.1.0 2-3|0.0.2.1 1-2|0.0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:42.851
(a2 / and 
      :ARG0-of (c / cope-01 
            :ARG1 (p / polyuria 
                  :mod (e / extreme)) 
            :domain-of (a / ability 
                  :polarity -) 
            :purpose-of (p2 / presume-01 
                  :ARG0 (f / figure) 
                  :ARG1 (s2 / suffer-01 
                        :ARG0 (m / mouse) 
                        :ARG1 (h / hydronephrosi 
                              :mod (s / severe))) 
                  :ARG2 (c2 / consequence))))

# ::snt We found distended kidneys in all Aqp2F204V/F204V mice ; however , the degree of inflation was variable in affected mice and worsened with age .
# ::tok We found distended kidneys in all Aqp2F204V/F204V mice ; however , the degree of inflation was variable in affected mice and worsened with age .
# ::alignments 23-24|0 21-22|0.1 20-21|0.1.2 19-20|0.2.0 18-19|0.2 16-17|0.1.1 14-15|0.0 12-13|0.0.0 8-9|0.0.0.0 7-8|0.1.0 5-6|0.1.0.0 3-4|0.1.2.0.1 2-3|0.1.2.0.1.0 1-2|0.1.2.0 0-1|0.1.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:43.856
(a / age-01 
      :ARG0 (i / inflation 
            :mod-of (d / degree 
                  :op1-of (a4 / and))) 
      :ARG2-of (w / worsen-01 
            :ARG0 (m2 / mouse 
                  :quant (a5 / all)) 
            :ARG1 (v / variable) 
            :op1-of (a2 / and 
                  :condition-of (f / find-01 
                        :ARG0 (w2 / we) 
                        :ARG1 (k / kidney 
                              :ARG1-of (d2 / distend-01))))) 
      :manner (a3 / affect-01 
            :ARG1 (m / mouse)))

# ::snt Severe hydronephrosis has previously been observed in double Aqp1/Aqp3 knock-out mice [ 17 ] , and appears at 6 wk .
# ::tok Severe hydronephrosis has previously been observed in double Aqp1/Aqp3 knock-out mice [ 17 ] , and appears at 6 wk .
# ::alignments 18-19|0.0.1.1 16-17|0.1 15-16|0 12-13|0.0.0 10-11|0.0.2 7-8|0.0.2.0 5-6|0.0 3-4|0.0.3 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:43.939
(a2 / and 
      :op1 (o / observe-01 
            :ARG0 17 
            :ARG1 (h / hydronephrosi 
                  :mod (s / severe) 
                  :poss-of 6) 
            :location (m / mouse 
                  :mod (d / double)) 
            :time (p / previous)) 
      :op2 (a / appear-02))

# ::snt Even at 4 wk , Aqp2F204V/F204V mice had hydronephrosis .
# ::tok Even at 4 wk , Aqp2F204V/F204V mice had hydronephrosis .
# ::alignments 8-9|0.0 6-7|0 2-3|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:43.955
(m / mouse 
      :location (h / hydronephrosi 
            :mod (e / even) 
            :op1-of 4))

# ::snt Histologic sections from Aqp2F204V/F204V mice demonstrated marked dilatation of the renal pelvis yet normal morphology of the ureter ( Figure 2C and 2D ) .
# ::tok Histologic sections from Aqp2F204V/F204V mice demonstrated marked dilatation of the renal pelvis yet normal morphology of the ureter ( Figure 2C and 2D ) .
# ::alignments 22-23|0.0.2 21-22|0 19-20|0.0.1.0.0.2.0 17-18|0.0.1.0.0.2.1.1 14-15|0.0.1.0.0.2.1 13-14|0.0.1.0.0.2 12-13|0.0.1.0.0 11-12|0.0.1.0.0.1 10-11|0.0.1.0.0.2.1.0 7-8|0.0.1 6-7|0.0.1.0 5-6|0.0 4-5|0.0.1.0.0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:44.341
(a / and 
      :op1 (d2 / demonstrate-01 
            :ARG0 (s / section 
                  :mod (h / histologic)) 
            :ARG1 (d / dilatation 
                  :ARG1-of (m2 / mark-01 
                        :ARG2 (y / yet 
                              :domain (m3 / mouse) 
                              :op1 (p / pelvi) 
                              :op2 (n / normal-02 
                                    :ARG0 (f / figure) 
                                    :ARG1 (m / morphology 
                                          :mod (r / renal) 
                                          :poss (u / uret)))))) 
            :ARG2 2d))

# ::snt In particular , the muscularis propria was neither hypertrophied nor thinned .
# ::tok In particular , the muscularis propria was neither hypertrophied nor thinned .
# ::alignments 10-11|0.0 4-5|0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:44.359
(m / musculari 
      :ARG0-of (t / thin-01 
            :ARG1 (p / particular)))

# ::snt There was the normal festooned appearance of the urothelium , and this transitional epithelium was of normal thickness .
# ::tok There was the normal festooned appearance of the urothelium , and this transitional epithelium was of normal thickness .
# ::alignments 17-18|0.0.3.0 16-17|0.0.3 13-14|0.0.3.1.0 12-13|0.0.3.1 11-12|0.0.3.1.0.0 10-11|0 8-9|0.0.0 5-6|0.0 4-5|0.0.2 3-4|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:44.538
(a / and 
      :op1 (a2 / appear-01 
            :ARG1 (u / urothelium) 
            :ARG1-of (n2 / normal-02) 
            :ARG1-of (f / festoon-01) 
            :purpose-of (n / normal-02 
                  :ARG1 (t / thickness) 
                  :topic-of (t2 / transitional 
                        :mod-of (e / epithelium 
                              :mod (t3 / this))))))

# ::snt There was thinning of the kidney as measured from renal capsule to renal pelvis .
# ::tok There was thinning of the kidney as measured from renal capsule to renal pelvis .
# ::alignments 13-14|0.0 12-13|0 10-11|0.0.0.0 9-10|0.0.0.0.0 7-8|0.0.0 5-6|0.0.0.1.0 2-3|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:44.570
(r / renal 
      :mod-of (p / pelvi 
            :ARG3-of (m / measure-01 
                  :ARG1 (c / capsule 
                        :mod (r2 / renal)) 
                  :manner-of (t / thin-01 
                        :ARG1 (k / kidney)))))

# ::snt However , the morphologic features of the glomeruli and proximal/distal tubules were unremarkable ( Figure 2D ) .
# ::tok However , the morphologic features of the glomeruli and proximal/distal tubules were unremarkable ( Figure 2D ) .
# ::alignments 15-16|0.0.0 14-15|0.0.1.1 12-13|0 10-11|0.0.2 8-9|0.0.1 7-8|0.0.1.0 4-5|0.0 3-4|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:44.620
(u / unremarkable 
      :domain (f2 / feature-01 
            :ARG0 2d 
            :ARG1 (a / and 
                  :op1 (g / glomerulus) 
                  :op2 (f / figure)) 
            :ARG2 (t / tubul) 
            :mod (m / morphologic)))

# ::snt As shown previously [ 18,22 ] , immunoblotting revealed three different forms of AQP2 , due to different degrees and forms of glycosylation ( Figure 3A ) .
# ::tok As shown previously [ 18,22 ] , immunoblotting revealed three different forms of AQP2 , due to different degrees and forms of glycosylation ( Figure 3A ) .
# ::alignments 24-25|0.2.0 22-23|0.2.1.1.0 20-21|0.2.1.1.0.0 19-20|0.2.1 18-19|0.2.1.1 17-18|0.2.1.0 13-14|0.1.1 11-12|0.1 10-11|0.1.0 9-10|0.1.2 8-9|0 7-8|0.0 2-3|0.2.2 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:44.806
(r / reveal-01 
      :ARG0 (i / immunoblott) 
      :ARG1 (f3 / form 
            :ARG1-of (d3 / differ-02) 
            :mod (a2 / AQP2) 
            :quant 3) 
      :condition (s / show-01 
            :ARG0 (f / figure) 
            :ARG1 (a / and 
                  :ARG1-of (d2 / differ-02) 
                  :op1 (d / degree 
                        :op1 (g / glycosylation 
                              :mod-of (f2 / form)))) 
            :time (p / previous)))

# ::snt Previous reports have demonstrated that nonglycosylated protein appears as a 29 kDa band , while complex glycosylated protein runs as a smear between 35 and 45 kDa .
# ::tok Previous reports have demonstrated that nonglycosylated protein appears as a 29 kDa band , while complex glycosylated protein runs as a smear between 35 and 45 kDa .
# ::alignments 25-26|0.0.0.0.1.1 24-25|0 23-24|0.0.0.0.1.0.0 21-22|0.0.1 18-19|0.0 17-18|0.0.0 16-17|0.0.0.1 15-16|0.0.0.2 12-13|0.0.0.0.2 11-12|0.0.0.0.1.0.2 10-11|0.0.0.0.2.0 7-8|0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0.0.0 3-4|0.0.0.0.1 1-2|0.0.0.0.1.0 0-1|0.0.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:45.314
(a / and 
      :op1 (r / run-02 
            :ARG0 (p / protein 
                  :ARG0-of (a2 / appear-02 
                        :ARG1 (p2 / protein 
                              :mod (n / nonglycosylat)) 
                        :ARG1-of (d / demonstrate-01 
                              :ARG0 (r2 / report-01 
                                    :ARG0 35 
                                    :manner (p3 / previou) 
                                    :op1-of (k / kDa)) 
                              :ARG2 45) 
                        :prep-as (b / band 
                              :quant 29)) 
                  :mod (g / glycosylat) 
                  :mod (c / complex)) 
            :ARG1 (s / smear)))

# ::snt A short-lived intermediate form of 31 kDa representing core , high-mannose glycosylation of AQP2 is apparent from pulse-chase labeling experiments [ 22 ] .
# ::tok A short-lived intermediate form of 31 kDa representing core , high-mannose glycosylation of AQP2 is apparent from pulse-chase labeling experiments [ 22 ] .
# ::alignments 21-22|0.0.0.1.0.0.0.0 19-20|0.0.0 18-19|0.0 15-16|0.0.0.1 11-12|0 8-9|0.0.0.0 7-8|0.0.0.1.0.0.0 6-7|0.0.0.1.0.0 5-6|0.0.0.1.0.0.1 3-4|0.0.0.1.0 2-3|0.0.0.1.0.1 1-2|0.0.0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:45.571
(g / glycosylation 
      :ARG0-of (l / label-01 
            :ARG1 (e / experiment-01 
                  :ARG1 (c / core) 
                  :source-of (a / apparent 
                        :domain (f / form 
                              :consist-of (k / kDa 
                                    :ARG1-of (r / represent-01 
                                          :ARG0 22) 
                                    :quant 31) 
                              :mod (i / intermediate) 
                              :mod (s / short-liv))))))

# ::snt Compared to that from the kidneys of wild-type animals , AQP2 from mutant animals was reduced in both the high molecular weight , diffuse form and the lowest molecular weight form , but enriched in the intermediate molecular weight form ( Figure 3A ) .
# ::tok Compared to that from the kidneys of wild-type animals , AQP2 from mutant animals was reduced in both the high molecular weight , diffuse form and the lowest molecular weight form , but enriched in the intermediate molecular weight form ( Figure 3A ) .
# ::alignments 41-42|0.0.0.1.1.0.0 39-40|0.2.1 38-39|0.2.1.0.0 37-38|0.2.1.1 36-37|0.2.1.0 33-34|0.2 32-33|0 30-31|0.0.0.2.0 29-30|0.0.0.2.0.0 28-29|0.0.0.2.0.1 27-28|0.0.0.2.1+0.0.0.2 25-26|0.0.0 24-25|0.0.0.1 23-24|0.0.0.1.0 21-22|0.0.0.1.1.1 20-21|0.0.0.1.1 19-20|0.0.0.1.1.0 17-18|0.0.0.1.0.0 15-16|0.0 13-14|0.0.0.0 12-13|0.0.0.0.0 8-9|0.2.0 5-6|0.2.0.0 2-3|0.1.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:46.175
(c / contrast-01 
      :ARG1 (r / reduce-01 
            :ARG0 (a / and 
                  :op1 (a2 / animal 
                        :mod (m5 / mutant)) 
                  :op2 (f4 / form 
                        :mod (d / diffuse-01 
                              :ARG1 (b / both)) 
                        :mod (m4 / molecule 
                              :ARG1-of (h / high-02 
                                    :ARG0 (f / figure)) 
                              :quant-of (w3 / weight))) 
                  :op3 (l / low-04 
                        :ARG1 (f3 / form 
                              :domain (w2 / weight) 
                              :mod (m2 / molecule)) 
                        :degree (m3 / most)))) 
      :ARG1-of (c2 / compare-01 
            :ARG0 (t / that)) 
      :ARG2 (e / enrich-01 
            :ARG1 (a3 / animal 
                  :mod-of (k / kidney)) 
            :manner (f2 / form 
                  :mod (i / intermediate 
                        :mod-of (w / weight)) 
                  :mod (m / molecule))))

# ::snt Heterozygous animals showed intermediate amounts of all three forms .
# ::tok Heterozygous animals showed intermediate amounts of all three forms .
# ::alignments 8-9|0.1.1 7-8|0.1.1.1 6-7|0.1.1.0 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:46.224
(s / show-01 
      :ARG0 (a3 / animal 
            :mod (h / heterozygou)) 
      :ARG1 (a2 / amount 
            :mod (i / intermediate) 
            :quant-of (f / form 
                  :mod (a / all) 
                  :quant 3)))

# ::snt The nature of these glycosylated forms was revealed by digestion with endoglycosidase H , which specifically cleaves mannose-rich carbohydrate from the protein backbone .
# ::tok The nature of these glycosylated forms was revealed by digestion with endoglycosidase H , which specifically cleaves mannose-rich carbohydrate from the protein backbone .
# ::alignments 22-23|0.2.0.1 21-22|0.2.0.1.0 18-19|0.2.0.0 16-17|0.2.0 15-16|0.2.0.2 11-13|0.2.1.1+0.2.1.0+0.2.1+0.2 9-10|0.0 7-8|0 5-6|0.1.0 4-5|0.1.0.0 3-4|0.1.0.1 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:46.607
(r / reveal-01 
      :ARG0 (d / digestion) 
      :ARG1 (n2 / nature 
            :poss (f / form 
                  :mod (g / glycosylat) 
                  :mod (t2 / this))) 
      :ARG2 (t / thing 
            :ARG0-of (c2 / cleave-01 
                  :ARG1 (c / carbohydrate) 
                  :ARG2 (b / backbone 
                        :mod (p / protein)) 
                  :manner (s / specific-02)) 
            :name (n / name 
                  :op1 (e / endoglycosidase) 
                  :op2 (h / H))))

# ::snt Treatment of endogenous AQP2 from kidneys of wild-type , heterozygous , and mutant animals specifically affected the intermediate molecular weight form ( Figure 3B ) .
# ::tok Treatment of endogenous AQP2 from kidneys of wild-type , heterozygous , and mutant animals specifically affected the intermediate molecular weight form ( Figure 3B ) .
# ::alignments 22-23|0.3.3 20-21|0.1 19-20|0.1.0.0 18-19|0.1.1 17-18|0.1.0 15-16|0 14-15|0.2 13-14|0.0 12-13|0.0.0 11-12|0.3 9-10|0.3.2 5-6|0.3.0 2-3|0.2.0 0-1|0.3.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:46.945
(a / affect-01 
      :ARG0 (a2 / animal 
            :mod (m2 / mutant)) 
      :ARG1 (f2 / form 
            :mod (i / intermediate 
                  :mod-of (w / weight)) 
            :mod (m / molecule)) 
      :manner (s / specific-02 
            :ARG1 (e / endogenou)) 
      :source (a3 / and 
            :domain-of (k / kidney) 
            :op1 (t / treatment) 
            :op2 (h / heterozygou) 
            :op3 (f / figure)))

# ::snt The presence of some mature glycosylated proteins ( 35 -- 45 kDa ) in Aqp2F204V/F204V mice presumably permits their survival compared to Aqp2T126M/T126M mice , and is consistent with a diminished response to dDAVP .
# ::tok The presence of some mature glycosylated proteins ( 35 -- 45 kDa ) in Aqp2F204V/F204V mice presumably permits their survival compared to Aqp2T126M/T126M mice , and is consistent with a diminished response to dDAVP .
# ::alignments 33-34|0.1.1 31-32|0.1 30-31|0 27-28|0.1.2 25-26|0.1.2.2 23-24|0.1.2.2.0.0.1.0 22-23|0.1.0.0.0+0.1.0.0+0.1.0 20-21|0.1.2.2.0.0.1 19-20|0.1.2.2.0.0 17-18|0.1.2.2.0 16-17|0.1.2.2.0.1 15-16|0.1.2.2.0.0.0 11-12|0.1.2.0.0 10-11|0.1.2.0 8-9|0.0 6-7|0.1.2.1.0 5-6|0.1.2.1.0.1 4-5|0.1.2.1.0.0 3-4|0.1.2.1.0.2 1-2|0.1.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:47.559
(d2 / diminish-01 
      :ARG0 35 
      :ARG1 (r / respond-01 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 "Aqp2T126M/T126M")) 
            :ARG1 (d / dDAVP) 
            :ARG2-of (c / consistent-01 
                  :ARG0 (4 / 45 
                        :quant-of (k / kDa)) 
                  :ARG1 (p4 / presence 
                        :poss (p3 / protein 
                              :ARG1-of (m3 / mature-02) 
                              :mod (g / glycosylat) 
                              :quant (s2 / some))) 
                  :op2-of (a / and 
                        :op1 (p / permit-01 
                              :ARG1 (s / survive-01 
                                    :ARG1 (m2 / mouse) 
                                    :ARG1-of (c2 / compare-01 
                                          :ARG2 (m / mouse))) 
                              :ARG1-of (p2 / presume-01))))))

# ::snt In humans , recessive alleles of Aqp2 are postulated to cause NDI because they do not properly translocate to the apical cell surface in response to AVP .
# ::tok In humans , recessive alleles of Aqp2 are postulated to cause NDI because they do not properly translocate to the apical cell surface in response to AVP .
# ::alignments 24-25|0.1.0 22-23|0.1.0.1 21-22|0.1.0.1.0 20-21|0.0 16-17|0.2.0 15-16|0.2.0.0 13-14|0.1 12-13|0.2 11-12|0.3.1.0.0+0.3.1.0+0.3.1 10-11|0.3 8-9|0 6-7|0.3.0.1 4-5|0.3.0 3-4|0.3.0.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:47.946
(p2 / postulate-01 
      :ARG0 (a / apical) 
      :ARG1 (t / they 
            :ARG0-of (r / respond-01 
                  :ARG1 (h / human) 
                  :ARG2 (s / surface 
                        :mod (c / cell)))) 
      :ARG1-of (c2 / cause-01 
            :ARG0 (p / proper 
                  :polarity -)) 
      :ARG2 (c3 / cause-01 
            :ARG0 (a3 / allel 
                  :mod (r2 / recessive) 
                  :mod (a2 / Aqp2)) 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "NDI"))))

# ::snt This postulate comes solely from in vitro studies in which mutant Aqp2 cDNAs corresponding to human disease mutations are transfected into kidney cell lines .
# ::tok This postulate comes solely from in vitro studies in which mutant Aqp2 cDNAs corresponding to human disease mutations are transfected into kidney cell lines .
# ::alignments 23-24|0.0.0.0.0.0.0.1 22-23|0.0.0.0.0.0.0 21-22|0.0.0.0.0.0.0.0 17-18|0.0.0.0.0.0 16-17|0.0.0.0.0.0.1 15-16|0.0.0.0.0.0.1.0 13-14|0.0.0.0.0 12-13|0.0.0.0 11-12|0.0.0 10-11|0.0.1.0.0 7-8|0.0 6-7|0 3-4|0.0.1.1 2-3|0.0.1 1-2|0.0.1.0 0-1|0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:48.140
(v / vitro 
      :ARG0-of (s / study-01 
            :ARG1 (a / Aqp2 
                  :mod-of (c3 / cdna 
                        :ARG1-of (c2 / correspond-01 
                              :ARG2 (m / mutate-01 
                                    :ARG0 (c / cell 
                                          :mod (k / kidney) 
                                          :mod-of (l / line)) 
                                    :ARG1 (d / disease 
                                          :mod (h / human)))))) 
            :ARG3-of (c4 / come-01 
                  :ARG1 (p / postulate-01 
                        :ARG1 (m2 / mutant) 
                        :mod (t / this)) 
                  :manner (s2 / sole))))

# ::snt In general , such recessive alleles , when visualized immunocytochemically , fail to localize to AVP-responsive vesicles .
# ::tok In general , such recessive alleles , when visualized immunocytochemically , fail to localize to AVP-responsive vesicles .
# ::alignments 16-17|0.2.0 13-14|0.2 11-12|0 8-9|0.1 5-6|0.0 4-5|0.0.1 3-4|0.0.0 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:48.194
(f / fail-01 
      :ARG0 (a / allel 
            :mod (s / such) 
            :mod (r / recessive 
                  :ARG1-of (g / general-02))) 
      :ARG1 (v2 / visualize-01) 
      :ARG2 (l / localize-01 
            :ARG1 (v / vesicl)))

# ::snt Rather , they get trapped in the endoplasmic reticulum ( ER ) .
# ::tok Rather , they get trapped in the endoplasmic reticulum ( ER ) .
# ::alignments 10-11|0.0 8-9|0.2 4-5|0 2-3|0.1 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:48.228
(t / trap-01 
      :ARG0 (e / e) 
      :ARG1 (t2 / they) 
      :ARG2 (r / reticulum) 
      :mod (r2 / rather))

# ::snt Our mouse model of NDI affords the first opportunity to test this hypothesis in a mature animal .
# ::tok Our mouse model of NDI affords the first opportunity to test this hypothesis in a mature animal .
# ::alignments 16-17|0.0.0.0.0.2 15-16|0.0.0.0.0.2.0 12-13|0.0.0.0.0.1 11-12|0.0.0.0.0.1.0 10-11|0.0.0.0.0 8-9|0.0.0.0 5-6|0.0.0 4-5|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 2-3|0.0 1-2|0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:48.415
(m3 / mouse 
      :mod-of (m2 / model 
            :ARG0-of (a2 / afford-01 
                  :ARG1 (o / opportunity 
                        :purpose (t2 / test-01 
                              :ARG0 (o2 / organization 
                                    :name (n / name 
                                          :op1 "NDI")) 
                              :ARG1 (h / hypothesi 
                                    :mod (t / this)) 
                              :prep-in (a / animal 
                                    :ARG1-of (m / mature-02))))) 
            :poss (w / we)))

# ::snt As shown in Figure 4A ( top row of photomicrographs ) , AQP2 ( stained red ) normally localized to the subapical region of collecting duct cells in kidneys of wild-type mice .
# ::tok As shown in Figure 4A ( top row of photomicrographs ) , AQP2 ( stained red ) normally localized to the subapical region of collecting duct cells in kidneys of wild-type mice .
# ::alignments 31-32|0.0.1.1.0.1.0 28-29|0.0.1.1.0.1 26-27|0.0.1.1.0.0 25-26|0.0.1.1.0.0.0 24-25|0.0.1.1.0 22-23|0.0.1.1 18-19|0.0.1 17-18|0.0.1.0 15-16|0.0.1.1.0.2.0 14-15|0.0.1.1.0.2 9-10|0.2 7-8|0 6-7|0.1 3-4|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:48.706
(r3 / row 
      :ARG1-of (s2 / show-01 
            :ARG0 (f / figure) 
            :purpose-of (l / localize-01 
                  :ARG1-of (n / normal-02) 
                  :ARG2 (r / region 
                        :mod (c2 / collect-01 
                              :ARG1 (c / cell 
                                    :mod (d / duct)) 
                              :ARG2 (k / kidney 
                                    :mod (m / mouse)) 
                              :ARG2-of (s / stain-01 
                                    :ARG1 (r2 / red)))))) 
      :mod (t / top) 
      :mod (p / photomicrograph))

# ::snt Upon stimulation with dDAVP , AQP2 translocated to or near the cell surface ( Figure 4A , second row ) .
# ::tok Upon stimulation with dDAVP , AQP2 translocated to or near the cell surface ( Figure 4A , second row ) .
# ::alignments 18-19|0.0.0.1.0 14-15|0.0.0.0 12-13|0.0 11-12|0.0.1 9-10|0.0.0 8-9|0 3-4|0.0.0.1 1-2|0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:48.811
(o / or 
      :op1 (s / surface 
            :ARG1-of (n / near-02 
                  :ARG0 (f / figure) 
                  :ARG2 (d / dDAVP 
                        :mod (r / row) 
                        :prep-with-of (s2 / stimulation))) 
            :mod (c / cell)))

# ::snt In kidneys taken from mutant animals , however , AQP2 was distributed randomly throughout the cell in the basal state ( Figure 4A , third row ) , while AQP3 ( green ) appropriately localized to the basolateral surface [ 23 ] .
# ::tok In kidneys taken from mutant animals , however , AQP2 was distributed randomly throughout the cell in the basal state ( Figure 4A , third row ) , while AQP3 ( green ) appropriately localized to the basolateral surface [ 23 ] .
# ::alignments 40-41|0.0.2.0 38-39|0.0.2.1.0.1 34-35|0.0.2.1.0 33-34|0.0.2.1.0.2 31-32|0.0.2.1 25-26|0 21-22|0.0.2.1.0.0 19-20|0.0.2.3 18-19|0.0.2.3.0 15-16|0.0.2.2.0 13-14|0.0.2.2 12-13|0.0.2.4 11-12|0.0.2 5-6|0.0.1 4-5|0.0.1.0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:49.081
(r / row 
      :ARG0-of (t2 / take-01 
            :ARG1 (k / kidney) 
            :ARG2 (a2 / animal 
                  :mod (m / mutant)) 
            :manner-of (d / distribute-01 
                  :ARG0 23 
                  :ARG1 (g / green-02 
                        :ARG1-of (l / localize-01 
                              :ARG0 (f / figure) 
                              :ARG2 (s / surface) 
                              :degree (a / appropriate))) 
                  :ARG2 (t / throughout 
                        :op1 (c / cell)) 
                  :location (s2 / state 
                        :mod (b / basal)) 
                  :time (r2 / random))))

# ::snt Furthermore , upon dDAVP stimulation , AQP2-F204V failed to translocate to the cell surface ( Figure 4A , bottom row ) .
# ::tok Furthermore , upon dDAVP stimulation , AQP2-F204V failed to translocate to the cell surface ( Figure 4A , bottom row ) .
# ::alignments 19-20|0 18-19|0.1 15-16|0.0.1.0.0 13-14|0.0.0.1.0 12-13|0.0.0.1 7-8|0.0 6-7|0.0.0.0.0+0.0.0.0+0.0.0 4-5|0.0.1 3-4|0.0.1.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:49.246
(r / row 
      :ARG0-of (f2 / fail-01 
            :ARG1 (p / person 
                  :name (n / name 
                        :op1 "AQP2-F204V") 
                  :poss (c / cell 
                        :mod-of (s / surface))) 
            :ARG2 (s2 / stimulation 
                  :mod (d / dDAVP 
                        :poss (f / figure))) 
            :time (f3 / furthermore)) 
      :mod (b / bottom))

# ::snt To confirm these findings , the staining was repeated in kidneys taken from two further mice for each class , wild-type or mutant , with or without dDAVP treatment , with identical results .
# ::tok To confirm these findings , the staining was repeated in kidneys taken from two further mice for each class , wild-type or mutant , with or without dDAVP treatment , with identical results .
# ::alignments 32-33|0.0.0.0.0.0.0+0.0.0.0.0.0.0.0 31-32|0.0.0.0.0.0.0.0.0 28-29|0.0.0.0.0.0 27-28|0.0.0.0.0.0.1 25-26|0 22-23|0.0.0.0.1.0.0.1.1 21-22|0.0.0.0.1.0.0.1 18-19|0.0.0.0.1.0.0.1.0 17-18|0.0.0.0.1.0.0.1.0.0 15-16|0.0.0.0.1.0.0 14-15|0.0.0.0.1.0.0.0 13-14|0.0.0.0.1.0.0.2 11-12|0.0.0.0.1.0 10-11|0.0.0.0.1 8-9|0.0.0.0 6-7|0.0.0.0.0 3-4|0.0.1+0.0 2-3|0.0.2 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:49.686
(o / or 
      :op1 (t4 / thing 
            :ARG1-of (c2 / confirm-01 
                  :purpose-of (r2 / repeat-01 
                        :ARG1 (s / stain-01 
                              :ARG1 (t2 / treat-03 
                                    :ARG1-of (r / result-01 
                                          :ARG2 (t / thing 
                                                :ARG2-of (i / identical-01))) 
                                    :ARG2 (d / dDAVP))) 
                        :time (k / kidney 
                              :ARG1-of (t3 / take-01 
                                    :ARG3 (m2 / mouse 
                                          :mod (f / further) 
                                          :op1-of (o2 / or 
                                                :op2 (c / class 
                                                      :mod (e / each)) 
                                                :op3 (m / mutant)) 
                                          :quant 2))))) 
            :ARG1-of (f2 / find-01) 
            :mod (t5 / this)))

# ::snt To investigate the mechanism of defective translocation of AQP2-F204V , we turned to transfection of MDCK cells .
# ::tok To investigate the mechanism of defective translocation of AQP2-F204V , we turned to transfection of MDCK cells .
# ::alignments 16-17|0.1.0 15-16|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 13-14|0.1 11-12|0 10-11|0.0 8-9|0.2.0.0.1.0.0+0.2.0.0.1.0+0.2.0.0.1 6-7|0.2.0.0 5-6|0.2.0.0.0 3-4|0.2.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:49.760
(t2 / turn-02 
      :ARG0 (w / we) 
      :ARG2 (t / transfection 
            :domain (c / cell 
                  :location (c2 / country 
                        :name (n / name 
                              :op1 "MDCK")))) 
      :time (i / investigate-01 
            :ARG1 (m / mechanism 
                  :mod (t3 / translocation 
                        :mod (d / defective) 
                        :poss (p / person 
                              :name (n2 / name 
                                    :op1 "AQP2-F204V"))))))

# ::snt Stable cell lines expressing mouse wild-type AQP2 and AQP2-F204V were established .
# ::tok Stable cell lines expressing mouse wild-type AQP2 and AQP2-F204V were established .
# ::alignments 10-11|0 8-9|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 7-8|0.0.0.1 6-7|0.0.0.0 4-5|0.0.2.0 3-4|0.0.0 2-3|0.0 1-2|0.0.1 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:50.016
(e / establish-01 
      :ARG1 (l / line 
            :ARG0-of (e2 / express-01 
                  :ARG1 (a2 / AQP2) 
                  :ARG2 (a / and 
                        :op1 (p / person 
                              :name (n / name 
                                    :op1 "AQP2-F204V")))) 
            :mod (c / cell) 
            :mod (s / stable-01 
                  :ARG1 (m / mouse))))

# ::snt Immunoblots of protein extracts from stable cell lines showed that MDCK cells recapitulate the glycosylation defect seen in mutant mice ( unpublished data ) .
# ::tok Immunoblots of protein extracts from stable cell lines showed that MDCK cells recapitulate the glycosylation defect seen in mutant mice ( unpublished data ) .
# ::alignments 22-23|0.1.1.0.0 21-22|0.1.1.0 19-20|0.1.1.1.0 18-19|0.1.1.1.0.0 16-17|0.1.1.1 15-16|0.1.1 12-13|0.1 11-12|0.1.0 10-11|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 8-9|0 7-8|0.0.0.0.1 6-7|0.0.0.0.1.1 5-6|0.0.0.0.1.0 3-4|0.0.0.0+0.0.0 2-3|0.0.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:50.622
(s2 / show-01 
      :ARG0 (i / immunoblot 
            :poss (t / thing 
                  :ARG1-of (e / extract-01 
                        :ARG0 (p / protein) 
                        :ARG2 (l / line 
                              :ARG1-of (s3 / stable-03) 
                              :mod (c3 / cell))))) 
      :ARG1 (r / recapitulate-01 
            :ARG0 (c / cell 
                  :location (c2 / country 
                        :name (n / name 
                              :op1 "MDCK"))) 
            :ARG1 (d2 / defect-01 
                  :ARG1 (u / unpublish 
                        :mod-of (d / data)) 
                  :ARG1-of (s / see-01 
                        :ARG0 (m / mouse 
                              :mod (m2 / mutant))))))

# ::snt The wild-type protein was again present in three different forms .
# ::tok The wild-type protein was again present in three different forms .
# ::alignments 9-10|0.0.0 8-9|0.0 7-8|0.0.0.0 5-6|0.1 4-5|0.1.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:50.655
(p2 / protein 
      :ARG0-of (d / differ-02 
            :ARG1 (f / form 
                  :quant 3)) 
      :domain-of (p / present 
            :mod (a / again)))

# ::snt Cells expressing AQP2-F204V lacked the 35 -- 45 kDa form and were enriched in the core-glycosylated 31 kDa form .
# ::tok Cells expressing AQP2-F204V lacked the 35 -- 45 kDa form and were enriched in the core-glycosylated 31 kDa form .
# ::alignments 18-19|0.0.1 16-17|0.0.1.1 15-16|0.0.1.0 12-13|0.0 10-11|0 9-10|0.1.1 8-9|0.1.1.0 7-8|0.1.0.0.0 5-6|0.1.0.0.1 3-4|0.1 2-3|0.1.0.1.0+0.1.0.1+0.1.0 1-2|0.1.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:51.084
(a / and 
      :ARG1-of (e / enrich-01 
            :ARG0 (c2 / cell) 
            :ARG2 (f / form 
                  :mod (c / core-glycosylat) 
                  :quant 31)) 
      :op1 (l / lack-01 
            :ARG0 (p / person 
                  :ARG1-of (e2 / express-01 
                        :ARG0 45 
                        :ARG2 35) 
                  :name (n / name 
                        :op1 "AQP2-F204V")) 
            :ARG1 (f2 / form 
                  :mod (k / kDa))))

# ::snt In transfected , unstimulated MDCK cells , wild-type AQP2 ( stained green ) appeared in a punctate pattern distributed throughout the subapical region ( Figure 4B , left column photomicrographs ) , consistent with vesicular compartmentalization .
# ::tok In transfected , unstimulated MDCK cells , wild-type AQP2 ( stained green ) appeared in a punctate pattern distributed throughout the subapical region ( Figure 4B , left column photomicrographs ) , consistent with vesicular compartmentalization .
# ::alignments 35-36|0.0.3.0 34-35|0.0.3.0.0 32-33|0.0.3 29-30|0.0.0.1 28-29|0.0.0 27-28|0.0.0.0 24-25|0.0.1 22-23|0.1.0.1 19-20|0.1.0.1.0 18-19|0.1.0 17-18|0.1 13-14|0 11-12|0.0 10-11|0.0.2 8-9|0.1.0.0 5-6|0.2 4-5|0.2.0.0.0+0.2.0.0+0.2.0 3-4|0.2.1 1-2|0.2.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:51.444
(a / appear-01 
      :ARG0 (g / green-02 
            :ARG0 (c3 / column 
                  :mod (l / left) 
                  :mod-of (p / photomicrograph)) 
            :ARG1 (f / figure) 
            :ARG1-of (s / stain-01) 
            :ARG1-of (c2 / consistent-01 
                  :ARG2 (c / compartmentalization 
                        :mod (v / vesicular)))) 
      :medium (p2 / pattern 
            :ARG1-of (d / distribute-01 
                  :ARG0 (a2 / AQP2) 
                  :location (r / region 
                        :op1-of (t / throughout)))) 
      :medium (c4 / cell 
            :location (c5 / country 
                  :name (n / name 
                        :op1 "MDCK")) 
            :mod (u / unstimulat) 
            :mod (t2 / transfect)))

# ::snt AQP2-F204V , on the other hand , appeared in a punctate but perinuclear pattern ( Figure 4B , third column ) .
# ::tok AQP2-F204V , on the other hand , appeared in a punctate but perinuclear pattern ( Figure 4B , third column ) .
# ::alignments 19-20|0.2.0 15-16|0.0 13-14|0.2.2 11-12|0 7-8|0.2 5-6|0.1 4-5|0.1.0 0-1|0.2.1.0.0+0.2.1.0+0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:51.515
(c2 / contrast-01 
      :ARG0 (f / figure) 
      :ARG1 (h / hand 
            :mod (o / other)) 
      :ARG2-of (a / appear-01 
            :ARG0 (c / column) 
            :ARG1 (p2 / person 
                  :name (n / name 
                        :op1 "AQP2-F204V")) 
            :medium (p / pattern)))

# ::snt Upon stimulation with forskolin , a cAMP-dependent protein kinase activator , wild-type AQP2 translocated to the apical surface of polarized MDCK cells ( Figure 4B , second column ) .
# ::tok Upon stimulation with forskolin , a cAMP-dependent protein kinase activator , wild-type AQP2 translocated to the apical surface of polarized MDCK cells ( Figure 4B , second column ) .
# ::alignments 27-28|0 23-24|0.0.1.1.0 21-22|0.0.1.0 20-21|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 19-20|0.0.1 17-18|0.0.1.0.2 16-17|0.0.1.0.2.0 12-13|0.0.1.0.1 9-10|0.0.0.1 8-9|0.0.0 7-8|0.0.0.0 3-4|0.0 1-2|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:51.677
(c / column 
      :mod (f2 / forskolin 
            :name-of (k / kinase 
                  :mod (p2 / protein) 
                  :mod-of (a3 / activator)) 
            :op1 (p / polarize-01 
                  :ARG1 (c2 / cell 
                        :location (c3 / country 
                              :name (n / name 
                                    :op1 "MDCK")) 
                        :mod (a2 / AQP2) 
                        :mod-of (s / surface 
                              :mod (a / apical))) 
                  :op1-of (s2 / stimulation 
                        :mod (f / figure)))))

# ::snt Along the z-axis , the perinuclear distribution of AQP2-F204V was clearly seen , and this distribution is not altered by forskolin ( Figure 4B , bottom row , two right columns ) .
# ::tok Along the z-axis , the perinuclear distribution of AQP2-F204V was clearly seen , and this distribution is not altered by forskolin ( Figure 4B , bottom row , two right columns ) .
# ::alignments 30-31|0.1.2.3.0 29-30|0.1.2.3 28-29|0.1.2.3.0.0 26-27|0.1.2.0.0 25-26|0.1.2.0 22-23|0.1.1.0 20-21|0.1.0 18-19|0.1 17-18|0.1.3 15-16|0.1.1 14-15|0.1.1.1 13-14|0 11-12|0.1.2 10-11|0.1.2.2 8-9|0.1.2.1.0.0.0+0.1.2.1.0.0+0.1.2.1.0 6-7|0.1.2.1 2-3|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:52.931
(a2 / and 
      :location (a3 / along 
            :op1 (z / z-axi)) 
      :op1 (a / alter-01 
            :ARG0 (f2 / forskolin) 
            :ARG1 (d / distribute-01 
                  :ARG1 (f / figure) 
                  :mod (t / this)) 
            :concession (s / see-01 
                  :ARG0 (b / bottom 
                        :mod-of (r2 / row)) 
                  :ARG1 (d2 / distribute-01 
                        :ARG1 (p / person 
                              :name (n / name 
                                    :op1 "AQP2-F204V"))) 
                  :ARG1-of (c2 / clear-06) 
                  :ARG2 (r / right 
                        :mod-of (c / column 
                              :quant 2))) 
            :polarity -))

# ::snt The perinuclear distribution of AQP2-F204V is consistent with an ER compartmentalization .
# ::tok The perinuclear distribution of AQP2-F204V is consistent with an ER compartmentalization .
# ::alignments 10-11|0.1 9-10|0.1.0 6-7|0 4-5|0.0.0.0.0+0.0.0.0+0.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:52.959
(c2 / consistent-01 
      :ARG1 (d / distribute-01 
            :ARG1 (p / person 
                  :name (n / name 
                        :op1 "AQP2-F204V"))) 
      :ARG2 (c / compartmentalization 
            :mod (e / e)))

# ::snt To test the idea that AQP2-F204V localizes to the ER , we co-stained cells transfected with Aqp2F204V ( cDNA ) for AQP2 and an ER marker , calnexin ( Figure 4C ) .
# ::tok To test the idea that AQP2-F204V localizes to the ER , we co-stained cells transfected with Aqp2F204V ( cDNA ) for AQP2 and an ER marker , calnexin ( Figure 4C ) .
# ::alignments 29-30|0.0.2 27-28|0 25-26|0.0.1 22-23|0.0 18-19|0.0.1.1 16-17|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 13-14|0.0.0.0.0 11-12|0.0.0.0.2.0.0 9-10|0.0.0.0.1 6-7|0.0.0.0 5-6|0.0.0.1.0+0.0.0.1+0.0.0 3-4|0.0.0.0.2 1-2|0.0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:53.418
(c / calnexin 
      :op3-of (a / and 
            :op1 (p / person 
                  :ARG0-of (l / localize-01 
                        :ARG1 (c3 / cell) 
                        :ARG2 (e / e) 
                        :topic-of (i / idea 
                              :ARG1-of (t2 / test-01 
                                    :ARG0 (w / we)))) 
                  :name (n2 / name 
                        :op1 "AQP2-F204V")) 
            :op2 (m / mark-01 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 "Aqp2F204V")) 
                  :ARG1 (c2 / cdna)) 
            :op4 (f / figure)))

# ::snt Colocalization of calnexin with AQP2 was investigated directly , and it was found that 80 % of all AQP2-F204V protein colocalized with calnexin .
# ::tok Colocalization of calnexin with AQP2 was investigated directly , and it was found that 80 % of all AQP2-F204V protein colocalized with calnexin .
# ::alignments 19-20|0 18-19|0.0.0.0+0.0.0+0.0 17-18|0.0.1.0.0 15-16|0.0.1.0.1 14-15|0.0.1.0.2.0 12-13|0.0.1.1 9-10|0.0.1 7-8|0.0.1.0.2 6-7|0.0.1.0 2-3|0.0.1.1.0.0 0-1|0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:53.655
(p / protein 
      :mod (p2 / person 
            :name (n / name 
                  :op1 "AQP2-F204V") 
            :op3-of (a2 / and 
                  :op1 (i / investigate-01 
                        :ARG0 (a / all) 
                        :ARG1 (p3 / percentage-entity) 
                        :ARG1-of (d / direct-02 
                              :ARG0 80)) 
                  :op2 (f / find-01 
                        :ARG0 (c2 / Colocalization 
                              :mod (c / calnexin))))))

# ::snt The remaining 20 % appeared at the periphery of the ER , representing AQP2-F204V that had potentially progressed beyond the ER .
# ::tok The remaining 20 % appeared at the periphery of the ER , representing AQP2-F204V that had potentially progressed beyond the ER .
# ::alignments 18-19|0.2.0.0.0.0 17-18|0.2.0.0.0+0.2.0.0.0.1 16-17|0.0 13-14|0.2.0.0.2.0+0.2.0.0.2+0.2.0.0 12-13|0.2.0 10-11|0.2.1 7-8|0.2 4-5|0 3-4|0.1.0 2-3|0.1 1-2|0.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:53.931
(a / appear-01 
      :ARG0 (p2 / potential) 
      :ARG1 (2 / 20 
            :value-of (p5 / percentage-entity)) 
      :location (p4 / periphery 
            :ARG1-of (r / represent-01 
                  :ARG0 (p3 / person 
                        :ARG0-of (p / progress-01 
                              :ARG1 (b / beyond) 
                              :ARG4 (t / thing)) 
                        :ARG1-of (r2 / remain-01) 
                        :name (n / name 
                              :op1 "AQP2-F204V"))) 
            :poss (e / e)))

# ::snt This `` ER escape '' was consistent with the small proportion of mature , complex glycosylated , AQP2-F204V in mutant kidneys ( see Figure 3A ) .
# ::tok This `` ER escape '' was consistent with the small proportion of mature , complex glycosylated , AQP2-F204V in mutant kidneys ( see Figure 3A ) .
# ::alignments 23-24|0.0.1.1.1 22-23|0.0.1.1 20-21|0.0.0 19-20|0.0.0.0 15-16|0 14-15|0.0.1.1.0 12-13|0.0 10-11|0.0.1.2.0 9-10|0.0.1.2.0.0 6-7|0.0.1.2 3-4|0.0.1 2-3|0.0.1.0 0-1|0.0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:54.197
(g / glycosylat 
      :ARG1-of (m2 / mature-02 
            :ARG2 (k / kidney 
                  :mod (m / mutant)) 
            :purpose-of (e / escape-01 
                  :ARG0 (e2 / e) 
                  :ARG1 (s / see-01 
                        :ARG0 (c / complex) 
                        :ARG1 (f / figure)) 
                  :ARG1-of (c2 / consistent-01 
                        :ARG2 (p / proportion 
                              :mod (s2 / small))) 
                  :mod (t / this))))

# ::snt Animals heterozygous for the Aqp2F204V mutation were not affected in their urine production or urine osmolality ( see Figure 1C and 1D ) .
# ::tok Animals heterozygous for the Aqp2F204V mutation were not affected in their urine production or urine osmolality ( see Figure 1C and 1D ) .
# ::alignments 20-21|0.1.1 18-19|0.1.1.0.0 17-18|0.1.1.0 15-16|0.1.2.1 14-15|0.1.0.0.0 13-14|0.1.2 12-13|0.1 11-12|0.1.0 8-9|0 7-8|0.2 5-6|0.1.0.0 4-5|0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:54.790
(a2 / affect-01 
      :ARG1 (h / heterozygou 
            :mod (a3 / animal)) 
      :manner (p / produce-01 
            :ARG1 (u2 / urine 
                  :poss (m / mutation 
                        :poss-of (u / urine))) 
            :op1-of (a / and 
                  :ARG1-of (s / see-01 
                        :ARG2 (f / figure))) 
            :op2-of (o2 / or 
                  :op1 (t / thing 
                        :name (n / name 
                              :op1 "Aqp2F204V")) 
                  :op3 (o / osmolality))) 
      :polarity -)

# ::snt It has also been shown that a recessive NDI allele , AQP2-R187C , does not interact with wild-type protein in oocytes [ 24 ] , nor does it homo-oligomerize in MDCK cells [ 22 ] .
# ::tok It has also been shown that a recessive NDI allele , AQP2-R187C , does not interact with wild-type protein in oocytes [ 24 ] , nor does it homo-oligomerize in MDCK cells [ 22 ] .
# ::alignments 33-34|0.4 31-32|0.0.0 30-31|0.0.1.0+0.0.1+0.0 22-23|0.2.3 20-21|0.2.1.0 18-19|0.2.1 15-16|0.2 14-15|0.2.2 9-10|0.2.0 8-9|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 7-8|0.2.0.1 4-5|0 2-3|0.3 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:55.598
(s / show-01 
      :ARG0 (c2 / country 
            :location-of (c / cell) 
            :name (n / name 
                  :op1 "MDCK")) 
      :ARG1 (i2 / it) 
      :ARG2 (i / interact-01 
            :ARG0 (a / allele 
                  :mod (o2 / organization 
                        :name (n2 / name 
                              :op1 "NDI")) 
                  :mod (r / recessive)) 
            :ARG1 (p / protein 
                  :location (o / oocyt)) 
            :polarity - 
            :time 24) 
      :mod (a2 / also) 
      :op1-of 22)

# ::snt Therefore , kidneys from heterozygous animals were examined for evidence of two populations of AQP2 protein .
# ::tok Therefore , kidneys from heterozygous animals were examined for evidence of two populations of AQP2 protein .
# ::alignments 15-16|0.1.0.0 14-15|0.1.0.0.0 12-13|0.1.0 11-12|0.1.0.1 9-10|0.1 7-8|0 5-6|0.1.1 4-5|0.1.1.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:55.681
(e2 / examine-01 
      :ARG1 (k / kidney) 
      :purpose (e / evidence-01 
            :ARG0 (p2 / population 
                  :mod (p / protein 
                        :mod (a / AQP2)) 
                  :quant 2) 
            :ARG1 (a2 / animal 
                  :mod (h / heterozygou))))

# ::snt Surprisingly , immunohistochemical staining of kidney collecting ducts from Aqp2F204V / + mice revealed a pattern remarkably similar to wild type ( Figure 5A ) .
# ::tok Surprisingly , immunohistochemical staining of kidney collecting ducts from Aqp2F204V / + mice revealed a pattern remarkably similar to wild type ( Figure 5A ) .
# ::alignments 22-23|0.0.0 20-21|0.1.0.2 19-20|0.1.0.2.0 17-18|0.1.0 16-17|0.1.0.1 15-16|0.1 13-14|0 12-13|0.0.1.0.1 10-11|0.0.1.0.1.0 9-10|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 7-8|0.0.1.0.0 6-7|0.0.1.0 5-6|0.0.1 3-4|0.0 0-1|0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:56.130
(r3 / reveal-01 
      :ARG0 (s2 / stain-01 
            :ARG0 (f / figure) 
            :ARG1 (k / kidney 
                  :ARG0-of (c / collect-01 
                        :ARG1 (d / duct) 
                        :ARG2 (m / mouse 
                              :op1-of (s / slash))))) 
      :ARG1 (p / pattern 
            :ARG1-of (r / resemble-01 
                  :ARG0 (t2 / thing 
                        :name (n / name 
                              :op1 "Aqp2F204V")) 
                  :ARG1-of (r2 / remarkable-02 
                        :ARG0 (s3 / surprisingly)) 
                  :ARG2 (t / type 
                        :mod (w / wild)))))

# ::snt AQP2 translocated completely to the apical cell surface upon dDAVP stimulation .
# ::tok AQP2 translocated completely to the apical cell surface upon dDAVP stimulation .
# ::alignments 10-11|0.0 9-10|0.0.0 7-8|0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0.0.0 2-3|0.0.0.0.0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:56.158
(a2 / AQP2 
      :poss-of (s / stimulation 
            :mod (d / dDAVP 
                  :location-of (s2 / surface 
                        :mod (c / cell 
                              :mod (a / apical 
                                    :ARG2-of (c2 / complete-02)))))))

# ::snt This wild-type staining pattern may simply reflect the fact that decreasing the amount of mutant protein by half makes it undetectable by immunocytochemistry .
# ::tok This wild-type staining pattern may simply reflect the fact that decreasing the amount of mutant protein by half makes it undetectable by immunocytochemistry .
# ::alignments 22-23|0.0.0.1.0 20-21|0.1.0.1.0 18-19|0.1.0.1 17-18|0.1.0.0 15-16|0 14-15|0.0 12-13|0.1 10-11|0.1.0 8-9|0.0.0.2 6-7|0.0.0 5-6|0.0.0.3 4-5|0.0.0.1 3-4|0.0.0.0 2-3|0.0.0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:56.414
(p / protein 
      :mod (m2 / mutant 
            :ARG0-of (r / reflect-01 
                  :ARG1 (p3 / pattern 
                        :ARG1-of (s2 / stain-01) 
                        :mod (t / this)) 
                  :ARG1-of (p2 / possible-01 
                        :ARG0 (i / immunocytochemistry)) 
                  :ARG2 (f / fact) 
                  :manner (s / simple))) 
      :quant (a / amount 
            :ARG1-of (d / decrease-01 
                  :ARG0 (h / half) 
                  :ARG0-of (m / make-02 
                        :ARG1 (u / undetectable)))))

# ::snt Alternatively , the presence of wild-type protein may alter the localization of the mutant protein .
# ::tok Alternatively , the presence of wild-type protein may alter the localization of the mutant protein .
# ::alignments 14-15|0.0.0.0 13-14|0.0.0.0.0 10-11|0.0.0 8-9|0.0 7-8|0 6-7|0.0.1.0 3-4|0.0.1 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:56.484
(p2 / possible-01 
      :ARG1 (a / alter-01 
            :ARG1 (l / localization 
                  :poss (p / protein 
                        :mod (m / mutant))) 
            :manner (p4 / presence 
                  :mod (p3 / protein))) 
      :degree (a2 / alternatively))

# ::snt Indeed , Hendriks et al. proposed a `` piggy-back '' mechanism to explain the transport of nonglycosylated subunits of AQP2 to the cell surface by glycosylated subunits [ 22 ] .
# ::tok Indeed , Hendriks et al. proposed a `` piggy-back '' mechanism to explain the transport of nonglycosylated subunits of AQP2 to the cell surface by glycosylated subunits [ 22 ] .
# ::alignments 28-29|0.1 26-27|0.2 25-26|0.0.0.1.0 23-24|0.0.0.1 22-23|0.0.0.1.1 17-18|0.0.0.0.0 16-17|0.0.0.0.0.0 14-15|0.0.0.0 12-13|0.0.0 10-11|0.0 5-6|0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:56.634
(p / propose-01 
      :ARG1 (m / mechanism 
            :ARG0-of (e / explain-01 
                  :ARG1 (t / transport-01 
                        :ARG1 (s3 / subunit 
                              :mod (n / nonglycosylat))) 
                  :ARG2 (s2 / surface 
                        :location (g / glycosylat) 
                        :mod (c / cell)))) 
      :ARG2 22 
      :manner (s / subunit) 
      :mod (i / indeed))

# ::snt It has also been shown that wild-type AQP2 protein can rescue a translocation-defective mutant protein , AQP2-P262L , when the two are coexpressed in MDCK cells [ 25 ] .
# ::tok It has also been shown that wild-type AQP2 protein can rescue a translocation-defective mutant protein , AQP2-P262L , when the two are coexpressed in MDCK cells [ 25 ] .
# ::alignments 27-28|0.3 25-26|0.4 24-25|0.4.0.0.0+0.4.0.0+0.4.0 20-21|0.0.0 14-15|0.1.0.1 13-14|0.1.0.1.0 10-11|0.1.0 9-10|0.1 8-9|0.1.0.0 7-8|0.1.0.0.0 4-5|0 2-3|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:57.684
(s / show-01 
      :ARG1 (i / it 
            :poss-of 2) 
      :ARG3 (p2 / possible-01 
            :ARG1 (r / rescue-01 
                  :ARG0 (p3 / protein 
                        :mod (a / AQP2)) 
                  :ARG1 (p / protein 
                        :mod (m / mutant)))) 
      :mod (a2 / also) 
      :op1-of 25 
      :op1-of (c / cell 
            :location (c2 / country 
                  :name (n / name 
                        :op1 "MDCK"))))

# ::snt In the collecting ducts from Aqp2F204V / + mice , the wild type may rescue the mutant protein as suggested by the subcellular distribution of AQP2 protein .
# ::tok In the collecting ducts from Aqp2F204V / + mice , the wild type may rescue the mutant protein as suggested by the subcellular distribution of AQP2 protein .
# ::alignments 26-27|0.0.1.0.0.1 25-26|0.0.1.0.0.1.0 23-24|0.0.1.0.0 19-20|0.0.1.0 17-18|0.0.1 16-17|0.0.1.1 14-15|0.0 13-14|0 12-13|0.0.0 11-12|0.0.0.0 8-9|0.0.1.0.0.0.0 6-7|0.0.1.0.0.0 5-6|0.0.1.0.0.0.0.0.0.0+0.0.1.0.0.0.0.0.0+0.0.1.0.0.0.0.0 3-4|0.0.1.0.0.2.0 2-3|0.0.1.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:57.965
(p3 / possible-01 
      :ARG1 (r / rescue-01 
            :ARG0 (t / type 
                  :mod (w / wild)) 
            :ARG1 (p2 / protein 
                  :ARG1-of (s / suggest-01 
                        :ARG0 (d / distribute-01 
                              :ARG0 (s2 / slash 
                                    :op1 (m2 / mouse 
                                          :mod (c / country 
                                                :name (n / name 
                                                      :op1 "Aqp2F204V")))) 
                              :ARG1 (p / protein 
                                    :mod (a / AQP2)) 
                              :ARG2-of (c2 / collect-01 
                                    :ARG1 (d2 / duct)))) 
                  :mod (m / mutant))))

# ::snt To test this idea , we first looked for an interaction between mutant and wild-type proteins in transfected MDCK cells ( Figure 5B ) .
# ::tok To test this idea , we first looked for an interaction between mutant and wild-type proteins in transfected MDCK cells ( Figure 5B ) .
# ::alignments 21-22|0.2.2 19-20|0.2.1.0 18-19|0.2.1.0.0.0.0+0.2.1.0.0.0+0.2.1.0.0 17-18|0.2.1.0.1 15-16|0.2.1 13-14|0.2 12-13|0.2.0 10-11|0.3 7-8|0 5-6|0.0 3-4|0.1 2-3|0.1.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:58.590
(l / look-01 
      :ARG0 (w / we) 
      :ARG1 (i2 / idea 
            :ARG1-of (t3 / test-01) 
            :mod (t2 / this)) 
      :direction (a / and 
            :op1 (m / mutant) 
            :op2 (p / protein 
                  :location (c / cell 
                        :location (c2 / country 
                              :name (n / name 
                                    :op1 "MDCK")) 
                        :mod (t / transfect))) 
            :op3 (f / figure)) 
      :purpose (i / interact-01))

# ::snt MDCK cells stably expressing wild-type AQP2 were transiently transfected with GFP expression constructs encoding GFP-tagged wild-type AQP2 , AQP2-F204V , or GFP alone .
# ::tok MDCK cells stably expressing wild-type AQP2 were transiently transfected with GFP expression constructs encoding GFP-tagged wild-type AQP2 , AQP2-F204V , or GFP alone .
# ::alignments 22-23|0.0.1 20-21|0 18-19|0.2.1.0+0.2.1+0.2 14-15|0.1.0.1 13-14|0.0 12-13|0.0.0 11-12|0.2.0 10-11|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 8-9|0.1.0.0.0 7-8|0.1.0.0.0.0 5-6|0.1 3-4|0.1.0 2-3|0.1.0.2 1-2|0.1.0.0 0-1|0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:39:59.655
(o / or 
      :ARG1-of (e / encode-01 
            :ARG0 (c / construct) 
            :manner (a / alone)) 
      :op1 (a2 / AQP2 
            :ARG1-of (e3 / express-01 
                  :ARG0 (c2 / cell 
                        :domain-of (t / transfect 
                              :mod (t2 / transiently)) 
                        :mod (m / MDCK)) 
                  :ARG2 (g / gfp-tagg) 
                  :mod (s / stably))) 
      :op2 (p / person 
            :ARG0-of (e2 / express-01 
                  :ARG1 (o2 / organization 
                        :name (n2 / name 
                              :op1 "GFP"))) 
            :name (n / name 
                  :op1 "AQP2-F204V")))

# ::snt Antibodies against GFP coimmunoprecipitated wild-type AQP2 when AQP2-GFP or AQP2-F204V-GFP was transiently transfected , but not when GFP by itself was transiently transfected into MDCK cells stably expressing wild-type AQP2 ( Figure 5B , upper blots ) .
# ::tok Antibodies against GFP coimmunoprecipitated wild-type AQP2 when AQP2-GFP or AQP2-F204V-GFP was transiently transfected , but not when GFP by itself was transiently transfected into MDCK cells stably expressing wild-type AQP2 ( Figure 5B , upper blots ) .
# ::alignments 35-36|0.1 34-35|0.1.1 31-32|0.0.1.1 27-28|0.0.1.0 26-27|0.0.1.0.1 25-26|0.0.1.0.0 24-25|0.0.1.0.0.0.0.0+0.0.1.0.0.0.0+0.0.1.0.0.0 15-16|0.1.0 14-15|0 12-13|0.0.0.0 11-12|0.0.0.0.0 9-10|0.0.1.2.0+0.0.1.2+0.0.1 8-9|0.0 7-8|0.0.0.1.0+0.0.0.1+0.0.0 5-6|0.0.1.0.2 2-3|0.0.1.0.3.0.0+0.0.1.0.3.0+0.0.1.0.3 0-1|0.0.1.0.3.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:00.119
(c3 / contrast-01 
      :ARG1 (o / or 
            :op1 (p2 / person 
                  :domain-of (t / transfect 
                        :mod (t2 / transiently)) 
                  :name (n3 / name 
                        :op1 "AQP2-GFP")) 
            :op2 (p / person 
                  :ARG0-of (e / express-01 
                        :ARG1 (c / cell 
                              :location (c2 / country 
                                    :name (n / name 
                                          :op1 "MDCK"))) 
                        :mod (s / stably) 
                        :op1-of (a / AQP2) 
                        :op1-of (o2 / organization 
                              :name (n4 / name 
                                    :op1 "GFP") 
                              :prep-against-of (a2 / antibodi))) 
                  :mod-of (f / figure) 
                  :name (n2 / name 
                        :op1 "AQP2-F204V-GFP"))) 
      :ARG2-of (b / blot-01 
            :ARG0 - 
            :mod (u / upper)))

# ::snt Western blot of total membranes showed that wild-type AQP2 is equivalently expressed in all three cases ( Figure 5B , lower blots ) .
# ::tok Western blot of total membranes showed that wild-type AQP2 is equivalently expressed in all three cases ( Figure 5B , lower blots ) .
# ::alignments 21-22|0.1.1.1.0 20-21|0.1.1.1.0.0 17-19|0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 15-16|0.1.1 14-15|0.1.1.1 13-14|0.1.1.0 11-12|0.1 8-9|0.1.0 5-6|0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.0 0-1|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:00.609
(s / show-01 
      :ARG0 (b2 / blot-01 
            :ARG1 (m / membran 
                  :ARG2-of (t2 / total-01 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 (f / Figure) 
                                    :op2 5B)))) 
            :mod (w / world-region 
                  :name (n2 / name 
                        :op1 "West") 
                  :wiki "Western_world")) 
      :ARG1 (e / express-01 
            :ARG1 (a2 / AQP2) 
            :time (c / case-03 
                  :mod (a / all) 
                  :quant (3 / 3 
                        :ARG1-of (b / blot-01 
                              :ARG1-of (l / low-04))))))

# ::snt If wild-type and mutant proteins are indeed interacting in the cell , is this interaction sufficient to rescue the localization of mutant protein ?
# ::tok If wild-type and mutant proteins are indeed interacting in the cell , is this interaction sufficient to rescue the localization of mutant protein ?
# ::alignments 23-24|0.1.3 22-23|0.0.0.0 21-22|0.0.0.0.0 19-20|0.0.0 17-18|0.0 15-16|0.0.2 14-15|0.0.1 13-14|0.0.1.0 10-11|0.1.1 7-8|0.1 6-7|0.1.2 4-5|0 3-4|0.1.0.0 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:01.059
(p2 / protein 
      :ARG0-of (r / rescue-01 
            :ARG1 (l / localization 
                  :mod (p / protein 
                        :mod (m / mutant))) 
            :ARG1-of (i2 / interact-01 
                  :mod (t / this)) 
            :ARG1-of (s / suffice-01)) 
      :ARG1-of (i3 / interact-01 
            :ARG0 (a / and 
                  :op1 (m2 / mutant)) 
            :location (c / cell) 
            :mod (i4 / indeed) 
            :mode (i / interrogative)))

# ::snt To answer this question , we used MDCK cells stably transfected with wild-type AQP2 expressing vector or with empty vector .
# ::tok To answer this question , we used MDCK cells stably transfected with wild-type AQP2 expressing vector or with empty vector .
# ::alignments 19-20|0.0 18-19|0 16-17|0.0.0 15-16|0.0.0.0.1 14-15|0.0.0.0 13-14|0.0.0.0.0 10-11|0.0.0.0.1.0 9-10|0.0.0.0.2.1.1 8-9|0.0.0.0.2.1 7-8|0.0.0.0.2.1.0.0.0+0.0.0.0.2.1.0.0+0.0.0.0.2.1.0 6-7|0.0.0.0.2 5-6|0.0.0.0.2.0 3-4|0.0.0.0.2.2 2-3|0.0.0.0.2.2.0 1-2|0.0.0.0.2.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:02.049
(e / empty-02 
      :mod-of (v / vector 
            :op2-of (o / or 
                  :op1 (e2 / express-01 
                        :ARG0 (a / AQP2) 
                        :ARG1 (v2 / vector 
                              :domain-of (t / transfect)) 
                        :ARG2-of (u / use-01 
                              :ARG0 (w / we) 
                              :ARG1 (c / cell 
                                    :location (c2 / country 
                                          :name (n / name 
                                                :op1 "MDCK")) 
                                    :mod (s / stably)) 
                              :time (q / question-01 
                                    :ARG1 (t2 / this) 
                                    :ARG1-of (a2 / answer-01)))))))

# ::snt On top of these , we transiently transfected AQP2-GFP or AQP2-F204V-GFP expression constructs .
# ::tok On top of these , we transiently transfected AQP2-GFP or AQP2-F204V-GFP expression constructs .
# ::alignments 12-13|0.0.0 11-12|0.3.1.0 10-11|0.3.1.1.0+0.3.1.1+0.3.1 9-10|0.3 8-9|0.3.0.0.0+0.3.0.0+0.3.0 7-8|0 6-7|0.2 5-6|0.0 3-4|0.3.1.0.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:02.116
(t / transfect 
      :ARG0 (w / we 
            :poss-of (c / construct)) 
      :location (t4 / top) 
      :mod (t2 / transiently) 
      :op1-of (o / or 
            :op2 (p2 / person 
                  :name (n2 / name 
                        :op1 "AQP2-GFP")) 
            :op3 (p / person 
                  :ARG0-of (e / express-01 
                        :ARG1 (t3 / this)) 
                  :name (n / name 
                        :op1 "AQP2-F204V-GFP"))))

# ::snt AQP2-GFP localized to the apical surface upon forskolin stimulation whether it was transiently transfected into vector-only cells ( Figure 5C , upper left images ) or into wild-type AQP2 cells ( Figure 5C , upper right ) .
# ::tok AQP2-GFP localized to the apical surface upon forskolin stimulation whether it was transiently transfected into vector-only cells ( Figure 5C , upper left images ) or into wild-type AQP2 cells ( Figure 5C , upper right ) .
# ::alignments 35-36|0 34-35|0.3 31-32|0.1.2 29-30|0.1.0.2.0 28-29|0.1.0.2 25-26|0.2 23-24|0.1.1 22-23|0.1.1.1 21-22|0.1.1.0 18-19|0.0 16-17|0.1.0.3.1 13-14|0.1.0.0 12-13|0.1.0.0.0 8-9|0.1.0.3 7-8|0.1.0.3.0 5-6|0.1.0.1 4-5|0.1.0.1.0 1-2|0.1.0 0-1|0.1.3.0+0.1.3+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:02.442
(r / right-05 
      :ARG0 (f2 / figure) 
      :ARG1 (p / person 
            :ARG0-of (l2 / localize-01 
                  :ARG1 (t / transfect 
                        :mod (t2 / transiently)) 
                  :ARG2 (s2 / surface 
                        :mod (a2 / apical)) 
                  :op1-of (a / AQP2 
                        :mod-of (c / cell)) 
                  :time (s / stimulation 
                        :mod (f3 / forskolin) 
                        :mod-of (c2 / cell))) 
            :mod-of (i / image 
                  :mod (u2 / upper) 
                  :mod (l / left)) 
            :mod-of (f / figure) 
            :name (n / name 
                  :op1 "AQP2-GFP")) 
      :concession (o / or) 
      :mod (u / upper))

# ::snt AQP2-F204V-GFP , when expressed by transient transfection into vector only cells , showed a diffuse cytoplasmic distribution pattern ( Figure 5C , lower left ) .
# ::tok AQP2-F204V-GFP , when expressed by transient transfection into vector only cells , showed a diffuse cytoplasmic distribution pattern ( Figure 5C , lower left ) .
# ::alignments 23-24|0.0.0.2.1 22-23|0.0.0.2 19-20|0.0.0.2.0 17-18|0.1 16-17|0.1.0 15-16|0.1.2 14-15|0.1.1 12-13|0 10-11|0.0.0.0 9-10|0.0.0.0.0 8-9|0.0.0.1 6-7|0.0.0.3 5-6|0.0.0.3.0 3-4|0.0.0 0-1|0.0.1.0+0.0.1+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:03.059
(s / show-01 
      :ARG0 (p2 / person 
            :ARG0-of (e / express-01 
                  :ARG1 (c2 / cell 
                        :mod (o / only)) 
                  :ARG2 (v / vector) 
                  :ARG2-of (l2 / low-04 
                        :ARG0 (f / figure) 
                        :ARG1 (l / left)) 
                  :ARG3 (t / transfection 
                        :mod (t2 / transient))) 
            :name (n / name 
                  :op1 "AQP2-F204V-GFP")) 
      :ARG1 (p / pattern 
            :ARG0-of (d / distribute-01) 
            :mod (d2 / diffuse-01) 
            :mod (c / cytoplasmic)))

# ::snt When expressed in wild-type AQP2 cells , however , AQP2-F204V-GFP localized to the apical surface to varying degrees ( Figure 5C , lower right images [ i -- iii ] ) .
# ::tok When expressed in wild-type AQP2 cells , however , AQP2-F204V-GFP localized to the apical surface to varying degrees ( Figure 5C , lower right images [ i -- iii ] ) .
# ::alignments 28-29|0.0.0.0.0.0.1 26-27|0.0.0.0.0.0.0 24-25|0.1 23-24|0 22-23|0.1.0 19-20|0.1.0.0 17-18|0.0.0 16-17|0.0.0.0 14-15|0.0.0.0.0 13-14|0.0.0.0.0.1 10-11|0.0.0.0.0.0 5-6|0.0.1 4-5|0.0.1.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:03.247
(r / right-05 
      :ARG1 (e / express-01 
            :ARG0 (d / degree 
                  :ARG1-of (v / vary-01 
                        :ARG0 (s / surface 
                              :ARG2-of (l2 / localize-01 
                                    :ARG0 (i2 / i) 
                                    :ARG1 (i / iii)) 
                              :mod (a / apical)))) 
            :ARG1 (c / cell 
                  :mod (a2 / AQP2))) 
      :topic-of (i3 / image 
            :ARG1-of (l / low-04 
                  :ARG0 (f / figure))))

# ::snt The lower right images of Figure 5C shows three cells from a single transfection .
# ::tok The lower right images of Figure 5C shows three cells from a single transfection .
# ::alignments 13-14|0.2 12-13|0.2.0 9-10|0.1 8-9|0.0.0.0 7-8|0 5-7|0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 3-4|0.0 2-3|0.0.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:03.465
(s2 / show-01 
      :ARG0 (i / image 
            :ARG1-of (l / low-04 
                  :ARG0 3) 
            :mod (r / right) 
            :topic (t2 / thing 
                  :name (n / name 
                        :op1 (f / Figure) 
                        :op2 5C))) 
      :ARG1 (c / cell) 
      :ARG2 (t / transfection 
            :ARG1-of (s / single-02)))

# ::snt The first is a nontransfected cell that shows the localization of the stably expressing wild-type AQP2 , which is apical upon forskolin stimulation .
# ::tok The first is a nontransfected cell that shows the localization of the stably expressing wild-type AQP2 , which is apical upon forskolin stimulation .
# ::alignments 22-23|0.0.0 21-22|0.0 19-20|0.0.0.0 15-16|0.1 13-14|0 12-13|0.2 9-10|0.1.0 7-8|0.1.0.0 5-6|0.1.0.0.0 4-5|0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:03.648
(e / express-01 
      :ARG0 (f / forskolin 
            :mod-of (s / stimulation 
                  :topic-of (a / apical))) 
      :ARG1 (a2 / AQP2 
            :poss-of (l / localization 
                  :ARG1-of (s3 / show-01 
                        :ARG0 (c / cell 
                              :mod (n / nontransfect))))) 
      :degree (s2 / stably))

# ::snt The next two show expression of both the stable wild-type AQP2 and the transient AQP2-F204V-GFP .
# ::tok The next two show expression of both the stable wild-type AQP2 and the transient AQP2-F204V-GFP .
# ::alignments 14-15|0.1.0.2.1.0+0.1.0.2.1+0.1.0.2 13-14|0.1.0.2.0 11-12|0.1.0 8-9|0.1.0.1 6-7|0.1.0.0 4-5|0.1 3-4|0 2-3|0.1.0.1.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:03.855
(s2 / show-01 
      :ARG0 (n2 / next) 
      :ARG1 (e / express-01 
            :ARG1 (a / and 
                  :mod (b / both) 
                  :op1 (s / stable-03 
                        :ARG1 2) 
                  :op2 (p / person 
                        :mod (t / transient) 
                        :name (n / name 
                              :op1 "AQP2-F204V-GFP")))))

# ::snt In cell ( ii ) , localization of wild-type AQP2 was indistinguishable from AQP2-F204V-GFP ; both were apical upon forskolin stimulation .
# ::tok In cell ( ii ) , localization of wild-type AQP2 was indistinguishable from AQP2-F204V-GFP ; both were apical upon forskolin stimulation .
# ::alignments 20-21|0.0 19-20|0 17-18|0.0.2 15-16|0.0.2.0 14-15|0.0.1.0.1 13-14|0.0.1.0.1.0.0.0+0.0.1.0.1.0.0+0.0.1.0.1.0 11-12|0.0.1.0 6-7|0.0.1.0.0 3-4|0.0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:03.924
(f / forskolin 
      :mod-of (s / stimulation 
            :poss (i2 / ii) 
            :poss (c / cell 
                  :location-of (i / indistinguishable 
                        :domain (l / localization) 
                        :op1-of (a2 / and 
                              :op2 (p / person 
                                    :name (n / name 
                                          :op1 "AQP2-F204V-GFP"))))) 
            :topic-of (a / apical 
                  :domain (b / both))))

# ::snt Although the effect was subtle in cell ( iii ) , AQP2-F204V-GFP was partly localized to the apical surface .
# ::tok Although the effect was subtle in cell ( iii ) , AQP2-F204V-GFP was partly localized to the apical surface .
# ::alignments 18-19|0.0.1 17-18|0.0.1.0 14-15|0.0 13-14|0.0.2 11-12|0.0.0.1.0+0.0.0.1+0.0.0 8-9|0 6-7|0.0.0.0.0.0 4-5|0.0.0.0.0 2-3|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:04.047
(i / iii 
      :ARG0-of (l / localize-01 
            :ARG1 (p2 / person 
                  :ARG1-of (e / effect-03 
                        :domain-of (s2 / subtle 
                              :location (c / cell))) 
                  :name (n / name 
                        :op1 "AQP2-F204V-GFP")) 
            :ARG2 (s / surface 
                  :mod (a / apical)) 
            :degree (p / part)))

# ::snt Generally , the localization of AQP2-F204V-GFP was clearly more apical when wild-type AQP2 was also expressed .
# ::tok Generally , the localization of AQP2-F204V-GFP was clearly more apical when wild-type AQP2 was also expressed .
# ::alignments 15-16|0.2.0 14-15|0.2.0.1 12-13|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 9-10|0 8-9|0.1 7-8|0.0 5-6|0.2.1.0.0+0.2.1.0+0.2.1 3-4|0.2 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:04.153
(a2 / apical 
      :ARG1-of (c / clear-06 
            :ARG1-of (g / general-02)) 
      :degree (m / more) 
      :domain (l / localization 
            :ARG0-of (e / express-01 
                  :ARG1 (o / organization 
                        :name (n / name 
                              :op1 "AQP2")) 
                  :mod (a / also)) 
            :poss (p / person 
                  :name (n2 / name 
                        :op1 "AQP2-F204V-GFP"))))

# ::snt To confirm these results biochemically , we transfected the same cell lines ( wild-type AQP2 or vector ) with F204V-GFP , biotinylated surface proteins after forskolin stimulation , and precipitated the biotinylated proteins ( Figure 5D ) .
# ::tok To confirm these results biochemically , we transfected the same cell lines ( wild-type AQP2 or vector ) with F204V-GFP , biotinylated surface proteins after forskolin stimulation , and precipitated the biotinylated proteins ( Figure 5D ) .
# ::alignments 34-35|0.1.0.1.0.0 32-33|0.1.1 31-32|0.1.1.0 29-30|0.1 28-29|0 26-27|0.2.0 25-26|0.2.0.0 24-25|0.2 23-24|0.2.1 22-23|0.2.1.0 19-20|0.0.0.0+0.0.0+0.0 16-17|0.1.0.1.2.1 15-16|0.1.0.1.2 14-15|0.1.0.1.2.0 11-12|0.1.0.1 10-11|0.1.0.1.1 9-10|0.1.0.1.0 6-7|0.1.0 4-5|0.1.0.0.1 3-4|0.1.0.0.0.0+0.1.0.0.0 2-3|0.1.0.0.0.1 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:04.698
(a / and 
      :op1 (p4 / person 
            :name (n / name 
                  :op1 "F204V-GFP")) 
      :op2 (p2 / precipitate-01 
            :ARG0 (w / we 
                  :ARG0-of (c2 / confirm-01 
                        :ARG1 (t / thing 
                              :ARG2-of (r / result-01) 
                              :mod (t2 / this)) 
                        :mod (b2 / biochemically)) 
                  :poss-of (l / line 
                        :ARG1-of (s3 / same-01 
                              :ARG0 (f / figure)) 
                        :mod (c / cell) 
                        :op1-of (o / or 
                              :op2 (a3 / AQP2) 
                              :op3 (v / vector)))) 
            :ARG1 (p / protein 
                  :mod (b / biotinylat))) 
      :time (a2 / after 
            :op1 (s / stimulation 
                  :mod (f2 / forskolin)) 
            :time-of (p3 / protein 
                  :mod (s2 / surface))))

# ::snt AQP2-F204V-GFP is expressed approximately equally in both cell lines ( Figure 5D , total cells ) , but is biotinylated only when wild-type AQP2 is also expressed ( Figure 5D , surface biotinylated ) .
# ::tok AQP2-F204V-GFP is expressed approximately equally in both cell lines ( Figure 5D , total cells ) , but is biotinylated only when wild-type AQP2 is also expressed ( Figure 5D , surface biotinylated ) .
# ::alignments 32-33|0.0.0 31-32|0.0 28-29|0.1.0.0.1 26-27|0.1.0.0 25-26|0.1.0.0.2 23-24|0.1.0.0.0 20-21|0.1.0.0.0.0 17-18|0 14-15|0.2.0 13-14|0.2 10-11|0.1.0.0.3 8-9|0.1.2 7-8|0.1.2.0 6-7|0.1.2.1 4-5|0.1.1 3-4|0.3 2-3|0.1 0-1|0.1.0.1.0+0.1.0.1+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:05.239
(c / contrast-01 
      :ARG0 (s / surface 
            :mod-of (b / biotinylat)) 
      :ARG1 (e3 / express-01 
            :ARG1 (p / person 
                  :ARG0-of (e / express-01 
                        :ARG1 (a2 / AQP2 
                              :mod (o / only)) 
                        :ARG2 (f / figure) 
                        :mod (a / also) 
                        :op1-of (f2 / figure)) 
                  :name (n / name 
                        :op1 "AQP2-F204V-GFP")) 
            :ARG2 (e2 / equal) 
            :manner (l / line 
                  :mod (c3 / cell) 
                  :mod (b2 / both))) 
      :ARG2 (t / total-01 
            :ARG1 (c2 / cell)) 
      :mod (a3 / approximately))

# ::snt Since only cell surface proteins are accessible to biotin , these results indicate that AQP2-F204V is transported to the cell surface when wild-type AQP2 is present , but not on its own .
# ::tok Since only cell surface proteins are accessible to biotin , these results indicate that AQP2-F204V is transported to the cell surface when wild-type AQP2 is present , but not on its own .
# ::alignments 28-29|0.1.2.1.0 27-28|0 25-26|0.0 23-24|0.0.0 20-21|0.1.3 19-20|0.1.3.0 16-17|0.1 14-15|0.1.1.0.0+0.1.1.0+0.1.1 12-13|0.1.2 11-12|0.1.2.0.0+0.1.2.0 10-11|0.1.2.0.1 8-9|0.1.2.1.2 6-7|0.1.2.1 4-5|0.1.2.1.1 3-4|0.1.2.1.1.0 2-3|0.1.2.1.1.0.0 1-2|0.1.2.1.1.0.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:05.728
(c / contrast-01 
      :ARG1 (p / present 
            :domain (a / AQP2)) 
      :ARG2 (t / transport-01 
            :ARG0 (s3 / since) 
            :ARG1 (p2 / person 
                  :name (n / name 
                        :op1 "AQP2-F204V")) 
            :ARG1-of (i / indicate-01 
                  :ARG0 (t2 / thing 
                        :ARG2-of (r / result-01) 
                        :mod (t3 / this)) 
                  :condition (a2 / access-01 
                        :ARG0 - 
                        :ARG1 (p3 / protein 
                              :mod (s2 / surface 
                                    :mod (c3 / cell 
                                          :mod (o / only)))) 
                        :ARG2 (b / biotin))) 
            :ARG2 (s / surface 
                  :mod (c2 / cell))))

# ::snt Aqp2F204/F204V mice are viable and grow and reproduce normally .
# ::tok Aqp2F204/F204V mice are viable and grow and reproduce normally .
# ::alignments 8-9|0.0.0 7-8|0.0 6-7|0 5-6|0.1.0 4-5|0.1 3-4|0.1.0.0.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:05.756
(a / and 
      :op1 (r / reproduce-01 
            :ARG1-of (n / normal-02)) 
      :op2-of (a2 / and 
            :op1 (g / grow-01 
                  :ARG1 (m / mouse 
                        :domain-of (v / viable)))))

# ::snt They are , however , severely defective in their ability to concentrate urine , leading to increased urine output and water intake , thus making them the first mouse model of NDI to survive to maturity .
# ::tok They are , however , severely defective in their ability to concentrate urine , leading to increased urine output and water intake , thus making them the first mouse model of NDI to survive to maturity .
# ::alignments 35-36|0.0.0.0.1 33-34|0.0.0.0 31-32|0.0.0.1.0+0.0.0.1+0.0.0 29-30|0.0.0.0.0 28-29|0.0.0.0.0.0 23-24|0.1.0.0 21-22|0.2 20-21|0.2.1 19-20|0 18-19|0.1 17-18|0.1.1 16-17|0.1.0 14-15|0.0 12-13|0.0.1.0 11-12|0.0.1 9-10|0.0.1.1 6-7|0.2.0.0 5-6|0.2.0.0.0 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:06.388
(a / and 
      :ARG1-of (l / lead-01 
            :ARG0 (o / organization 
                  :ARG0-of (s / survive-01 
                        :ARG1 (m2 / model 
                              :mod (m3 / mouse)) 
                        :ARG2 (m / maturity)) 
                  :name (n / name 
                        :op1 "NDI")) 
            :ARG2-of (c / concentrate-01 
                  :ARG1 (u2 / urine) 
                  :purpose-of (a2 / ability))) 
      :op1 (o2 / output 
            :ARG1-of (i / increase-01 
                  :ARG0 (t / thus-far)) 
            :mod (u / urine)) 
      :op2 (t2 / take-01 
            :ARG0 (t3 / they 
                  :poss-of (d / defective 
                        :degree (s2 / severe))) 
            :ARG1 (w / water)))

# ::snt In humans , NDI is caused by mutations in Avpr2 or Aqp2 .
# ::tok In humans , NDI is caused by mutations in Avpr2 or Aqp2 .
# ::alignments 11-12|0.0.0.1 10-11|0.0.0 9-10|0.0.0.0 7-8|0.0 5-6|0 3-4|0.1.0.0+0.1.0+0.1 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:06.434
(c / cause-01 
      :ARG0 (m / mutate-01 
            :ARG1 (o / or 
                  :op1 (a2 / Avpr2) 
                  :op2 (a / Aqp2))) 
      :ARG1 (o2 / organization 
            :name (n / name 
                  :op1 "NDI")) 
      :location (h / human))

# ::snt Knockout of the X-linked Avpr2 gene in mice [ 15 ] gave an NDI-like phenotype in male , hemizygous neonates , but the phenotype could not be assessed in adults as the mice died within 1 wk of birth .
# ::tok Knockout of the X-linked Avpr2 gene in mice [ 15 ] gave an NDI-like phenotype in male , hemizygous neonates , but the phenotype could not be assessed in adults as the mice died within 1 wk of birth .
# ::alignments 38-39|0.0.2 35-36|0.0.0 33-34|0.1.1 32-33|0.1.1.1 29-30|0.1.0.2 27-28|0.1.0 25-26|0.1.2 24-25|0.1 23-24|0.1.0.1 21-22|0 19-20|0.0.3 18-19|0.0.3.0 16-17|0.0.2.0 14-15|0.0.1 13-14|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 11-12|0.0 9-10|0.1.1.0 7-8|0.1.0.0.0.0 5-6|0.1.0.0.0 3-4|0.1.0.0.0.1 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:07.163
(c / contrast-01 
      :ARG1 (g / give-01 
            :ARG0 1 
            :ARG1 (p3 / phenotype 
                  :mod (t / thing 
                        :name (n2 / name 
                              :op1 "NDI-like"))) 
            :ARG2-of (b / birth-01 
                  :ARG1 (m2 / male)) 
            :manner (n / neonat 
                  :mod (h / hemizygou))) 
      :ARG2 (p / possible-01 
            :ARG1 (a2 / assess-01 
                  :ARG0 (k / knockout 
                        :poss (g2 / gene 
                              :location (m3 / mouse) 
                              :mod (x / x-link))) 
                  :ARG1 (p2 / phenotype) 
                  :location (a / adult)) 
            :condition (d / die-01 
                  :ARG0 15 
                  :ARG1 (m / mouse)) 
            :polarity -))

# ::snt The adult heterozygous females showed a mild tendency toward increased urinary output and water intake and decreased urine osmolality .
# ::tok The adult heterozygous females showed a mild tendency toward increased urinary output and water intake and decreased urine osmolality .
# ::alignments 18-19|0.2.0.1 17-18|0.2.0.1.0 16-17|0.2.0 15-16|0.2 14-15|0.2.0.2.2 13-14|0.2.0.2.2.0 12-13|0.2.0.2 11-12|0.2.0.2.1.0 10-11|0.2.0.2.0 9-10|0.2.0.2.1 7-8|0.1 6-7|0.1.0 4-5|0 3-4|0.0 2-3|0.0.0 1-2|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:07.541
(s / show-01 
      :ARG0 (f / female 
            :mod (h / heterozygou)) 
      :ARG1 (t2 / tendency 
            :mod (m / mild)) 
      :op1-of (a / and 
            :op2 (d / decrease-01 
                  :ARG0 (a3 / adult) 
                  :ARG1 (o / osmolality 
                        :mod (u / urine)) 
                  :op3-of (a2 / and 
                        :mod (u2 / urinary) 
                        :op1 (i / increase-01 
                              :ARG1 (o2 / output)) 
                        :op2 (t / take-01 
                              :ARG1 (w / water))))))

# ::snt Knockout of the mouse Aqp2 gene has not been reported .
# ::tok Knockout of the mouse Aqp2 gene has not been reported .
# ::alignments 9-10|0 7-8|0.2 5-6|0.0.0 3-4|0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:07.579
(r / report-01 
      :ARG1 (k / knockout 
            :poss (g / gene)) 
      :ARG2 (m / mouse) 
      :polarity -)

# ::snt A knock-in of a human disease-causing mutation ( T126M ) , however , has been made [ 18 ] .
# ::tok A knock-in of a human disease-causing mutation ( T126M ) , however , has been made [ 18 ] .
# ::alignments 17-18|0.0.0 6-7|0.1 5-6|0 4-5|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:07.604
(d / disease-caus 
      :mod (h / human 
            :poss-of 18) 
      :mod-of (m / mutation))

# ::snt These mice have a severe urine-concentrating defect resulting in dehydration and death within 1 wk of birth .
# ::tok These mice have a severe urine-concentrating defect resulting in dehydration and death within 1 wk of birth .
# ::alignments 16-17|0.0.1 13-14|0.0.0 11-12|0.0.2.0.1 10-11|0.0.2.0 9-10|0.0.2.0.0 7-8|0.0.2 6-7|0.0 5-6|0.0.4 4-5|0.0.3 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:07.726
(m / mouse 
      :ARG1-of (d3 / defect-01 
            :ARG0 1 
            :ARG1-of (b / birth-01) 
            :ARG1-of (r / result-01 
                  :ARG2 (a / and 
                        :op1 (d2 / dehydrate-01) 
                        :op2 (d / die-01))) 
            :mod (s / severe) 
            :mod (u / urine-concentrat)) 
      :mod (t / this))

# ::snt Curiously , AQP2-T126M does localize properly in at least a subset of cells .
# ::tok Curiously , AQP2-T126M does localize properly in at least a subset of cells .
# ::alignments 12-13|0.1.0 10-11|0.1 5-6|0.3 4-5|0 2-3|0.0.0.0+0.0.0+0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:07.758
(l / localize-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "AQP2-T126M")) 
      :ARG1 (s / subset 
            :domain (c / cell)) 
      :location (c2 / curiously) 
      :manner (p / proper))

# ::snt The grossly abnormal collecting duct morphology makes it impossible to pinpoint the molecular defect in these knock-in mice .
# ::tok The grossly abnormal collecting duct morphology makes it impossible to pinpoint the molecular defect in these knock-in mice .
# ::alignments 17-18|0.0 15-16|0.0.0 13-14|0 12-13|0.2 10-11|0.1 6-7|0.1.0.0 5-6|0.1.0 4-5|0.1.0.3 3-4|0.1.0.1 2-3|0.1.0.2 1-2|0.1.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:07.819
(d / defect-01 
      :ARG1 (m / mouse 
            :mod (t / this)) 
      :ARG1-of (p / pinpoint-01 
            :ARG0 (m4 / morphology 
                  :ARG0-of (m3 / make-02) 
                  :ARG1-of (c / collect-01) 
                  :mod (a / abnormal 
                        :ARG1-of (g / gross-06)) 
                  :mod (d2 / duct))) 
      :mod (m2 / molecule))

# ::snt The T126M knock-in clearly shows that Aqp2 is an essential gene [ 18 ] .
# ::tok The T126M knock-in clearly shows that Aqp2 is an essential gene [ 18 ] .
# ::alignments 12-13|0.1.0 10-11|0.1.1 9-10|0.1.1.0 6-7|0.0 4-5|0 3-4|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:07.897
(s / show-01 
      :ARG1 (a / Aqp2) 
      :ARG1-of (c / clear-06 
            :ARG0 18 
            :ARG2 (g / gene 
                  :mod (e / essential))))

# ::snt The fact that our mice survive shows either that AQP2-F204V possesses some residual water transporting ability or that there are AVP-independent pathways for water reabsorption .
# ::tok The fact that our mice survive shows either that AQP2-F204V possesses some residual water transporting ability or that there are AVP-independent pathways for water reabsorption .
# ::alignments 24-25|0.1.2.0.0 23-24|0.1.2.0.0.0 21-22|0.1.2.0 16-17|0.1.3 15-16|0.1.2.1 14-15|0.1.2 13-14|0.1.1 12-13|0.1.1.0 11-12|0.1.1.1 10-11|0.1 9-10|0.1.0.0.0+0.1.0.0+0.1.0 7-8|0.3 6-7|0 5-6|0.2 4-5|0.2.0 3-4|0.2.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:09.003
(s2 / show-01 
      :ARG0 (f / fact) 
      :ARG1 (p2 / possess-01 
            :ARG0 (p3 / person 
                  :name (n / name 
                        :op1 "AQP2-F204V")) 
            :ARG1 (w2 / water 
                  :mod (r2 / residual) 
                  :quant (s / some)) 
            :ARG2 (t / transport-01 
                  :ARG0 (p / pathway 
                        :purpose (r / reabsorption 
                              :mod (w / water))) 
                  :ARG1 (a / ability)) 
            :op1-of (o / or)) 
      :manner (s3 / survive-01 
            :ARG1 (m / mouse 
                  :poss (w3 / we))) 
      :mod (e / either))

# ::snt Residual activity of AQP2-F204V is likely , as mutant animals show some small response to dDAVP , although dDAVP-stimulated urine osmolality remains quite low .
# ::tok Residual activity of AQP2-F204V is likely , as mutant animals show some small response to dDAVP , although dDAVP-stimulated urine osmolality remains quite low .
# ::alignments 23-24|0.0.0.0 22-23|0.0.0.0.0 21-22|0.0.0 20-21|0.0 19-20|0.0.1 18-19|0 15-16|0.0.0.1.1.1 13-14|0.0.0.1.1 12-13|0.0.0.1.1.2 11-12|0.0.0.1.1.3 10-11|0.0.0.1 9-10|0.0.0.1.1.0 8-9|0.0.0.1.0.0.0 5-6|0.0.0.1.0.1 3-4|0.0.0.1.0.0.1.0+0.0.0.1.0.0.1+0.0.0.1.0.0 1-2|0.0.0.1.0 0-1|0.0.0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:09.727
(d / ddavp-stimulat 
      :mod-of (o / osmolality 
            :ARG1-of (r / remain-01 
                  :ARG3 (l / low-04 
                        :degree (q / quite)) 
                  :condition-of (s3 / show-01 
                        :ARG0 (a2 / activity-06 
                              :ARG0 (p / person 
                                    :mod (m / mutant) 
                                    :name (n / name 
                                          :op1 "AQP2-F204V")) 
                              :ARG1 (l2 / likely-01) 
                              :mod (r3 / residual)) 
                        :ARG1 (r2 / respond-01 
                              :ARG0 (a / animal) 
                              :ARG1 (d2 / dDAVP) 
                              :mod (s / small) 
                              :quant (s2 / some)))) 
            :mod (u / urine)))

# ::snt Immunostaining of kidney shows that AQP2-F204V does not efficiently transport water , because it fails to localize to the apical cell surface after dDAVP treatment .
# ::tok Immunostaining of kidney shows that AQP2-F204V does not efficiently transport water , because it fails to localize to the apical cell surface after dDAVP treatment .
# ::alignments 24-25|0.2.0.0.1.0 23-24|0.2.0.0.1.0.0 22-23|0.2.0.0.1 21-22|0.2.0.0.0 20-21|0.2.0.0.0.0 19-20|0.2.1.1.0.0 16-17|0.2.0.0 14-15|0.2.0 12-13|0.2 10-11|0.2.1.1 9-10|0.2.1.1.0 8-9|0.2.1 7-8|0.2.1.2 5-6|0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 3-4|0 2-3|0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:11.587
(s2 / show-01 
      :ARG0 (i / immunostain) 
      :ARG1 (k / kidney) 
      :ARG2-of (c2 / cause-01 
            :ARG0 (f / fail-01 
                  :ARG2 (l / localize-01 
                        :ARG2 (s / surface 
                              :mod (c / cell)) 
                        :time (a / after 
                              :op1 (t / treat-03 
                                    :ARG2 (d / dDAVP))))) 
            :ARG1 (e / efficient-01 
                  :ARG0 (p / person 
                        :name (n / name 
                              :op1 "AQP2-F204V")) 
                  :ARG1 (w / water 
                        :mod (t2 / transport-01 
                              :ARG1 (a2 / apical))) 
                  :polarity -)))

# ::snt Some residual activity of AQP2 would imply that some small , undetectable portion of the mutant protein is getting to the cell surface .
# ::tok Some residual activity of AQP2 would imply that some small , undetectable portion of the mutant protein is getting to the cell surface .
# ::alignments 22-23|0.0.0.0 21-22|0.0.0 16-17|0.1.2 15-16|0.1.2.0 12-13|0.1 11-12|0.1.1 9-10|0.1.0 8-9|0.1.3 6-7|0 2-3|0.0 1-2|0.0.2 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:11.668
(i / imply-01 
      :ARG0 (a / activity-06 
            :ARG1 (c / cell 
                  :mod-of (s / surface)) 
            :mod (s4 / some) 
            :mod (r / residual)) 
      :ARG1 (p2 / portion 
            :mod (s2 / small) 
            :mod (u / undetectable) 
            :part-of (p / protein 
                  :mod (m / mutant)) 
            :quant (s3 / some)))

# ::snt The surface biotinylation experiment ( Figure 5D ) suggests that no mutant protein gets to the surface , but this does not necessarily reflect the situation in vivo .
# ::tok The surface biotinylation experiment ( Figure 5D ) suggests that no mutant protein gets to the surface , but this does not necessarily reflect the situation in vivo .
# ::alignments 27-28|0.1.1.0 25-26|0.1.1 23-24|0.1 22-23|0.1.2 21-22|0.1.3 19-20|0.1.0 18-19|0 16-17|0.0.3 13-14|0.0 12-13|0.0.0 11-12|0.0.0.0 10-11|0.0.4 8-9|0.0.2 5-6|0.0.1 3-4|0.0.2.0 2-3|0.0.2.0.0 1-2|0.0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:12.060
(c / contrast-01 
      :ARG1 (g / get-01 
            :ARG0 (p / protein 
                  :mod (m / mutant)) 
            :ARG1 (f / figure) 
            :ARG1-of (s3 / suggest-01 
                  :ARG0 (e / experiment-01 
                        :ARG0 (b / biotinylation) 
                        :ARG1 (s4 / surface))) 
            :ARG2 (s2 / surface) 
            :polarity -) 
      :ARG2 (r / reflect-01 
            :ARG0 (t / this) 
            :ARG2 (s / situation 
                  :mod (v / vivo)) 
            :manner (n / necessarily) 
            :polarity -))

# ::snt While this small fraction of protein may not be detectable by immunofluorescence , Western blotting shows that some mutant protein does progress beyond the ER ( 35 -- 45 kDa species in Figure 3A ) .
# ::tok While this small fraction of protein may not be detectable by immunofluorescence , Western blotting shows that some mutant protein does progress beyond the ER ( 35 -- 45 kDa species in Figure 3A ) .
# ::alignments 32-33|0.0.2.2 30-31|0.1.0 29-30|0.1.0.0 28-29|0.1 26-27|0.0.2.0 24-25|0.0.2.1.0.2.0.0.0+0.0.2.1.0.2.0.0+0.0.2.1.0.2.0 22-23|0.0.2.1.0.2 21-22|0.0.2.1.0 19-20|0.0.2.1.0.1 18-19|0.0.2.1.0.1.0 17-18|0.0.2.1.0.1.1 15-16|0.0.2.1 14-15|0.0.2 13-14|0.0.2.3.1+0.0.2.3.0.0+0.0.2.3.0+0.0.2.3 11-12|0.0.2.1.0.0 9-10|0.0 7-8|0.0.0.0 6-7|0 5-6|0.0.1.2 3-4|0.0.1 2-3|0.0.1.0 1-2|0.0.1.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:12.875
(p3 / possible-01 
      :ARG1 (d / detectable 
            :ARG0-of (w2 / while-01 
                  :ARG1 -) 
            :domain (f2 / fraction 
                  :mod (s4 / small) 
                  :mod (t / this) 
                  :part-of (p4 / protein)) 
            :domain (b2 / blot-01 
                  :ARG0 35 
                  :ARG0-of (s3 / show-01 
                        :ARG1 (p / progress-01 
                              :ARG0 (i / immunofluorescence) 
                              :ARG1 (p2 / protein 
                                    :mod (m / mutant) 
                                    :quant (s2 / some)) 
                              :location (b / beyond 
                                    :op1 (o / organization 
                                          :name (n / name 
                                                :op1 "ER"))))) 
                  :ARG1 (f / figure) 
                  :mod (w / world-region 
                        :name (n2 / name 
                              :op1 "West") 
                        :wiki "Western_world"))) 
      :ARG2 (4 / 45 
            :quant-of (s / species 
                  :mod (k / kDa))))

# ::snt Compared to wild-type , mutant protein is enriched in the high-mannose , core-glycosylated form ( 31 kDa ) and deficient in nonglycosylated ( 29 kDa ) and complex glycosylated ( 35 -- 45 kDa ) forms .
# ::tok Compared to wild-type , mutant protein is enriched in the high-mannose , core-glycosylated form ( 31 kDa ) and deficient in nonglycosylated ( 29 kDa ) and complex glycosylated ( 35 -- 45 kDa ) forms .
# ::alignments 35-36|0.2.2 32-33|0.2.1.1 30-31|0.2.0.3 28-29|0.1 27-28|0.2.0.2 26-27|0 23-24|0.2.0.1 21-22|0.0 18-19|0.2 16-17|0.2.0.0.0 15-16|0.2.0.0 13-14|0.2.1.2 12-13|0.2.1.2.0 7-8|0.2.1 5-6|0.2.1.0 4-5|0.2.1.0.0 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:13.131
(a / and 
      :op1 (n / nonglycosylat) 
      :op2 (g / glycosylat) 
      :op2-of (a2 / and 
            :ARG1-of (c3 / compare-01 
                  :op1-of (32 / 31 
                        :quant-of (k / kDa)) 
                  :op1-of 29 
                  :op1-of (c / complex) 
                  :op1-of 35) 
            :op1 (e / enrich-01 
                  :ARG1 (p / protein 
                        :mod (m / mutant)) 
                  :ARG2 45 
                  :manner (f2 / form 
                        :mod (c2 / core-glycosylat))) 
            :time (f / form)))

# ::snt The presence of a reduced but detectable amount of protein in the 35 -- 45 kDa range indicates that mutant protein is transported out of the ER , but with greatly reduced efficiency .
# ::tok The presence of a reduced but detectable amount of protein in the 35 -- 45 kDa range indicates that mutant protein is transported out of the ER , but with greatly reduced efficiency .
# ::alignments 32-33|0.0.0.0.0.1.1 31-32|0.0.0.0.0.1.1.0 30-31|0.0.0.0.0.1.1.0.0 28-29|0.0.0.0.0.0.1 26-27|0.0.0.0.0.0.2.0.0+0.0.0.0.0.0.2.0+0.0.0.0.0.0.2 22-23|0.0.0.0.0.0 20-21|0.0.0.0.0.0.0 19-20|0.0.0.0.0.0.0.0 17-18|0.0.0.0.0 16-17|0.0.0.0.0.1 15-16|0.0.0.0.0.1.0 14-15|0.0.0.0.0.1.2 12-13|0.0.0.0.0.0.1.0 9-10|0.0.0.2 7-8|0.0.0 6-7|0.0.0.1 5-6|0 4-5|0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:13.764
(c2 / contrast-01 
      :ARG1 (r3 / reduce-01 
            :ARG1 (a / amount 
                  :beneficiary-of (p3 / presence 
                        :ARG0-of (i / indicate-01 
                              :ARG1 (t / transport-01 
                                    :ARG1 (p / protein 
                                          :mod (m / mutant)) 
                                    :ARG2-of (c / contrast-01 
                                          :ARG0 35) 
                                    :source (o / organization 
                                          :name (n / name 
                                                :op1 "ER"))) 
                              :manner (r2 / range-01 
                                    :ARG1 (k / kDa) 
                                    :ARG1-of (e / efficient-01 
                                          :ARG1-of (r / reduce-01 
                                                :degree (g / great))) 
                                    :time 45))) 
                  :mod (d / detectable) 
                  :quant-of (p2 / protein))))

# ::snt Colocalization of AQP2-F204V with the ER protein calnexin in transfected MDCK cells shows that , while most of the mutant protein is trapped in the ER , some does progress beyond the ER .
# ::tok Colocalization of AQP2-F204V with the ER protein calnexin in transfected MDCK cells shows that , while most of the mutant protein is trapped in the ER , some does progress beyond the ER .
# ::alignments 30-31|0.0.0.3 29-30|0.0.0 27-28|0.0.0.1 22-23|0.0 20-21|0 19-20|0.1 16-17|0.0.0.0 12-13|0.0.0.2 11-12|0.0.0.2.1 9-10|0.0.0.2.1.1 7-8|0.0.0.2.1.0 6-7|0.0.0.2.1.0.0 5-6|0.0.0.2.1.0.1.0.0+0.0.0.2.1.0.1.0+0.0.0.2.1.0.1 2-3|0.0.0.2.0.0.0+0.0.0.2.0.0+0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:14.412
(p2 / protein 
      :ARG1-of (t / trap-01 
            :ARG2-of (p / progress-01 
                  :ARG0 (m2 / most) 
                  :ARG1 (s / some) 
                  :ARG1-of (s2 / show-01 
                        :ARG0 (p4 / person 
                              :name (n2 / name 
                                    :op1 "AQP2-F204V")) 
                        :manner (c / cell 
                              :location-of (c2 / calnexin 
                                    :mod (p3 / protein) 
                                    :mod (o / organization 
                                          :name (n / name 
                                                :op1 "ER"))) 
                              :mod (t2 / transfect))) 
                  :location (b / beyond))) 
      :mod (m / mutant))

# ::snt Diminished response to dDAVP , diminished abundance of mature glycosylated protein in mutant animals , and the transport of a fraction of mutant protein beyond the ER in MDCK cells are all consistent with the notion that AQP2-F204V misfolding is limited and that it may retain some residual water transporting activity .
# ::tok Diminished response to dDAVP , diminished abundance of mature glycosylated protein in mutant animals , and the transport of a fraction of mutant protein beyond the ER in MDCK cells are all consistent with the notion that AQP2-F204V misfolding is limited and that it may retain some residual water transporting activity .
# ::alignments 50-51|0.0.0.0.0.2.0.0.1.0 49-50|0.0.0.0.0.2.0.0.1.0.0 48-49|0.0.0.0.0.2.0.0.1 47-48|0.0.0.0.0.2.0.0.1.1 46-47|0.0.0.0.0.2.0.0.1.2 45-46|0.0.0.0.0.2.0.0 44-45|0.0.0.0.0.2.0 41-42|0.0.0.0.0.2 40-41|0.0.0.0.0.2.0.0.0.0 38-39|0.0.0.0.0.2.0.0.0 37-38|0.0.0.0.0.2.0.0.0.1.0.0+0.0.0.0.0.2.0.0.0.1.0+0.0.0.0.0.2.0.0.0.1 35-36|0.0.0.0.0.0 32-33|0.0.0.0.0 31-32|0.0.0.0.0.1 29-30|0.0.0.1.1.0 28-29|0.0.0.1.1.0.0 26-27|0.0.0.1.1.1.0+0.0.0.1.1.1+0.0.0.1.1 24-25|0.0.0.1.1.2 23-24|0.0.0.1.0.0 22-23|0.0.0.1.0.0.0 20-21|0.0.0.1.0 17-18|0.0.0.1 15-16|0.0.0 13-14|0.0.0.1.2 12-13|0.0.0.1.2.0 10-11|0.0.1 9-10|0.0.1.1 8-9|0.0.1.0 6-7|0.0 5-6|0 3-4|0.0.0.0.2 1-2|0.0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:17.388
(d / diminish-01 
      :ARG1 (a6 / abundance 
            :op1-of (a4 / and 
                  :ARG1-of (r3 / respond-01 
                        :ARG1-of (c / consistent-01 
                              :ARG2 (n2 / notion) 
                              :degree (a3 / all) 
                              :op1-of (a2 / and 
                                    :op2 (p / possible-01 
                                          :ARG1 (r2 / retain-01 
                                                :ARG0 (m / misfold 
                                                      :ARG1-of (l / limit-01) 
                                                      :mod (p2 / person 
                                                            :name (n / name 
                                                                  :op1 "AQP2-F204V"))) 
                                                :ARG1 (w / water 
                                                      :ARG1-of (a / activity-06 
                                                            :ARG1-of (t / transport-01)) 
                                                      :mod (r / residual) 
                                                      :quant (s / some)))))) 
                        :ARG1-of (d3 / diminish-01) 
                        :ARG2 (d2 / dDAVP)) 
                  :op2 (t2 / transport-01 
                        :ARG0 (f / fraction 
                              :part-of (p3 / protein 
                                    :mod (m3 / mutant))) 
                        :ARG1 (o / organization 
                              :location (c2 / cell 
                                    :mod (m2 / MDCK)) 
                              :name (n3 / name 
                                    :op1 "ER") 
                              :op1-of (b / beyond)) 
                        :beneficiary (a5 / animal 
                              :mod (m4 / mutant)))) 
            :poss (p4 / protein 
                  :ARG1-of (m5 / mature-02) 
                  :mod (g / glycosylat))))

# ::snt Evidently this residual activity is sufficient for the viability and growth of mutant animals .
# ::tok Evidently this residual activity is sufficient for the viability and growth of mutant animals .
# ::alignments 13-14|0.1.1.0 12-13|0.1.1.0.0 10-11|0.1.1 9-10|0.1 8-9|0.1.0 5-6|0 3-4|0.0 2-3|0.0.1 1-2|0.0.0 0-1|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:17.485
(s / suffice-01 
      :ARG0 (a3 / activity-06 
            :mod (t / this) 
            :mod (r / residual)) 
      :ARG1 (a2 / and 
            :op1 (v / viability) 
            :op2 (g / grow-01 
                  :ARG1 (a / animal 
                        :mod (m / mutant))) 
            :prep-for-of (e / evidently)))

# ::snt Reduced efficiency in exiting the ER may explain why AQP2-F204V is enriched in the 31 kDa high-mannose glycosylated form .
# ::tok Reduced efficiency in exiting the ER may explain why AQP2-F204V is enriched in the 31 kDa high-mannose glycosylated form .
# ::alignments 18-19|0.0.0.3 17-18|0.0.0.3.0 14-15|0.0.0.3.1 11-12|0.0.0.0 9-10|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 7-8|0.0 6-7|0 5-6|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 3-4|0.0.0.1 1-2|0.0.0 0-1|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:17.645
(p2 / possible-01 
      :ARG1 (e2 / explain-01 
            :ARG1 (e4 / efficient-01 
                  :ARG0-of (e / enrich-01 
                        :ARG1 (p / person 
                              :name (n / name 
                                    :op1 "AQP2-F204V"))) 
                  :ARG1 (e3 / exit-01 
                        :ARG1 (o / organization 
                              :name (n2 / name 
                                    :op1 "ER"))) 
                  :ARG1-of (r / reduce-01) 
                  :ARG2 (f / form 
                        :mod (g / glycosylat) 
                        :quant 31))))

# ::snt The high-mannose core oligosaccharide is added in the ER and is later modified and elaborated in the Golgi apparatus [ 26 ] .
# ::tok The high-mannose core oligosaccharide is added in the ER and is later modified and elaborated in the Golgi apparatus [ 26 ] .
# ::alignments 20-21|0.1.0.0.1 18-19|0.1.1.1.0 17-18|0.1.1.1.1.0+0.1.1.1.1+0.1.1.1 14-15|0.1.1.0 13-14|0.1.1 12-13|0.1.0 11-12|0.1.0.1 9-10|0.1 8-9|0.0.0.0+0.0.0+0.0 5-6|0 3-4|0.1.0.0 2-3|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:17.774
(a4 / add-01 
      :ARG1 (o / organization 
            :name (n2 / name 
                  :op1 "ER")) 
      :op1-of (a3 / and 
            :op2 (m / modify-01 
                  :ARG1 (o2 / oligosaccharide 
                        :mod (c2 / core) 
                        :poss 26) 
                  :time (l / late)) 
            :op3 (a2 / and 
                  :op1 (e / elaborate-01) 
                  :op2 (c / country 
                        :mod-of (a / apparatus) 
                        :name (n / name 
                              :op1 "Golgi")))))

# ::snt The increase in the high-mannose glycosylated form of AQP2-F204V may simply reflect its prolonged presence in the ER and exposure to oligosaccharyl transferase .
# ::tok The increase in the high-mannose glycosylated form of AQP2-F204V may simply reflect its prolonged presence in the ER and exposure to oligosaccharyl transferase .
# ::alignments 22-23|0.0.0.0.0 19-20|0.0.0.0 18-19|0.0.0 17-18|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 14-15|0.0.1 13-14|0.0.1.0 11-12|0.0 10-11|0.0.2 9-10|0 8-9|0.0.1.2.0.0+0.0.1.2.0+0.0.1.2 6-7|0.0.1.2.1 5-6|0.0.1.2.1.0 1-2|0.0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:18.217
(p3 / possible-01 
      :ARG1 (r / reflect-01 
            :ARG1 (a / and 
                  :op1 (e / expose-01 
                        :ARG1 (t / transferase))) 
            :ARG2 (p / presence 
                  :ARG1-of (p2 / prolong-01) 
                  :location (o / organization 
                        :name (n / name 
                              :op1 "ER")) 
                  :poss (p4 / person 
                        :name (n2 / name 
                              :op1 "AQP2-F204V") 
                        :poss-of (f / form 
                              :mod (g / glycosylat))) 
                  :poss (i / increase-01)) 
            :manner (s / simple)))

# ::snt While improper localization of AQP2 explains the phenotype of homozygous mutant mice , the complete lack of a phenotype in heterozygous mice is more difficult to explain .
# ::tok While improper localization of AQP2 explains the phenotype of homozygous mutant mice , the complete lack of a phenotype in heterozygous mice is more difficult to explain .
# ::alignments 26-27|0.2 24-25|0 23-24|0.1 21-22|0.0.1 20-21|0.0.1.0 18-19|0.2.0.0 15-16|0.2.0 14-15|0.2.0.1 11-12|0.0.0.1.0 10-11|0.0.0.1.0.0 9-10|0.0.0.1.0.1 7-8|0.0.0.1 5-6|0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:18.682
(d / difficult 
      :ARG0-of (w / while-01 
            :ARG1 (e2 / explain-01 
                  :ARG0 (l2 / localization 
                        :mod (i / improper)) 
                  :ARG1 (p2 / phenotype 
                        :poss (m3 / mouse 
                              :mod (m4 / mutant) 
                              :mod (h2 / homozygou)))) 
            :ARG2 (m2 / mouse 
                  :mod (h / heterozygou))) 
      :degree (m / more) 
      :domain (e / explain-01 
            :ARG1 (l / lack-01 
                  :ARG1 (p / phenotype) 
                  :ARG1-of (c / complete-02))))

# ::snt Physiologically , heterozygous mice have no symptoms ( see Figure 1C ) , and they are indistinguishable from wild type on immunostaining of kidneys ( Figure 5A ) .
# ::tok Physiologically , heterozygous mice have no symptoms ( see Figure 1C ) , and they are indistinguishable from wild type on immunostaining of kidneys ( Figure 5A ) .
# ::alignments 25-26|0.3 23-24|0.2.0.1 21-22|0.2.0.1.0 19-20|0.2.0.1.0.0 18-19|0.2.0.1.0.0.0 16-17|0.2 14-15|0.2.0 13-14|0 9-10|0.2.0.0.0 8-9|0.2.0.0 6-7|0.1 5-6|0.2.1 3-4|0.0 2-3|0.0.0 0-1|0.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:18.861
(a / and 
      :op1 (m / mouse 
            :mod (h / heterozygou)) 
      :op2 (s2 / symptom) 
      :op3 (i2 / indistinguishable 
            :domain (t2 / they 
                  :ARG0-of (s / see-01 
                        :ARG1 (f2 / figure)) 
                  :mod-of (k / kidney 
                        :mod-of (i / immunostain 
                              :location-of (t / type 
                                    :mod (w / wild))))) 
            :polarity -) 
      :op4 (f / figure) 
      :time (p / physiologically))

# ::snt The presence of 50 % of the normal amount of wild-type protein may explain the lack of symptoms , but it can not explain the lack of any ER-retained mutant protein .
# ::tok The presence of 50 % of the normal amount of wild-type protein may explain the lack of symptoms , but it can not explain the lack of any ER-retained mutant protein .
# ::alignments 30-31|0.1.0.1.0 29-30|0.1.0.1.0.0 28-29|0.0.0.1.0.0.0.0.0+0.0.0.1.0.0.0.0+0.0.0.1.0.0.0 27-28|0.1.0.1.0.1 25-26|0.1.0.1 23-24|0.1.0 22-23|0.0.1 21-22|0.1 19-20|0 17-18|0.0.0.1.1 15-16|0.0.0.1 13-14|0.0.0 12-13|0.0 11-12|0.0.0.1.0.1 8-9|0.0.0.1.0 7-8|0.0.0.1.0.0 4-5|0.0.0.0 3-4|0.0.0.0.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:19.489
(c / contrast-01 
      :ARG1 (p3 / possible-01 
            :ARG1 (e2 / explain-01 
                  :ARG0 (p5 / percentage-entity 
                        :value 50) 
                  :ARG1 (l2 / lack-01 
                        :ARG0 (a2 / amount 
                              :ARG1-of (n2 / normal-02 
                                    :ARG0 (t / thing 
                                          :name (n / name 
                                                :op1 "ER-retained"))) 
                              :quant-of (p4 / protein)) 
                        :ARG1 (s / symptom))) 
            :polarity -) 
      :ARG2 (p2 / possible-01 
            :ARG1 (e / explain-01 
                  :ARG0 (p6 / presence) 
                  :ARG1 (l / lack-01 
                        :ARG1 (p / protein 
                              :mod (m / mutant) 
                              :mod (a / any))))))

# ::snt Rather , the phenotype of the Aqp2F204V / + animals suggests that the mutant protein is being rescued by the wild-type protein .
# ::tok Rather , the phenotype of the Aqp2F204V / + animals suggests that the mutant protein is being rescued by the wild-type protein .
# ::alignments 21-22|0.1.0 17-18|0.1 14-15|0.1.1 13-14|0.1.1.0 10-11|0 9-10|0.0.0 7-8|0.0.0.0 3-4|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:19.635
(s / suggest-01 
      :ARG0 (p3 / phenotype 
            :poss (a / animal 
                  :op1-of (s2 / slash))) 
      :ARG1 (r / rescue-01 
            :ARG0 (p / protein) 
            :ARG1 (p2 / protein 
                  :mod (m / mutant))) 
      :mod (r2 / rather))

# ::snt Indeed , de Mattia et al. ( 26 ) have demonstrated that one recessive allele of Aqp2 , P262L , does not properly translocate when expressed by itself in MDCK cells , but that in the presence of wild-type protein , it localizes normally .
# ::tok Indeed , de Mattia et al. ( 26 ) have demonstrated that one recessive allele of Aqp2 , P262L , does not properly translocate when expressed by itself in MDCK cells , but that in the presence of wild-type protein , it localizes normally .
# ::alignments 43-44|0.1.2 42-43|0.1 39-40|0.1.1.0 36-37|0.1.1 32-33|0 30-31|0.2.1 29-30|0.2.1.0 25-26|0.2 22-23|0.0 21-22|0.0.0 14-15|0.1.0 13-14|0.1.0.0 10-11|0.2.0.0 7-8|0.2.0.0.0 2-4|0.2.0.1.1+0.2.0.1.0+0.2.0.1+0.2.0 0-1|0.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:20.012
(c / contrast-01 
      :ARG1 (p3 / proper 
            :polarity -) 
      :ARG2 (l / localize-01 
            :ARG0 (a / allele 
                  :mod (r / recessive)) 
            :ARG1 (p2 / presence 
                  :mod (p / protein)) 
            :ARG1-of (n / normal-02)) 
      :time (e / express-01 
            :ARG0 (p4 / person 
                  :ARG0-of (d / demonstrate-01 
                        :ARG1 26 
                        :time (i / indeed)) 
                  :name (n2 / name 
                        :op1 "de" 
                        :op2 "Mattia")) 
            :manner (c2 / cell 
                  :mod (m / MDCK))))

# ::snt The same mechanism seems to apply in vivo with Aqp2F204V / + mice .
# ::tok The same mechanism seems to apply in vivo with Aqp2F204V / + mice .
# ::alignments 12-13|0.0.1 10-11|0.0.1.0 7-8|0.0.2 5-6|0.0 3-4|0 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:20.101
(s2 / seem-01 
      :ARG1 (a / apply-01 
            :ARG0 (m2 / mechanism 
                  :ARG1-of (s3 / same-01)) 
            :ARG1 (m / mouse 
                  :op1-of (s / slash)) 
            :ARG2 (v / vivo)))

# ::snt In support of this , AQP2-F204V can interact with wild-type AQP2 ( Figure 5B ) , and when coexpressed with wild-type protein , AQP2-F204V can reach the cell surface ( Figure 5C bottom right panel and 5D ) .
# ::tok In support of this , AQP2-F204V can interact with wild-type AQP2 ( Figure 5B ) , and when coexpressed with wild-type protein , AQP2-F204V can reach the cell surface ( Figure 5C bottom right panel and 5D ) .
# ::alignments 35-36|0 34-35|0.2 33-34|0.2.0 32-33|0.2.1 30-31|0.0.1.0.0.1 28-29|0.0.1.0.1.0 27-28|0.0.1.0.1.0.0 25-26|0.0.1.0.1 24-25|0.0.1.0.1.1 21-22|0.0.0 16-17|0.0.1.0.1.1.0 12-13|0.1 10-11|0.0.1.1 7-8|0.0.1 6-7|0.0 5-6|0.0.1.0.2.0+0.0.1.0.2+0.0.1.0 3-4|0.0.1.0.0.0 1-2|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:20.469
(a / and 
      :op1 (p4 / possible-01 
            :ARG0 (p3 / protein) 
            :ARG1 (i / interact-01 
                  :ARG0 (p5 / person 
                        :ARG0-of (s2 / support-01 
                              :ARG1 (t / this) 
                              :op1-of (f / figure)) 
                        :ARG0-of (r2 / reach-01 
                              :ARG1 (s / surface 
                                    :mod (c / cell)) 
                              :ARG1-of (p2 / possible-01 
                                    :op1-of (a2 / and))) 
                        :name (n / name 
                              :op1 "AQP2-F204V")) 
                  :ARG1 (a3 / AQP2))) 
      :op2 (f2 / figure) 
      :op3 (p / panel 
            :mod (r / right) 
            :mod (b / bottom)))

# ::snt Although it has been demonstrated that a recessive allele ( encoding AQP2-R187C ) of NDI fails to interact with wild-type AQP2 [ 6 ] , here we show that AQP2-F204V does interact with the wild-type protein , presumably as part of heterotetramers , and represents a rescuable allele , both in vitro and in vivo .
# ::tok Although it has been demonstrated that a recessive allele ( encoding AQP2-R187C ) of NDI fails to interact with wild-type AQP2 [ 6 ] , here we show that AQP2-F204V does interact with the wild-type protein , presumably as part of heterotetramers , and represents a rescuable allele , both in vitro and in vivo .
# ::alignments 54-55|0.1.0.1.0.3.1 52-53|0.1.0.1.0.3 49-50|0.0 47-48|0.1.1.1 44-45|0.1.1 43-44|0.1 41-42|0.1.0.1.0.3.0 37-38|0 35-36|0.1.1.0.0.0 31-32|0.1.1.0.0 29-30|0.1.1.0.1.0+0.1.1.0.1+0.1.1.0 27-28|0.1.0 26-27|0.1.0.0 25-26|0.1.0.2 22-23|0.1.0.1.0.0.0.0 20-21|0.1.0.1.0.1.0.0+0.1.0.1.0.1.0+0.1.0.1.0.1 17-18|0.1.0.1.0.2 15-16|0.1.0.1.0 14-15|0.1.0.1.0.2.0.0.0+0.1.0.1.0.2.0.0+0.1.0.1.0.2.0 11-12|0.1.0.1.0.0.1.0+0.1.0.1.0.0.1+0.1.0.1.0.0 10-11|0.1.0.1.0.0.0 8-9|0.1.0.1.0.2.1 7-8|0.1.0.1.0.2.1.0 4-5|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:22.510
(p / presume-01 
      :ARG0 (b / both) 
      :ARG1 (a3 / and 
            :ARG1-of (s / show-01 
                  :ARG0 (w / we) 
                  :condition (d / demonstrate-01 
                        :ARG1 (f / fail-01 
                              :ARG0 (t / thing 
                                    :ARG1-of (e / encode-01 
                                          :ARG0 6) 
                                    :name (n4 / name 
                                          :op1 "AQP2-R187C")) 
                              :ARG1 (o / organization 
                                    :name (n2 / name 
                                          :op1 "AQP2")) 
                              :ARG2 (i2 / interact-01 
                                    :ARG0 (o2 / organization 
                                          :name (n3 / name 
                                                :op1 "NDI")) 
                                    :ARG1 (a4 / allele 
                                          :mod (r2 / recessive))) 
                              :op1-of (a / and 
                                    :op2 (h / heterotetramer) 
                                    :op3 (v / vivo)))) 
                  :time (h2 / here)) 
            :op1 (r / represent-01 
                  :ARG0 (p3 / person 
                        :ARG0-of (i / interact-01 
                              :ARG1 (p2 / protein)) 
                        :name (n / name 
                              :op1 "AQP2-F204V")) 
                  :ARG1 (a2 / allele))))

# ::snt Immunostaining the kidneys of homozygous Aqp2F204V/F204V mice shows that the mutant-expressing collecting duct cells can not mediate water reabsorption , because it fails to insert into the apical plasma membrane in response to dDAVP .
# ::tok Immunostaining the kidneys of homozygous Aqp2F204V/F204V mice shows that the mutant-expressing collecting duct cells can not mediate water reabsorption , because it fails to insert into the apical plasma membrane in response to dDAVP .
# ::alignments 33-34|0.0 31-32|0 29-30|0.1.0 28-29|0.1.0.0 27-28|0.1.0.1 24-25|0.1 22-23|0.1.1 20-21|0.1.1.0 18-19|0.1.1.0.0.1 17-18|0.1.1.1 16-17|0.1.1.0.0 15-16|0.1.1.0.0.2.1 14-15|0.1.1.0.0.2 13-14|0.1.1.0.0.0 12-13|0.1.1.0.0.0.1 11-12|0.1.1.0.0.0.0 10-11|0.1.1.0.0.0.2 7-8|0.1.1.0.0.2.0 6-7|0.1.1.0.0.2.0.0 4-5|0.1.1.0.0.2.0.0.0 2-3|0.1.1.0.0.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:22.964
(r / respond-01 
      :ARG1 (d / dDAVP) 
      :ARG2 (i / insert-01 
            :ARG2 (m / membrane 
                  :mod (p / plasma) 
                  :mod (a / apical)) 
            :ARG2-of (f / fail-01 
                  :ARG0-of (c / cause-01 
                        :ARG1 (m2 / mediate-01 
                              :ARG0 (c2 / cell 
                                    :ARG1-of (c3 / collect-01) 
                                    :mod (d2 / duct) 
                                    :mod (m3 / mutant-express)) 
                              :ARG1 (r2 / reabsorption) 
                              :ARG1-of (p2 / possible-01 
                                    :ARG1-of (s / show-01 
                                          :ARG0 (m4 / mouse 
                                                :mod (h / homozygou) 
                                                :poss-of (k / kidney))) 
                                    :polarity -))) 
                  :ARG1 (w / water))))

# ::snt This is this first in vivo proof of a long-standing hypothesis that comes from in vitro studies with recessive Aqp2 mutations .
# ::tok This is this first in vivo proof of a long-standing hypothesis that comes from in vitro studies with recessive Aqp2 mutations .
# ::alignments 20-21|0.0 18-19|0 16-17|0.0.2 15-16|0.0.2.2 12-13|0.0.2.1 10-11|0.0.2.1.0 9-10|0.0.2.1.0.0 6-7|0.0.2.0 2-3|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:23.173
(r / recessive 
      :mod-of (m / mutate-01 
            :ARG0 (t2 / this) 
            :ARG1 (t / this) 
            :ARG2-of (s / study-01 
                  :ARG1 (p / proof) 
                  :ARG3-of (c / come-01 
                        :ARG0 (h / hypothesi 
                              :mod (l / long-stand))) 
                  :mod (v / vitro))))

# ::snt Transfection into MDCK cells of any of several Aqp2 mutations corresponding to recessive human alleles shows abnormal subcellular localization [ 25 ] , [ 27 ] and failure to appropriately translocate to the plasma membrane .
# ::tok Transfection into MDCK cells of any of several Aqp2 mutations corresponding to recessive human alleles shows abnormal subcellular localization [ 25 ] , [ 27 ] and failure to appropriately translocate to the plasma membrane .
# ::alignments 34-35|0.0.4.1.0.1 33-34|0.0.4.1.0.1.0 30-31|0.0.4.1.0 29-30|0.0.4.1.0.0 27-28|0.0.4 26-27|0.0.4.1 24-25|0.0.2.1 20-21|0.0.0 18-19|0.0.1.0 17-18|0.0.1.0.0 16-17|0.0.4.0 15-16|0.0.1 14-15|0 13-14|0.1 10-11|0.0.2 9-10|0.0 7-8|0.0.5 5-6|0.0.3 3-4|0.0.2.0 2-3|0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:24.121
(a4 / allel 
      :ARG1-of (m2 / mutate-01 
            :ARG0 25 
            :ARG0-of (s2 / show-01 
                  :ARG1 (l / localization 
                        :mod (s / subcellular))) 
            :ARG1-of (c / correspond-01 
                  :ARG0 (c2 / cell 
                        :mod (m3 / MDCK)) 
                  :op1-of 27) 
            :mod (a5 / any) 
            :purpose (f / fail-01 
                  :ARG0 (a3 / abnormal) 
                  :op1-of (a2 / and 
                        :poss-of (t / translocate 
                              :mod (a / appropriate) 
                              :op1 (m / membrane 
                                    :mod (p / plasma))))) 
            :quant (s3 / several)) 
      :mod (h / human))

# ::snt Thus , misfolding , retention in the ER , and failure to translocate in response to dDAVP were proposed as the mechanism for autosomal recessive NDI .
# ::tok Thus , misfolding , retention in the ER , and failure to translocate in response to dDAVP were proposed as the mechanism for autosomal recessive NDI .
# ::alignments 25-26|0.2.1.0.2.0+0.2.1.0.2+0.2.1.0 24-25|0.2.1.0.0 23-24|0.2.1.0.1 21-22|0.2.1 18-19|0.2 16-17|0.1 14-15|0 10-11|0.2.0.2 9-10|0.2.0 7-8|0.2.0.1.0.0.0+0.2.0.1.0.0+0.2.0.1.0 4-5|0.2.0.1 2-3|0.2.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:24.671
(r2 / respond-01 
      :ARG0 (t / thu) 
      :ARG1 (d / dDAVP) 
      :purpose (p / propose-01 
            :ARG1 (a2 / and 
                  :op1 (m2 / misfold) 
                  :op2 (r3 / retention 
                        :location (o2 / organization 
                              :name (n2 / name 
                                    :op1 "ER"))) 
                  :op3 (f / fail-01)) 
            :ARG2 (m / mechanism 
                  :beneficiary (o / organization 
                        :mod (r / recessive) 
                        :mod (a / autosomal) 
                        :name (n / name 
                              :op1 "NDI")))))

# ::snt Here we not only prove this hypothesis but also establish a useful model for human NDI .
# ::tok Here we not only prove this hypothesis but also establish a useful model for human NDI .
# ::alignments 15-16|0.1.1.1.1.0+0.1.1.1.1+0.1.1.1 14-15|0.1.1.1.0 12-13|0.1.1 11-12|0.1.1.0 9-10|0.1 8-9|0.1.2 7-8|0 6-7|0.1.0.0.0 5-6|0.1.0.0.0.0 4-5|0.1.0.0 3-4|0.1.0.0.1 2-3|0.1.0.0.1.0 1-2|0.1.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:24.948
(c / contrast-01 
      :ARG1 (h3 / here) 
      :ARG2 (e / establish-01 
            :ARG0 (w / we 
                  :ARG0-of (p / prove-01 
                        :ARG1 (h2 / hypothesi 
                              :mod (t / this)) 
                        :mod (o2 / only 
                              :polarity -))) 
            :ARG1 (m / model 
                  :ARG1-of (u / useful-05) 
                  :beneficiary (o / organization 
                        :mod (h / human) 
                        :name (n / name 
                              :op1 "NDI"))) 
            :mod (a / also)))

# ::snt This mouse model of NDI based on an Aqp2 allele that can be rescued provides the opportunity to test therapies , including gene therapy , that may promote proper subcellular localization .
# ::tok This mouse model of NDI based on an Aqp2 allele that can be rescued provides the opportunity to test therapies , including gene therapy , that may promote proper subcellular localization .
# ::alignments 30-31|0.1.0.1.0.0.0.0 29-30|0.1.0.1.0.0.0.0.1 28-29|0.1.0.1.0.0.0.0.0 27-28|0.1.0.1.0.0.0 26-27|0.1.0.1.0.0.0.1 23-24|0.0 22-23|0.0.0 19-20|0.1.0.1.0.0 18-19|0.1.0.1.0 16-17|0.1.0.1 14-15|0.1.0 13-14|0.1 11-12|0 9-10|0.1.0.0.0.1 5-6|0.1.0.0.0 4-5|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 2-3|0.1.0.0 1-2|0.1.0.0.2 0-1|0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:25.509
(p5 / possible-01 
      :ARG0 (t / therapy 
            :mod (g / gene)) 
      :ARG1 (r / rescue-01 
            :ARG1 (p4 / provide-01 
                  :ARG0 (m / model 
                        :ARG1-of (b / base-02 
                              :ARG0 (o2 / organization 
                                    :name (n / name 
                                          :op1 "NDI")) 
                              :ARG2 (a / allele)) 
                        :mod (t4 / this) 
                        :mod (m2 / mouse)) 
                  :ARG1 (o / opportunity 
                        :purpose (t3 / test-01 
                              :ARG1 (t2 / therapi 
                                    :ARG0-of (p2 / promote-02 
                                          :ARG1 (l / localization 
                                                :mod (p / proper) 
                                                :mod (s / subcellular)) 
                                          :ARG1-of (p3 / possible-01))))))))

# ::snt Generation of ENU mice and housing .
# ::tok Generation of ENU mice and housing .
# ::alignments 5-6|0.1 4-5|0 3-4|0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:25.527
(a / and 
      :op1 (m / mouse) 
      :op2 (h / house-01 
            :ARG1 (g / generation)))

# ::snt ENU mutagenized C57BL/6 mice were generated as described [ 19 ] .
# ::tok ENU mutagenized C57BL/6 mice were generated as described [ 19 ] .
# ::alignments 9-10|0.0 7-8|0.1.0 5-6|0 3-4|0.1 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:25.563
(g / generate-01 
      :ARG0 19 
      :ARG1 (m / mouse 
            :ARG1-of (d / describe-01) 
            :mod (m2 / mutageniz)))

# ::snt Mice were maintained by backcrossing affected animals to C57BL/6 and housed in the Genomics Institute of the Novartis Research Foundation Specific Pathogen Free animal facility ( La Jolla , California , United States ) .
# ::tok Mice were maintained by backcrossing affected animals to C57BL/6 and housed in the Genomics Institute of the Novartis Research Foundation Specific Pathogen Free animal facility ( La Jolla , California , United States ) .
# ::alignments 31-33|0.1.1.1.0.0.1+0.1.1.1.0.0.0.1+0.1.1.1.0.0.0.0+0.1.1.1.0.0.0+0.1.1.1.0.0 29-30|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 26-28|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 24-25|0.1.1.1 23-24|0.1.1.1.0.1 22-23|0.1.1.1.0 20-22|0.1.1.3.0.1+0.1.1.3.0.0+0.1.1.3.0+0.1.1.3 17-20|0.1.1.2.0.2+0.1.1.2.0.1+0.1.1.2.0.0+0.1.1.2.0+0.1.1.2 13-15|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 10-11|0.1 9-10|0 6-7|0.0.2 5-6|0.0.2.0 2-3|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:25.941
(a2 / and 
      :op1 (m / maintain-01 
            :ARG0 (c2 / country 
                  :name (n3 / name 
                        :op1 "La" 
                        :op2 "Jolla")) 
            :ARG1 (m2 / mouse) 
            :ARG2 (a3 / animal 
                  :ARG1-of (a4 / affect-01))) 
      :op2 (h / house-01 
            :ARG1 (s / state 
                  :name (n2 / name 
                        :op1 "California") 
                  :wiki "California") 
            :ARG2 (o2 / organization 
                  :name (n6 / name 
                        :op1 "Genomics" 
                        :op2 "Institute") 
                  :poss (f / facility 
                        :ARG0-of (f2 / free-04 
                              :ARG1 (c / country 
                                    :name (n / name 
                                          :op1 "United" 
                                          :op2 "States") 
                                    :wiki "United_States") 
                              :mod-of (a / animal))) 
                  :poss (o / organization 
                        :name (n5 / name 
                              :op1 "Novartis" 
                              :op2 "Research" 
                              :op3 "Foundation")) 
                  :poss (t / thing 
                        :name (n4 / name 
                              :op1 (s2 / Specific) 
                              :op2 (p / Pathogen))))))

# ::snt All procedures were approved by the Genomics Institute of the Novartis Research Foundation Institutional Animal Care and Use Committee .
# ::tok All procedures were approved by the Genomics Institute of the Novartis Research Foundation Institutional Animal Care and Use Committee .
# ::alignments 17-19|0.0.1.1.0.0.1+0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 16-17|0.0.1.1 10-16|0.0.1.0.5+0.0.1.0.4+0.0.1.0.3+0.0.1.0.2+0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 6-8|0.0.0.1+0.0.0.0+0.0.0+0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:26.214
(a2 / approve-01 
      :ARG0 (o3 / organization 
            :name (n3 / name 
                  :op1 "Genomics" 
                  :op2 "Institute") 
            :part-of (o2 / organization 
                  :name (n2 / name 
                        :op1 "Novartis" 
                        :op2 "Research" 
                        :op3 "Foundation" 
                        :op4 "Institutional" 
                        :op5 "Animal" 
                        :op6 "Care") 
                  :op1-of (a / and 
                        :op2 (o / organization 
                              :name (n / name 
                                    :op1 "Use" 
                                    :op2 "Committee"))))) 
      :ARG1 (p / procedure 
            :quant (a3 / all)))

# ::snt Constructs .
# ::tok Constructs .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:26.217
(c / construct-01)

# ::snt The complete coding sequence of mouse AQP2 from an IMAGE clone was digested from the pCMV  SPORT6 plasmid with EcoRI and NotI and ligated into pcDNA3 .1 ( Invitrogen , Carlsbad , California , United States ) .
# ::tok The complete coding sequence of mouse AQP2 from an IMAGE clone was digested from the pCMV  SPORT6 plasmid with EcoRI and NotI and ligated into pcDNA3 .1 ( Invitrogen , Carlsbad , California , United States ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:26.219
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The F204V mutation was introduced by site-directed mutagenesis ( Stratagene , La Jolla , California , United States ) , using the sense oligonucleotide 5  - GATGATCACTGGGTCGTCTGGATCGGACCCC-3  , and antisense oligonucleotide 5  - GGGGTCCGATCCAGACGACCCAGTGATCATC-3  .
# ::tok The F204V mutation was introduced by site-directed mutagenesis ( Stratagene , La Jolla , California , United States ) , using the sense oligonucleotide 5  - GATGATCACTGGGTCGTCTGGATCGGACCCC-3  , and antisense oligonucleotide 5  - GGGGTCCGATCCAGACGACCCAGTGATCATC-3  .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:26.229
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt To generate GFP fusions of AQP2 , the pCMV  SPORT6 AQP2 construct was used in a PCR reaction with the primers Sp6 and 5  - GACTGGATCCCGGCCTTGCTGCCGCGCGGCAG-3  to remove the stop codon of AQP2 .
# ::tok To generate GFP fusions of AQP2 , the pCMV  SPORT6 AQP2 construct was used in a PCR reaction with the primers Sp6 and 5  - GACTGGATCCCGGCCTTGCTGCCGCGCGGCAG-3  to remove the stop codon of AQP2 .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:26.233
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The product was digested with KpnI and BamHI and ligated into pEGFP-N2 ( BD Biosciences , San Diego , California , United States ) .
# ::tok The product was digested with KpnI and BamHI and ligated into pEGFP-N2 ( BD Biosciences , San Diego , California , United States ) .
# ::alignments 21-23|0.2.3.0.1+0.2.3.0.0.1+0.2.3.0.0.0+0.2.3.0.0+0.2.3.0 19-20|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 16-18|0.2.0.1+0.2.0.0.1+0.2.0.0.0+0.2.0.0+0.2.0 13-15|0.2.2.0.1+0.2.2.0.0+0.2.2.0+0.2.2 9-10|0.2 8-9|0 7-8|0.1.0.0+0.1.0+0.1 6-7|0.2.3 5-6|0.0.0.0.0+0.0.0.0+0.0.0 3-4|0.0 1-2|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:26.927
(a / and 
      :ARG2-of (d / digest-01 
            :ARG1 (t2 / thing 
                  :name (n6 / name 
                        :op1 "KpnI")) 
            :op1-of (s / state 
                  :name (n2 / name 
                        :op1 "California") 
                  :wiki "California")) 
      :op1 (t / thing 
            :name (n5 / name 
                  :op1 "BamHI")) 
      :op2 (l / ligate-01 
            :ARG0 (c2 / city 
                  :name (n3 / name 
                        :op1 "San" 
                        :op2 "Diego") 
                  :wiki "San_Diego") 
            :ARG1 (p / product) 
            :ARG2 (o / organization 
                  :name (n4 / name 
                        :op1 "BD" 
                        :op2 "Biosciences")) 
            :op1-of (a2 / and 
                  :op2 (c / country 
                        :name (n / name 
                              :op1 "United" 
                              :op2 "States") 
                        :wiki "United_States"))))

# ::snt The F204V mutation was introduced using the same mutagenic oligonucleotides .
# ::tok The F204V mutation was introduced using the same mutagenic oligonucleotides .
# ::alignments 9-10|0.0.1 8-9|0.0.1.1 7-8|0.0.1.0 5-6|0.0 4-5|0 2-3|0.0.0 1-2|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:27.132
(i / introduce-02 
      :ARG1 (u / use-01 
            :ARG0 (m2 / mutation 
                  :mod (p / person 
                        :name (n / name 
                              :op1 "F204V"))) 
            :ARG1 (o / oligonucleotid 
                  :ARG1-of (s / same-01) 
                  :mod (m / mutagenic))))

# ::snt Cell culture and generation of stable cell lines .
# ::tok Cell culture and generation of stable cell lines .
# ::alignments 7-8|0.0.1 6-7|0.0.1.1 5-6|0.0.1.0 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:27.158
(a / and 
      :op1 (c2 / culture 
            :mod (c3 / cell) 
            :poss (l / line 
                  :ARG1-of (s / stable-03) 
                  :mod (c / cell))) 
      :op2 (g / generation))

# ::snt MDCK cells ( CCL-34 ; ATCC , Manassas , Virginia , United States ) were cultured in DMEM ( Sigma-Aldrich , St. Louis , Missouri , United States ) supplemented with 10 % FBS ( Sigma-Aldrich ) , 100 U/ml of penicillin , and 100 g/ml of streptomycin at 37 C in 5 % CO2 .
# ::tok MDCK cells ( CCL-34 ; ATCC , Manassas , Virginia , United States ) were cultured in DMEM ( Sigma-Aldrich , St. Louis , Missouri , United States ) supplemented with 10 % FBS ( Sigma-Aldrich ) , 100 U/ml of penicillin , and 100 g/ml of streptomycin at 37 C in 5 % CO2 .
# ::alignments 54-55|0.1.0.0.0.0.0 53-54|0.1.0.0.0.0 52-53|0.1.0.0.0.0.1 50-51|0.1.0.1.0.1 49-50|0.1.0.2 47-48|0.1.3 44-45|0.1.1.0 43-44|0.1 41-42|0.1.2 38-39|0.5.0 33-34|0.1.0.1 32-33|0.1.0.0 31-32|0.1.0.0.0 29-30|0.1.0 26-28|0.7.1+0.7.0.1+0.7.0.0+0.7.0+0.7 24-25|0.6.1+0.6.0.0+0.6.0+0.6 21-23|0.1.1.1.1+0.1.1.1.0+0.1.1.1+0.1.1 15-16|0.1.0.1.0 11-13|0.5.2+0.5.1.1+0.5.1.0+0.5.1+0.5 9-10|0.4.1+0.4.0.0+0.4.0+0.4 7-8|0.3.0.0+0.3.0+0.3 5-6|0.2.0.0+0.2.0+0.2 4-5|0 3-4|0.0.0.0+0.0.0+0.0 1-2|0.1.0.1.0.0 0-1|0.1.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:30.157
(a2 / and 
      :op1 (o2 / organization 
            :name (n8 / name 
                  :op1 "CCL-34")) 
      :op1-of (a / and 
            :ARG0-of (s2 / supplement-01 
                  :ARG1 (p3 / percentage-entity 
                        :value (13 / 10 
                              :value-of (p / percentage-entity 
                                    :mod-of (c / co2) 
                                    :quant 5))) 
                  :ARG2 (f / fb 
                        :ARG0-of (c5 / culture-01 
                              :ARG1 (c8 / cell 
                                    :mod (m / MDCK)) 
                              :op1-of (c2 / C))) 
                  :op1-of 37) 
            :op2 (c4 / country 
                  :mod-of 100 
                  :name (n3 / name 
                        :op1 "St." 
                        :op2 "Louis")) 
            :op3 (p2 / penicillin) 
            :op4 (s / streptomycin)) 
      :op2 (o / organization 
            :name (n7 / name 
                  :op1 "ATCC")) 
      :op3 (c7 / country 
            :name (n6 / name 
                  :op1 "Manassas")) 
      :op4 (s4 / state 
            :name (n5 / name 
                  :op1 "Virginia") 
            :wiki "Virginia") 
      :op5 (c6 / country 
            :mod-of 100 
            :name (n4 / name 
                  :op1 "United" 
                  :op2 "States") 
            :wiki "United_States") 
      :op6 (s3 / state 
            :name (n2 / name 
                  :op1 "Missouri") 
            :wiki "Missouri") 
      :op7 (c3 / country 
            :name (n / name 
                  :op1 "United" 
                  :op2 "States") 
            :wiki "United_States"))

# ::snt To generate stable MDCK cell lines , cells were transfected using Lipofectamine 2000 ( Invitrogen ) and the pcDNA3 .1 expression constructs ( containing wild-type AQP2 , AQP2-F204V , or no insert ) and selected with 900 g/ml G418 ( Sigma-Aldrich ) .
# ::tok To generate stable MDCK cell lines , cells were transfected using Lipofectamine 2000 ( Invitrogen ) and the pcDNA3 .1 expression constructs ( containing wild-type AQP2 , AQP2-F204V , or no insert ) and selected with 900 g/ml G418 ( Sigma-Aldrich ) .
# ::alignments 40-41|0.0.0.0+0.0.0+0.0 38-39|0.1.1.1.0.1.0.0.1.0+0.1.1.1.0.1.0.0.1+0.1.1.1.0.1.0.0 34-35|0.1.1.1.0.1.0 33-34|0.1.1.1.0.1.0.1 31-32|0.1.2 30-31|0.1.2.1 29-30|0.1 27-28|0.1.1.0.0+0.1.1.0+0.1.1 25-26|0.1.0 23-24|0 21-22|0.1.1.1.0.1.0.0.0.0 20-21|0.1.1.1.0.1.0.0.0 16-17|0.1.1.1 14-15|0.1.1.1.0.1.0.1.0.0.0.0.0.0.0+0.1.1.1.0.1.0.1.0.0.0.0.0.0+0.1.1.1.0.1.0.1.0.0.0.0.0 12-13|0.1.2.0.0+0.1.2.0 11-12|0.1.1.1.0.0.0.0+0.1.1.1.0.0.0+0.1.1.1.0.0 10-11|0.1.1.1.0 7-8|0.1.1.1.0.1 5-6|0.1.1.1.0.1.0.1.0.0.0 4-5|0.1.1.1.0.1.0.1.0.0 2-3|0.1.1.1.0.1.0.1.0.0.0.0 1-2|0.1.1.1.0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:33.080
(c / contain-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "Sigma-Aldrich")) 
      :ARG1 (o2 / or 
            :op1 (a2 / AQP2) 
            :op2 (p2 / person 
                  :name (n3 / name 
                        :op1 "AQP2-F204V") 
                  :op1-of (a3 / and 
                        :ARG0-of (u / use-01 
                              :ARG1 (o4 / organization 
                                    :name (n5 / name 
                                          :op1 "Lipofectamine")) 
                              :ARG2 (c3 / cell 
                                    :ARG0-of (s / select-01 
                                          :ARG1 (p / person 
                                                :ARG0-of (e / express-01 
                                                      :ARG1 (c2 / construct)) 
                                                :name (n2 / name 
                                                      :op1 "G418")) 
                                          :op1-of (a / and 
                                                :time (g / generate-01 
                                                      :ARG1 (c4 / cell 
                                                            :mod-of (l / line 
                                                                  :ARG1-of (s2 / stable-03 
                                                                        :ARG0 (o3 / organization 
                                                                              :name (n4 / name 
                                                                                    :op1 "Invitrogen")))))))))))) 
            :op3 (i / insert-01 
                  :ARG1 (d / date-entity 
                        :year 2000) 
                  :polarity -)))

# ::snt Individual colonies were expanded 14 d later .
# ::tok Individual colonies were expanded 14 d later .
# ::alignments 6-7|0.2 5-6|0.1 4-5|0.1.0 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:33.239
(e / expand-01 
      :ARG1 (c / colony 
            :mod (i / individual)) 
      :ARG2 (d / d 
            :quant 14) 
      :ARG3 (l / late))

# ::snt For the duration of these experiments , the antibiotic was continually added to the media .
# ::tok For the duration of these experiments , the antibiotic was continually added to the media .
# ::alignments 14-15|0.1 11-12|0 10-11|0.2 8-9|0.0 5-6|0.3 4-5|0.3.0 2-3|0.3.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:33.286
(a / add-01 
      :ARG1 (a2 / antibiotic) 
      :ARG2 (m / media) 
      :manner (c / continue-01) 
      :manner (e / experiment-01 
            :mod (t / this) 
            :poss-of (d / duration)))

# ::snt Transient GFP transfections were carried out in subconfluent stable cells lines also using Lipofectamine 2000 .
# ::tok Transient GFP transfections were carried out in subconfluent stable cells lines also using Lipofectamine 2000 .
# ::alignments 14-15|0.0.0+0.0 13-14|0.2.1.0.0+0.2.1.0+0.2.1 12-13|0.2 11-12|0.2.2 10-11|0.2.0 9-10|0.2.0.1 8-9|0.2.0.0 4-5|0 2-3|0.1 1-2|0.1.0.0.0+0.1.0.0+0.1.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:33.668
(c2 / carry-out-03 
      :ARG0 (d / date-entity 
            :year 2000) 
      :ARG1 (t / transfection 
            :mod (o2 / organization 
                  :name (n2 / name 
                        :op1 "GFP")) 
            :mod (t2 / transient)) 
      :manner (u / use-01 
            :ARG0 (l / line 
                  :ARG1-of (s / stable-03) 
                  :mod (c / cell)) 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "Lipofectamine")) 
            :mod (a / also)))

# ::snt Sequencing of Aqp2 and genotyping of mice .
# ::tok Sequencing of Aqp2 and genotyping of mice .
# ::alignments 6-7|0.0.2 4-5|0.0.1 3-4|0.0 2-3|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:33.687
(s / sequence 
      :op1-of (a / and 
            :op2 (a2 / Aqp2) 
            :op3 (g / genotyp) 
            :op4 (m / mouse)))

# ::snt All exons of Aqp2 were amplified from mouse genomic DNA and sequenced .
# ::tok All exons of Aqp2 were amplified from mouse genomic DNA and sequenced .
# ::alignments 11-12|0.1.1 10-11|0.1 9-10|0.1.0 7-8|0.2 5-6|0 3-4|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:33.778
(a2 / amplify-01 
      :ARG0 (e / exon 
            :mod (a3 / Aqp2) 
            :quant (a4 / all)) 
      :ARG1 (a / and 
            :op1 (d / DNA) 
            :op2 (s / sequence)) 
      :ARG2 (m / mouse))

# ::snt For genotyping , exon 4 was amplified using the primers 5  - TCAGAACTTGCCCACTAGCC-3  and 5  - TGTAGAGGAGGGAACCGATG-3  .
# ::tok For genotyping , exon 4 was amplified using the primers 5  - TCAGAACTTGCCCACTAGCC-3  and 5  - TGTAGAGGAGGGAACCGATG-3  .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:33.780
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Urine measurements .
# ::tok Urine measurements .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:33.787
(m / measure-01 
      :ARG1 (u / urine))

# ::snt Total urine output was measured by separately housing adult mice in Nalgene Metabolic Cages ( Minimitter , Bend , Oregon , United States ) for 2 -- 3 d and collecting urine every 24 h period .
# ::tok Total urine output was measured by separately housing adult mice in Nalgene Metabolic Cages ( Minimitter , Bend , Oregon , United States ) for 2 -- 3 d and collecting urine every 24 h period .
# ::alignments 35-36|0.3.1.0 34-35|0.3.1.0.0 33-34|0.3.1.0.1 32-33|0.3.1.0.0.0 31-32|0.3.1 30-31|0.3 29-30|0 28-29|0.0.0.1 27-28|0.0.0.0.1.0 25-26|0.0.0.0.0.0.0.0 21-23|0.0.0.0.0.0.0.1.1+0.0.0.0.0.0.0.1.0.1+0.0.0.0.0.0.0.1.0.0+0.0.0.0.0.0.0.1.0+0.0.0.0.0.0.0.1 19-20|0.2.0.0+0.2.0+0.2 17-18|0.1.0.0+0.1.0+0.1 15-16|0.0.0.0.1.1 12-14|0.0.1.1+0.0.1.0+0.0.1+0.0 9-10|0.0.0.0 8-9|0.3.0 7-8|0.0.0 6-7|0.0.0.0.1 4-5|0.0.0.0.0 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0.0.1 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:34.865
(a / and 
      :op1 (p2 / person 
            :ARG1-of (h2 / house-01 
                  :ARG0 (m2 / mouse 
                        :ARG0-of (m3 / measure-01 
                              :ARG1 (o / output 
                                    :ARG1-of (t / total-01 
                                          :ARG0 2 
                                          :location (c2 / country 
                                                :name (n / name 
                                                      :op1 "United" 
                                                      :op2 "States") 
                                                :wiki "United_States")) 
                                    :mod (u2 / urine))) 
                        :ARG1-of (s / separate-02 
                              :ARG0 3 
                              :ARG2 (m / minimitt))) 
                  :ARG2 (d / d)) 
            :name (n4 / name 
                  :op1 "Metabolic" 
                  :op2 "Cages")) 
      :op2 (c4 / country 
            :name (n3 / name 
                  :op1 "Bend")) 
      :op3 (c3 / country 
            :name (n2 / name 
                  :op1 "Oregon")) 
      :op4 (c / collect-01 
            :ARG0 (a2 / adult) 
            :ARG1 (u / urine 
                  :ARG1 (p / period 
                        :mod (h / h 
                              :mod (e / every)) 
                        :quant 24))))

# ::snt Urine osmolalities were determined using an Osmometer ( Osmette 5004 ; Precision Systems , Natick , Massachusetts , United States ) .
# ::tok Urine osmolalities were determined using an Osmometer ( Osmette 5004 ; Precision Systems , Natick , Massachusetts , United States ) .
# ::alignments 18-20|0.2.1+0.2.0.1+0.2.0.0+0.2.0+0.2 16-17|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 14-15|0.1.1.1.2.0.0+0.1.1.1.2.0+0.1.1.1.2 11-13|0.1.1.1.1.0.1+0.1.1.1.1.0.0+0.1.1.1.1.0+0.1.1.1.1 10-11|0.1.1.1 9-10|0.1.1.1.0.0+0.1.1.1.0 6-7|0.1.1.0.0+0.1.1.0+0.1.1 4-5|0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:35.287
(d2 / determined-02 
      :ARG0 (o2 / osmolaliti 
            :mod (u2 / urine)) 
      :ARG1 (u / use-01 
            :ARG0 (s / state 
                  :name (n2 / name 
                        :op1 "Massachusetts") 
                  :wiki "Massachusetts") 
            :ARG1 (p / person 
                  :name (n5 / name 
                        :op1 "Osmometer") 
                  :op1-of (a / and 
                        :op2 (d / date-entity 
                              :year 5004) 
                        :op3 (o / organization 
                              :name (n4 / name 
                                    :op1 "Precision" 
                                    :op2 "Systems")) 
                        :op4 (c2 / country 
                              :name (n3 / name 
                                    :op1 "Natick"))))) 
      :ARG2 (c / country 
            :name (n / name 
                  :op1 "United" 
                  :op2 "States") 
            :wiki "United_States"))

# ::snt Urine concentrating experiments were carried out by intraperitoneal injection of dDAVP ( 0.4 g/kg ) .
# ::tok Urine concentrating experiments were carried out by intraperitoneal injection of dDAVP ( 0.4 g/kg ) .
# ::alignments 10-11|0.0.0 8-9|0.0 7-8|0.0.1 4-5|0 2-3|0.1 1-2|0.1.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:35.326
(c / carry-out-03 
      :ARG0 (i / inject-01 
            :ARG1 (d / dDAVP) 
            :mod (i2 / intraperitoneal)) 
      :ARG1 (e / experiment-01 
            :ARG1-of (c2 / concentrate-01) 
            :mod (u / urine)))

# ::snt Mice were injected twice with dDAVP , once at time 0 and again at 30 min .
# ::tok Mice were injected twice with dDAVP , once at time 0 and again at 30 min .
# ::alignments 15-16|0.0.0 14-15|0.0.0.0 12-13|0.0.1 11-12|0 10-11|0.0.4.0 9-10|0.0.4 7-8|0.0.4.1 5-6|0.0.3 2-3|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:35.396
(a2 / and 
      :time-of (i / inject-01 
            :ARG0 (m / min 
                  :quant 30) 
            :ARG1 (a / again) 
            :ARG2 (m2 / mouse) 
            :instrument (d / dDAVP) 
            :time (t / time 
                  :mod 0 
                  :mod (o / once))))

# ::snt Urine was collected at the start of the experiment and 30 min after the second injection .
# ::tok Urine was collected at the start of the experiment and 30 min after the second injection .
# ::alignments 15-16|0.2.1.0 12-13|0.2.1 11-12|0.2.0 10-11|0.2.1.1 9-10|0.2 8-9|0.1.0 5-6|0.1 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:35.454
(c / collect-01 
      :ARG1 (u / urine) 
      :ARG2 (s / start-01 
            :ARG1 (e / experiment-01)) 
      :op1-of (a2 / and 
            :op2 (m / min) 
            :time (a / after 
                  :op1 (i / inject-01) 
                  :time-of 30)))

# ::snt Kidney membrane preparation .
# ::tok Kidney membrane preparation .
# ::alignments 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:35.459
(p / prepare-02 
      :ARG1 (k / kidney))

# ::snt Whole mouse kidneys were homogenized in 10 mM Tris ( pH 7.4 ) , 350 mM sucrose , and 5 mM EDTA containing protease inhibitors ( Sigma-Aldrich , # P-8340 ) in a Potter-Elvehjem homogenizer .
# ::tok Whole mouse kidneys were homogenized in 10 mM Tris ( pH 7.4 ) , 350 mM sucrose , and 5 mM EDTA containing protease inhibitors ( Sigma-Aldrich , # P-8340 ) in a Potter-Elvehjem homogenizer .
# ::alignments 34-35|0.0.1 33-34|0.0.3.0+0.0.3+0.0 26-27|0.0.0.2.2.0.0+0.0.0.2.2.0+0.0.0.2.2 24-25|0.0.0.2.1.0.0 23-24|0.0.0.2.1.0.0.0 22-23|0.0.0.2.1.0 21-22|0.0.0.2.1.1.0+0.0.0.2.1.1+0.0.0.2.1 19-20|0.0.0.2.1.2 18-19|0.0.0.2 16-17|0.0.0.2.0 14-15|0.0.0.2.0.0 11-12|0.0.2 10-11|0 8-9|0.0.0.1.0+0.0.0.1+0.0.0 7-8|0.0.0.0 6-7|0.0.0.3 2-3|0.0.0.2.1.0.1.0 1-2|0.0.0.2.1.0.1 0-1|0.0.0.2.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:36.066
(p2 / ph 
      :mod (c / country 
            :mod-of (p3 / person 
                  :mod (m / mm) 
                  :name (n4 / name 
                        :op1 "Tris") 
                  :op1-of (a / and 
                        :op2 (s / sucrose 
                              :quant 350) 
                        :op3 (o2 / organization 
                              :ARG0-of (c2 / contain-01 
                                    :ARG1 (i / inhibitor 
                                          :mod (p / protease)) 
                                    :ARG2 (m2 / mouse 
                                          :mod-of (k / kidney)) 
                                    :op1-of (w / whole)) 
                              :name (n3 / name 
                                    :op1 "EDTA") 
                              :quant 5) 
                        :op4 (o / organization 
                              :name (n2 / name 
                                    :op1 "Sigma-Aldrich"))) 
                  :quant 10) 
            :mod-of (h / homogeniz) 
            :mod-of 7.4 
            :name (n / name 
                  :op1 "Potter-Elvehjem")))

# ::snt The homogenate was centrifuged at 2,000 g for 10 min and the supernatant was subjected to ultracentrifugation at 100,000 g for 1 h at 4 C .
# ::tok The homogenate was centrifuged at 2,000 g for 10 min and the supernatant was subjected to ultracentrifugation at 100,000 g for 1 h at 4 C .
# ::alignments 25-26|0.1.2.0 24-25|0.1.2 22-23|0.1.0.0 21-22|0.1.0.0.0 14-15|0.1 12-13|0.1.1 10-11|0 9-10|0.0 8-9|0.0.0 6-7|0.1.2.0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:36.250
(a / and 
      :op1 (m / min 
            :quant 10) 
      :op2 (s / subject-01 
            :ARG0 (h2 / homogenate 
                  :mod-of (h / h 
                        :quant 1)) 
            :ARG1 (s2 / supernatant) 
            :ARG2 (4 / 4 
                  :era (c / C 
                        :poss (g / g)))))

# ::snt Pelleted membranes were resuspended in the same buffer , and protein concentration was determined by Bradford assay .
# ::tok Pelleted membranes were resuspended in the same buffer , and protein concentration was determined by Bradford assay .
# ::alignments 16-17|0.0.0.0 15-16|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 13-14|0.0.0 11-12|0.0 10-11|0 9-10|0.0.0.2 7-8|0.0.0.1.0 6-7|0.0.0.1.0.0 1-2|0.0.0.1 0-1|0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:36.791
(p / protein 
      :ARG1-of (c / concentrate-02 
            :ARG1-of (d / determined-02 
                  :ARG0 (a / assay 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "Bradford"))) 
                  :ARG2 (m / membran 
                        :ARG0-of (b / buffer-01 
                              :ARG1-of (s / same-01)) 
                        :mod (p2 / pellet)) 
                  :op1-of (a2 / and))))

# ::snt Immunoblotting .
# ::tok Immunoblotting .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:36.794
(i / immunoblott)

# ::snt Kidney membrane fractions ( 60 g ) were resolved on a 12 % SDS-polyacrylamide gel and transferred to a nitrocellulose membrane .
# ::tok Kidney membrane fractions ( 60 g ) were resolved on a 12 % SDS-polyacrylamide gel and transferred to a nitrocellulose membrane .
# ::alignments 20-21|0.1.2 19-20|0.1.2.0 16-17|0.1 15-16|0 14-15|0.0 12-13|0.1.1.0.0 11-12|0.1.1.0 8-9|0.1.1.1 5-6|0.1.0 4-5|0.1.1.1.0 2-3|0.1.1 1-2|0.1.1.2 0-1|0.1.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:36.974
(a / and 
      :op1 (g / gel) 
      :op2 (t / transfer-01 
            :ARG0 (g2 / g) 
            :ARG1 (f / fraction-01 
                  :ARG1 (1 / 12 
                        :quant-of (p / percentage-entity)) 
                  :ARG1-of (r / resolve-01 
                        :ARG0 60) 
                  :mod (m2 / membrane) 
                  :mod (k / kidney)) 
            :ARG2 (m / membrane 
                  :mod (n / nitrocellulose))))

# ::snt Membranes were blocked in 5 % nonfat milk in Tris-buffered saline with 0.05 % Tween 20 ( TBST ) , followed by an overnight incubation ( at 4 C ) with AQP2 polyclonal antibody ( Santa Cruz Biotechnology , Santa Cruz , California , United States ; #sc -9882 ) .
# ::tok Membranes were blocked in 5 % nonfat milk in Tris-buffered saline with 0.05 % Tween 20 ( TBST ) , followed by an overnight incubation ( at 4 C ) with AQP2 polyclonal antibody ( Santa Cruz Biotechnology , Santa Cruz , California , United States ; #sc -9882 ) .
# ::alignments 46-47|0 44-46|0.3.1+0.3.0.1+0.3.0.0+0.3.0+0.3 42-43|0.2.1+0.2.0.0+0.2.0+0.2 39-41|0.1.2.0.1+0.1.2.0.0+0.1.2.0+0.1.2 35-38|0.0.2.0.2+0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 33-34|0.1.3 28-29|0.1.4.2 27-28|0.1.4.3 24-25|0.1.1 23-24|0.1.1.0 20-21|0.1 15-16|0.1.0.0.0 14-15|0.0.1.0+0.0.1+0.0 13-14|0.0.0 10-11|0.1.4.1.1 9-10|0.1.4.1.1.0 7-8|0.1.4.1 6-7|0.1.4.1.0 5-6|0.1.0.0 4-5|0.1.0 2-3|0.1.4 0-1|0.1.4.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:37.697
(a / and 
      :op1 (o3 / organization 
            :mod (p / percentage-entity) 
            :name (n5 / name 
                  :op1 "Tween") 
            :part (o / organization 
                  :name (n4 / name 
                        :op1 "Santa" 
                        :op2 "Cruz" 
                        :op3 "Biotechnology"))) 
      :op2 (f / follow-01 
            :ARG0 (5 / 5 
                  :quant-of (p2 / percentage-entity 
                        :value 20)) 
            :ARG1 (i / incubation 
                  :time (o2 / overnight)) 
            :ARG2 (c2 / country 
                  :name (n3 / name 
                        :op1 "Santa" 
                        :op2 "Cruz")) 
            :duration (a2 / antibody) 
            :manner-of (b / block-01 
                  :ARG1 (m2 / membran) 
                  :location (m / milk 
                        :mod (n6 / nonfat) 
                        :mod (s2 / saline 
                              :mod (t / tris-buffer))) 
                  :op1-of (c3 / C) 
                  :op1-of 4)) 
      :op3 (s / state 
            :name (n2 / name 
                  :op1 "California") 
            :wiki "California") 
      :op4 (c / country 
            :name (n / name 
                  :op1 "United" 
                  :op2 "States") 
            :wiki "United_States"))

# ::snt Membranes were washed in TBST then incubated with HRP-conjugated donkey anti-goat antibody .
# ::tok Membranes were washed in TBST then incubated with HRP-conjugated donkey anti-goat antibody .
# ::alignments 11-12|0.2.0 9-10|0.2.0.0 8-9|0.2 6-7|0 5-6|0.0 2-3|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:37.741
(i / incubate-01 
      :ARG0 (t / then) 
      :ARG1 (w / wash-01 
            :ARG1 (m / membran)) 
      :compared-to (h / hrp-conjugat 
            :mod-of (a / antibody 
                  :mod (d / donkey))))

# ::snt Membranes were washed further in TBST and bands were visualized using ECL reagent ( Amersham Biosciences , Little Chalfont , United Kingdom ) .
# ::tok Membranes were washed further in TBST and bands were visualized using ECL reagent ( Amersham Biosciences , Little Chalfont , United Kingdom ) .
# ::alignments 20-22|0.2.1+0.2.0.1+0.2.0.0+0.2.0+0.2 17-19|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 14-16|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 12-13|0.1.1.1 11-12|0.1.1.1.0.0.0+0.1.1.1.0.0+0.1.1.1.0 10-11|0.1.1 9-10|0.1 7-8|0.1.1.0 6-7|0 3-4|0.0.2 2-3|0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:38.410
(a / and 
      :op1 (w / wash-01 
            :ARG0 (o / organization 
                  :name (n3 / name 
                        :op1 "Amersham" 
                        :op2 "Biosciences")) 
            :ARG1 (c2 / country 
                  :name (n2 / name 
                        :op1 "Little" 
                        :op2 "Chalfont")) 
            :degree (f / further)) 
      :op2 (v / visualize-01 
            :ARG0 (m / membran) 
            :ARG1 (u / use-01 
                  :ARG0 (b / band) 
                  :ARG1 (r / reagent 
                        :mod (o2 / organization 
                              :name (n4 / name 
                                    :op1 "ECL"))))) 
      :op3 (c / country 
            :name (n / name 
                  :op1 "United" 
                  :op2 "Kingdom") 
            :wiki "United_Kingdom"))

# ::snt Endoglycosidase digestion .
# ::tok Endoglycosidase digestion .
# ::alignments 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:38.415
(d / digestion)

# ::snt Kidney membranes ( 60 g ) were incubated in 50 mM sodium phosphate ( pH 5.5 ) , 0.1 % SDS , and 50 mM -mercaptoethanol , heated to 100 C for 5 min , then cooled .
# ::tok Kidney membranes ( 60 g ) were incubated in 50 mM sodium phosphate ( pH 5.5 ) , 0.1 % SDS , and 50 mM -mercaptoethanol , heated to 100 C for 5 min , then cooled .
# ::alignments 36-37|0.0 35-36|0.0.2 33-34|0 32-33|0.1.3 30-31|0.1.4.0 29-30|0.1.4 27-28|0.1.1.0.0 23-24|0.0.0 22-23|0.1.0 20-21|0.1.0.0 19-20|0.1.0.0.0 18-19|0.1.0.0.0.0 15-16|0.0.1 14-15|0.1.1.0.0.0 12-13|0.1.2 11-12|0.1.2.0 10-11|0.1.2.0.0 9-10|0.1.2.1 7-8|0.1 3-4|0.1.1.0.0.1 1-2|0.1.1 0-1|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:38.965
(m / min 
      :ARG4-of (c / cool-01 
            :ARG1 50 
            :ARG2 5.5 
            :time (t / then)) 
      :op1 (i / incubate-01 
            :ARG0 (a / and 
                  :op1 (s / sd 
                        :mod (p / percentage-entity 
                              :value 0.1))) 
            :ARG1 (m3 / membran 
                  :mod (k / kidney 
                        :op1 (h / heat-01 
                              :ARG1 (p2 / ph) 
                              :ARG2 60))) 
            :ARG2 (p3 / phosphate 
                  :mod (s2 / sodium 
                        :mod (m2 / mm)) 
                  :quant 50) 
            :op1-of 5 
            :op1-of (1 / 100 
                  :quant-of (c2 / C))))

# ::snt Endoglycosidase H ( 0.01 units ; Sigma-Aldrich ) was added and incubated at 37 C for 2 h .
# ::tok Endoglycosidase H ( 0.01 units ; Sigma-Aldrich ) was added and incubated at 37 C for 2 h .
# ::alignments 17-18|0.2 16-17|0.2.0 14-15|0.0.0 13-14|0.0 11-12|0.1.0 10-11|0.1 9-10|0 6-7|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 5-6|0.1.0.0.0 4-5|0.1.0.0 0-2|0.1.0.1.0.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:39.125
(a2 / add-01 
      :ARG1 (3 / 37 
            :era (c / C)) 
      :op1-of (a / and 
            :op2 (i / incubate-01 
                  :ARG0 (u / unit 
                        :op1-of (a3 / and 
                              :op2 (o / organization 
                                    :name (n / name 
                                          :op1 "Sigma-Aldrich")))) 
                  :ARG1 (t / thing 
                        :name (n2 / name 
                              :op1 (e / Endoglycosidase) 
                              :op2 (h2 / H))))) 
      :purpose (h / h 
            :quant 2))

# ::snt The reaction was stopped by boiling the samples in Laemmli buffer .
# ::tok The reaction was stopped by boiling the samples in Laemmli buffer .
# ::alignments 10-11|0.1.1 9-10|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 7-8|0.1.0.0+0.1.0 5-6|0.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:39.240
(s2 / stop-01 
      :ARG1 (r / react-01) 
      :ARG2 (b2 / boil-01 
            :ARG1 (t / thing 
                  :ARG1-of (s / sample-01)) 
            :location (b / buffer-01 
                  :ARG1 (c / country 
                        :name (n / name 
                              :op1 "Laemmli")))))

# ::snt Total reactants were immunoblotted as described above .
# ::tok Total reactants were immunoblotted as described above .
# ::alignments 6-7|0 5-6|0.0.0.0 1-2|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:39.253
(a / above 
      :ARG0-of (t / total-01 
            :ARG1 (r / reactant 
                  :ARG1-of (d / describe-01))))

# ::snt Coimmunoprecipitation and biotinylation in MDCK cells .
# ::tok Coimmunoprecipitation and biotinylation in MDCK cells .
# ::alignments 5-6|0.0.0 4-5|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:39.268
(a / and 
      :location (m / MDCK 
            :mod-of (c / cell)))

# ::snt MDCK cells stably expressing wild-type AQP2 ( grown on 10-cm plates ) were transfected with pEGFP-wild-type AQP2 , pEGFP-AQP2-F204V , or vector alone .
# ::tok MDCK cells stably expressing wild-type AQP2 ( grown on 10-cm plates ) were transfected with pEGFP-wild-type AQP2 , pEGFP-AQP2-F204V , or vector alone .
# ::alignments 22-23|0.0.0 21-22|0.0 20-21|0.0.1 10-11|0.1 7-8|0 5-6|0.0.1.0.1 3-4|0.0.1.0 2-3|0.0.1.0.2 1-2|0.0.1.0.0 0-1|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:39.564
(g / grow-03 
      :ARG0 (v / vector 
            :mod (a / alone) 
            :op1-of (o / or 
                  :ARG2-of (e / express-01 
                        :ARG0 (c / cell 
                              :mod (m / MDCK)) 
                        :ARG1 (a2 / AQP2) 
                        :mod (s / stably)))) 
      :ARG1 (p / plate))

# ::snt The cells were homogenized in 10 mM Tris ( pH 7.4 ) , 1 mM EDTA , and 250 mM sucrose 40 h later .
# ::tok The cells were homogenized in 10 mM Tris ( pH 7.4 ) , 1 mM EDTA , and 250 mM sucrose 40 h later .
# ::alignments 23-24|0.0.0 22-23|0 21-22|0.2 20-21|0.0.0.0 18-19|0.0.1 17-18|0.0.0.0.0 15-16|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 13-14|0.0.0.0.0.1.1 10-11|0.2.0 9-10|0.1 7-8|0.0.0.0.0.0.1.0+0.0.0.0.0.0.1+0.0.0.0.0.0 6-7|0.0.0.0.0.0.0 5-6|0.0.0.0.0.0.2 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:39.689
(h / h 
      :mod-of (c / cell 
            :mod (l / late 
                  :op1 (s / sucrose 
                        :op3-of (a / and 
                              :op1 (p2 / person 
                                    :mod (m / mm) 
                                    :name (n2 / name 
                                          :op1 "Tris") 
                                    :quant 10) 
                              :op2 (o / organization 
                                    :name (n / name 
                                          :op1 "EDTA") 
                                    :quant 1)))) 
            :poss 250) 
      :poss (p / ph) 
      :quant (4 / 40 
            :poss 7.4))

# ::snt The clarified supernatant was centrifuged at 200,000 g for 30 min .
# ::tok The clarified supernatant was centrifuged at 200,000 g for 30 min .
# ::alignments 10-11|0.0.0.0 9-10|0.0.0 7-8|0.0.0.0.0 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:39.735
(s / supernatant 
      :ARG1-of (c / clarify-01 
            :ARG0 (3 / 30 
                  :quant-of (m / min 
                        :location-of (g / g)))))

# ::snt Pelleted membranes were resuspended in the same buffer but containing 4 % sodium deoxycholate and incubated at 37 C for 1 h. From the dissolved membranes , a 30 l sample was removed and used as the total membrane fraction .
# ::tok Pelleted membranes were resuspended in the same buffer but containing 4 % sodium deoxycholate and incubated at 37 C for 1 h. From the dissolved membranes , a 30 l sample was removed and used as the total membrane fraction .
# ::alignments 39-40|0.1.2.1.0.1 38-39|0.1.2.1.0.1.0 37-38|0.1.2.0.1 34-35|0.1.2.1.0.0.1 33-34|0.1.2.1 32-33|0.1.2.1.0 30-31|0.1.2.1.0.0 29-30|0.1.2.1.0.0.0 28-29|0.1.0.0.1.0 25-26|0.1.2.1.0.0.2 24-25|0.1.2.1.0.0.2.0 20-21|0.1.0.0.0 18-19|0.1.2.0.0 17-18|0.0 15-16|0.1.2.0 14-15|0.1.2 13-14|0.1.1 12-13|0.1.0.0.2 11-12|0.1.0.0.1.1 10-11|0.1.0.0.1.1.0 9-10|0.1 8-9|0 7-8|0.1.0.0 6-7|0.1.0.0.1 1-2|0.1.0 0-1|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:41.601
(c3 / contrast-01 
      :ARG1 37 
      :ARG2 (c2 / contain-01 
            :ARG0 (m3 / membran 
                  :ARG0-of (b / buffer-01 
                        :ARG1 1 
                        :ARG1-of (s3 / same-01 
                              :ARG0 30 
                              :purpose (p / percentage-entity 
                                    :value 4)) 
                        :mod (s2 / sodium)) 
                  :mod (p2 / pellet)) 
            :ARG1 (d2 / deoxycholate) 
            :op1-of (a2 / and 
                  :op2 (i / incubate-01 
                        :ARG1 (c / C) 
                        :ARG1-of (t / total-01)) 
                  :op3 (a / and 
                        :op1 (r / remove-01 
                              :ARG1 (s / sample-01 
                                    :ARG1 (l / l) 
                                    :ARG1-of (u / use-01) 
                                    :op1-of (m2 / membran 
                                          :ARG1-of (d / dissolve-01))) 
                              :ARG2 (f / fraction 
                                    :mod (m / membrane)))))))

# ::snt The remaining membranes were diluted with 600 l of the homogenization buffer , and incubated with 1 l of GFP antisera ( Invitrogen , # 46 -- 0092 ) and protein A/G sepharose .
# ::tok The remaining membranes were diluted with 600 l of the homogenization buffer , and incubated with 1 l of GFP antisera ( Invitrogen , # 46 -- 0092 ) and protein A/G sepharose .
# ::alignments 30-31|0.0.2 29-30|0.2.0 27-28|0.0.3.0+0.0.3 25-26|0.1.0 22-23|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 20-21|0.2.1.0 19-20|0.2.1.1.0+0.2.1.1+0.2.1 16-17|0.0.0.0.1 14-15|0.2 13-14|0 11-12|0.1 10-11|0.1.1 7-8|0.0.1 6-7|0.0.1.0 4-5|0.0 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:42.160
(a3 / and 
      :op1 (d2 / dilute-01 
            :ARG1 (m / membran 
                  :ARG1-of (r / remain-01 
                        :ARG2 (o / organization 
                              :name (n / name 
                                    :op1 "Invitrogen")) 
                        :op1-of 1)) 
            :ARG2 (l / l 
                  :quant 600) 
            :op1-of (p / protein) 
            :op1-of (d / date-entity 
                  :year 0092)) 
      :op2 (b / buffer-01 
            :ARG0 46 
            :ARG1 (h / homogenization)) 
      :op3 (i / incubate-01 
            :ARG1 (a / and) 
            :ARG3 (o2 / organization 
                  :mod-of (a2 / antiserum) 
                  :name (n2 / name 
                        :op1 "GFP"))))

# ::snt Following overnight incubation , the precipitated proteins were washed in RIPA buffer and finally boiled in 50 l of Laemmli buffer .
# ::tok Following overnight incubation , the precipitated proteins were washed in RIPA buffer and finally boiled in 50 l of Laemmli buffer .
# ::alignments 20-21|0.1.1.0 19-20|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 17-18|0.1.1 16-17|0.1.1.1 14-15|0.1 13-14|0.1.2 12-13|0 11-12|0.1.0.0 10-11|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 8-9|0.0 6-7|0.1.0 5-6|0.1.0.1 2-3|0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:42.348
(a / and 
      :op1 (w / wash-01 
            :ARG1-of (f2 / follow-01 
                  :ARG2 (i / incubation 
                        :time (o / overnight)))) 
      :op2 (b2 / boil-01 
            :ARG0 (p / protein 
                  :ARG0-of (b3 / buffer-01 
                        :ARG1 (c2 / country 
                              :name (n2 / name 
                                    :op1 "RIPA"))) 
                  :ARG1-of (p2 / precipitate-01)) 
            :ARG1 (l / l 
                  :mod (b / buffer-01 
                        :ARG1 (c / country 
                              :name (n / name 
                                    :op1 "Laemmli"))) 
                  :quant 50) 
            :time (f / final)))

# ::snt Half of the total membrane and the IP fractions were processed for immunoblotting .
# ::tok Half of the total membrane and the IP fractions were processed for immunoblotting .
# ::alignments 12-13|0.1 10-11|0 8-9|0.2.0 7-8|0.2.0.1 5-6|0.2 4-5|0.2.0.0 3-4|0.2.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:42.648
(p / process-01 
      :ARG1 (h / half) 
      :ARG2 (i / immunoblott) 
      :purpose (a / and 
            :op1 (f / fraction-01 
                  :ARG1 (m / membrane 
                        :ARG2-of (t / total-01)) 
                  :mod (i2 / IP))))

# ::snt Cell surface biotinylation was performed in a similar manner .
# ::tok Cell surface biotinylation was performed in a similar manner .
# ::alignments 8-9|0.1 7-8|0.1.0 4-5|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:42.668
(p / perform-02 
      :ARG1 (s / surface 
            :mod (c / cell)) 
      :ARG2 (m / manner 
            :ARG1-of (r / resemble-01)))

# ::snt However , pEGFP-AQP2-F204V , was transfected into MDCK cells stably expressing wild-type AQP2 and cells made stable with vector alone .
# ::tok However , pEGFP-AQP2-F204V , was transfected into MDCK cells stably expressing wild-type AQP2 and cells made stable with vector alone .
# ::alignments 19-20|0.0.0 18-19|0 16-17|0.0 14-15|0.0.1 13-14|0.0.1.0 12-13|0.0.1.0.0.1 10-11|0.0.1.0.0 9-10|0.0.1.0.0.2 8-9|0.0.1.0.0.0 7-8|0.0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:43.077
(v / vector 
      :ARG2-of (s / stable-03 
            :ARG0 (a / alone) 
            :ARG1 (c / cell 
                  :op1-of (a2 / and 
                        :ARG2-of (e / express-01 
                              :ARG0 (c2 / cell 
                                    :mod (m / MDCK)) 
                              :ARG1 (a3 / AQP2) 
                              :mod (s2 / stably))))))

# ::snt Twenty-four hours post-transfection , cells were stimulated with forskolin , trypsinized , resuspended in 1 ml of PBS ( 2.5  106 cells/ml ) , and incubated with 0.5 mg of NHS-PEO4-biotin ( Pierce Biotechnology ) for 30 min at room temperature .
# ::tok Twenty-four hours post-transfection , cells were stimulated with forskolin , trypsinized , resuspended in 1 ml of PBS ( 2.5  106 cells/ml ) , and incubated with 0.5 mg of NHS-PEO4-biotin ( Pierce Biotechnology ) for 30 min at room temperature .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:43.080
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Cells were washed once in 10 mM Tris ( pH 8 ) and three times in PBS , after which membranes were purified and solubilized as described above .
# ::tok Cells were washed once in 10 mM Tris ( pH 8 ) and three times in PBS , after which membranes were purified and solubilized as described above .
# ::alignments 27-28|0.0.2 26-27|0.0 23-24|0 22-23|0.1 20-21|0.1.1 18-19|0.1.3 16-17|0.1.2 13-14|0.1.0.0.0 12-13|0.1.0 10-11|0.0.1 9-10|0.0.0 7-8|0.1.0.1.1.0+0.1.0.1.1+0.1.0.1 6-7|0.1.0.1.0 5-6|0.1.0.1.2 3-4|0.1.0.0.2 2-3|0.1.0.0 0-1|0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:43.609
(a2 / and 
      :ARG1-of (d / describe-01 
            :op1-of (p3 / ph) 
            :op1-of 8 
            :path (a / above)) 
      :op1 (p / purify-01 
            :ARG0 (a4 / and 
                  :ARG2-of (w / wash-01 
                        :ARG0 3 
                        :ARG1 (c / cell) 
                        :time (o / once)) 
                  :op1 (p4 / person 
                        :mod (m2 / mm) 
                        :name (n / name 
                              :op1 "Tris") 
                        :quant 10)) 
            :ARG1 (m / membran) 
            :ARG2 (p2 / pb) 
            :time (a3 / after)))

# ::snt Solubilized membranes were incubated with 20 l of immobilized streptavidin ( Pierce Biotechnology ) for 2 h at 4 C .
# ::tok Solubilized membranes were incubated with 20 l of immobilized streptavidin ( Pierce Biotechnology ) for 2 h at 4 C .
# ::alignments 19-20|0.2.0.0.0 18-19|0.2.0.0.0.0 16-17|0.3 15-16|0.3.0 11-13|0.0.0.1+0.0.0.0+0.0.0+0.0 9-10|0.2.0 8-9|0.2.0.0 6-7|0.2 5-6|0.2.1 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:43.801
(i2 / incubate-01 
      :ARG0 (c2 / country 
            :name (n / name 
                  :op1 "Pierce" 
                  :op2 "Biotechnology")) 
      :ARG1 (m / membran 
            :mod (s2 / solubiliz)) 
      :ARG2 (l / l 
            :mod (s / streptavidin 
                  :ARG1-of (i / immobilize-01 
                        :ARG0 (c / C 
                              :era-of 4))) 
            :quant 20) 
      :duration (h / h 
            :quant 2))

# ::snt Finally the precipitated proteins were washed in RIPA buffer and boiled in 50 l of Laemmli buffer .
# ::tok Finally the precipitated proteins were washed in RIPA buffer and boiled in 50 l of Laemmli buffer .
# ::alignments 16-17|0.1.1.0 15-16|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 13-14|0.1.1 12-13|0.1.1.1 10-11|0.1 9-10|0 8-9|0.1.0.0 7-8|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 5-6|0.0 3-4|0.1.0 2-3|0.1.0.1 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:44.045
(a / and 
      :op1 (w / wash-01) 
      :op2 (b2 / boil-01 
            :ARG1 (p / protein 
                  :ARG0-of (b3 / buffer-01 
                        :ARG1 (c2 / country 
                              :name (n2 / name 
                                    :op1 "RIPA"))) 
                  :ARG1-of (p2 / precipitate-01)) 
            :ARG2 (l / l 
                  :mod (b / buffer-01 
                        :ARG1 (c / country 
                              :name (n / name 
                                    :op1 "Laemmli"))) 
                  :quant 50)) 
      :time (f / final))

# ::snt Total cells and the biotinylated precipitates were immunoblotting using an antibody to AQP2 .
# ::tok Total cells and the biotinylated precipitates were immunoblotting using an antibody to AQP2 .
# ::alignments 10-11|0.0.0.0.0 8-9|0.0.0.0 5-6|0.0 4-5|0 2-3|0.0.0 1-2|0.0.0.0.1 0-1|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:44.107
(b / biotinylat 
      :ARG1-of (p / precipitate-01 
            :op1-of (a2 / and 
                  :op2 (u / use-01 
                        :ARG1 (a / antibody) 
                        :ARG2 (c / cell 
                              :ARG1-of (t / total-01))))))

# ::snt Kidney immunohistochemistry .
# ::tok Kidney immunohistochemistry .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:44.113
(i / immunohistochemistry 
      :mod (k / kidney))

# ::snt Whole mouse kidneys were fixed in 10 % phosphate-buffered formalin for 24 h. Kidneys were embedded in paraffin , and 5-m sections were prepared .
# ::tok Whole mouse kidneys were fixed in 10 % phosphate-buffered formalin for 24 h. Kidneys were embedded in paraffin , and 5-m sections were prepared .
# ::alignments 23-24|0.1 21-22|0.1.1 19-20|0 17-18|0.0.1.2 15-16|0.0.1 13-14|0.0.1.1 11-12|0.0.1.1.0 9-10|0.0.2 8-9|0.0.2.0 7-8|0.1.0.0 6-7|0.1.0 4-5|0.0 2-3|0.0.0 1-2|0.0.0.0 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:44.371
(a / and 
      :op1 (f2 / fix-03 
            :ARG1 (k2 / kidney 
                  :mod (m / mouse)) 
            :ARG2 (e / embed-01 
                  :ARG0 (w / whole) 
                  :ARG1 (k / kidney 
                        :quant 24) 
                  :location (p2 / paraffin)) 
            :location (f / formalin 
                  :mod (p3 / phosphate-buffer))) 
      :op2 (p / prepare-02 
            :ARG0 (1 / 10 
                  :value-of (p4 / percentage-entity)) 
            :ARG1 (s / section)))

# ::snt Following antigen retrieval using 10 mM sodium citrate ( pH 8 ) for 10 min at 98 C , sections were sequentially probed , first for AQP3 and then for AQP2 .
# ::tok Following antigen retrieval using 10 mM sodium citrate ( pH 8 ) for 10 min at 98 C , sections were sequentially probed , first for AQP3 and then for AQP2 .
# ::alignments 28-29|0.0.0.1.0.1.0.2 27-28|0 26-27|0.0.1.0+0.0.1+0.0 22-23|0.0.0 21-22|0.0.0.2 19-20|0.0.0.1 17-18|0.0.0.1.0.2.0 16-17|0.0.0.1.0.2 14-15|0.0.0.1.0.1.0.1 13-14|0.0.0.1.0.0 10-11|0.0.0.0 9-10|0.0.0.3 7-8|0.0.0.1.0.1.0.0 6-7|0.0.0.1.0.1.0.0.0 5-6|0.0.0.1.0.1.0.0.0.0 4-5|0.0.0.4 3-4|0.0.0.1.0.1.0 2-3|0.0.0.1.0.1 1-2|0.0.0.1.0.1.1 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:44.845
(a / and 
      :op1 (p / person 
            :ARG2-of (p2 / probe-01 
                  :ARG0 8 
                  :ARG1 (s2 / section 
                        :ARG1-of (f / follow-01 
                              :ARG0 10 
                              :ARG2 (r / retrieval 
                                    :ARG0-of (u / use-01 
                                          :ARG1 (c2 / citrate 
                                                :mod (s3 / sodium 
                                                      :mod (m2 / mm))) 
                                          :ARG2 (m / min) 
                                          :time (t / then)) 
                                    :mod (a2 / antigen)) 
                              :op1-of (9 / 98 
                                    :era (c / C)))) 
                  :degree (s / sequentially) 
                  :op1-of (p3 / ph) 
                  :op1-of 10) 
            :name (n / name 
                  :op1 "AQP3")))

# ::snt Sections were incubated in 5 % donkey serum and then in goat anti-AQP3 antibody ( 1:100 ; Santa Cruz Biotechnology ; #sc -9885 ) .
# ::tok Sections were incubated in 5 % donkey serum and then in goat anti-AQP3 antibody ( 1:100 ; Santa Cruz Biotechnology ; #sc -9885 ) .
# ::alignments 17-20|0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 16-17|0 13-14|0.0.1 11-12|0.0.1.0 9-10|0.0.0.0.0 8-9|0.0 7-8|0.0.0.1 6-7|0.0.0.1.0 5-6|0.0.0.1.1 4-5|0.0.0.1.1.0 2-3|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:45.087
(a / and 
      :op1 (a3 / and 
            :ARG2-of (i / incubate-01 
                  :ARG1 (s2 / section-01 
                        :ARG0 (t / then)) 
                  :location (s / serum 
                        :mod (d / donkey) 
                        :mod (p / percentage-entity 
                              :quant 5))) 
            :op1 (a2 / antibody 
                  :mod (g / goat))) 
      :op2 (o / organization 
            :name (n / name 
                  :op1 "Santa" 
                  :op2 "Cruz" 
                  :op3 "Biotechnology")))

# ::snt Slides were washed with PBS and incubated with AlexaFluor 488-conjugated donkey anti-goat antibody ( Molecular Probes , Eugene , Oregon , United States ) .
# ::tok Slides were washed with PBS and incubated with AlexaFluor 488-conjugated donkey anti-goat antibody ( Molecular Probes , Eugene , Oregon , United States ) .
# ::alignments 21-23|0.1.0.1.1+0.1.0.1.0.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 19-20|0.3.0.0+0.3.0+0.3 17-18|0.0.1.0.0+0.0.1.0+0.0.1 14-16|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 12-13|0.1.1 10-11|0.1.1.1 9-10|0.1.1.0 8-9|0.2.0.0+0.2.0+0.2 6-7|0.1 5-6|0 4-5|0.0.0 2-3|0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:45.432
(a2 / and 
      :op1 (w / wash-01 
            :ARG0 (p / pb) 
            :ARG1 (o / organization 
                  :name (n3 / name 
                        :op1 "Eugene"))) 
      :op2 (i / incubate-01 
            :ARG1 (s / slide-01 
                  :ARG0 (o2 / organization 
                        :name (n4 / name 
                              :op1 "Molecular" 
                              :op2 "Probes")) 
                  :ARG1 (c / country 
                        :name (n / name 
                              :op1 "United" 
                              :op2 "States") 
                        :wiki "United_States")) 
            :ARG2 (a / antibody 
                  :mod 488-conjugat 
                  :mod (d / donkey))) 
      :op3 (t / thing 
            :name (n5 / name 
                  :op1 "AlexaFluor")) 
      :op4 (c2 / country 
            :name (n2 / name 
                  :op1 "Oregon")))

# ::snt The slides were subsequently blocked in 5 % chicken serum , incubated with a rabbit anti-AQP2 antibody ( 1:250 ; USB , Cleveland , Ohio , United States ; #A3000 -- 06 ) , which was detected with a AlexaFluor 594-conjugated chicken anti-rabbit antibody ( 1:500 ; Molecular Probes ) .
# ::tok The slides were subsequently blocked in 5 % chicken serum , incubated with a rabbit anti-AQP2 antibody ( 1:250 ; USB , Cleveland , Ohio , United States ; #A3000 -- 06 ) , which was detected with a AlexaFluor 594-conjugated chicken anti-rabbit antibody ( 1:500 ; Molecular Probes ) .
# ::alignments 47-49|0.2.0.1+0.2.0.0+0.2.0+0.2 43-44|0.0.0 41-42|0.1 40-41|0.0.0.0.1.0.1.0 39-40|0.0.1.0+0.0.1+0.0 36-37|0.0.0.0 26-28|0.0.0.0.1.0.0.0.1+0.0.0.0.1.0.0.0.0.1+0.0.0.0.1.0.0.0.0.0+0.0.0.0.1.0.0.0.0+0.0.0.0.1.0.0.0 24-25|0.0.0.0.1.0.0.1.1.0.0+0.0.0.0.1.0.0.1.1.0+0.0.0.0.1.0.0.1.1 22-23|0.0.0.0.1.0.0.1.0.0.0+0.0.0.0.1.0.0.1.0.0+0.0.0.0.1.0.0.1.0 19-20|0 16-17|0.0.0.0.1 14-15|0.0.0.0.1.0.1 11-12|0.0.0.0.1.0 9-10|0.0.0.0.1.0.0.2 8-9|0.0.0.0.1.0.0.2.0 7-8|0.0.0.0.1.0.0.2.0.0 6-7|0.0.0.0.0 4-5|0.0.0.0.1.0.0 3-4|0.0.0.0.1.0.0.3 1-2|0.0.0.0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:46.126
(a2 / and 
      :op1 (t / thing 
            :mod-of (a / antibody 
                  :accompanier-of (d / detect-01 
                        :ARG0 5 
                        :ARG1 (a3 / antibody 
                              :ARG0-of (i / incubate-01 
                                    :ARG1 (b / block-01 
                                          :ARG0 (c2 / country 
                                                :name (n3 / name 
                                                      :op1 "United" 
                                                      :op2 "States") 
                                                :wiki "United_States") 
                                          :ARG1 (s3 / slide-01 
                                                :ARG1 (c4 / country 
                                                      :name (n5 / name 
                                                            :op1 "Cleveland")) 
                                                :op1-of (c3 / country 
                                                      :name (n4 / name 
                                                            :op1 "Ohio"))) 
                                          :location (s / serum 
                                                :mod (c5 / chicken 
                                                      :mod (p / percentage-entity))) 
                                          :time (s2 / subsequent)) 
                                    :ARG2 (r / rabbit-01 
                                          :ARG0 594-conjugat))))) 
            :name (n2 / name 
                  :op1 "AlexaFluor")) 
      :op2 (c / chicken) 
      :op3 (o / organization 
            :name (n / name 
                  :op1 "Molecular" 
                  :op2 "Probes")))

# ::snt The sections were stained with DAPI and mounted in Vectashield ( Vector Labs , Burlingame , California , United States ) .
# ::tok The sections were stained with DAPI and mounted in Vectashield ( Vector Labs , Burlingame , California , United States ) .
# ::alignments 18-20|0.4.1+0.4.0.1+0.4.0.0+0.4.0+0.4 16-17|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 14-15|0.3.0.0+0.3.0+0.3 11-13|0.2.0.1+0.2.0.0+0.2.0+0.2 7-8|0.1 6-7|0 5-6|0.0.1.0.0+0.0.1.0+0.0.1 3-4|0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:46.526
(a / and 
      :op1 (s2 / stain-01 
            :ARG0 (s / state 
                  :name (n2 / name 
                        :op1 "California") 
                  :wiki "California") 
            :ARG1 (t / thing 
                  :name (n5 / name 
                        :op1 "DAPI"))) 
      :op2 (m / mount-01 
            :ARG1 (s3 / section)) 
      :op3 (o / organization 
            :name (n4 / name 
                  :op1 "Vector" 
                  :op2 "Labs")) 
      :op4 (c2 / country 
            :name (n3 / name 
                  :op1 "Burlingame")) 
      :op5 (c / country 
            :name (n / name 
                  :op1 "United" 
                  :op2 "States") 
            :wiki "United_States"))

# ::snt Immunocytochemistry on MDCK cells .
# ::tok Immunocytochemistry on MDCK cells .
# ::alignments 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:46.532
(c / cell 
      :mod (m / MDCK))

# ::snt MDCK stable cell lines expressing vector alone , wild-type AQP2 , or AQP2-F204V ( and in some cases transiently expressing a GFP construct ) were grown on fibronectin-coated coverslips until tight junctions formed .
# ::tok MDCK stable cell lines expressing vector alone , wild-type AQP2 , or AQP2-F204V ( and in some cases transiently expressing a GFP construct ) were grown on fibronectin-coated coverslips until tight junctions formed .
# ::alignments 32-33|0.1.1.3 31-32|0.1.1.3.0 30-31|0.1.1.3.0.0 29-30|0.1.1.3.0.1 28-29|0.1.1.3.0.1.0.0 27-28|0.1.1.3.0.1.0.0.0 25-26|0.1.1.3.0.1.0 22-23|0.1 21-22|0.1.0.0.0+0.1.0.0+0.1.0 19-20|0 18-19|0.2 17-18|0.0 16-17|0.0.0 14-15|0.1.2 12-13|0.1.1.2.0.0+0.1.1.2.0+0.1.1.2 11-12|0.1.1 9-10|0.1.1.1 6-7|0.1.1.0.2 5-6|0.1.1.0.1 4-5|0.1.1.0 3-4|0.1.1.0.0 2-3|0.1.1.0.0.1 1-2|0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:47.779
(e / express-01 
      :ARG0 (c3 / case-03 
            :mod (s / some)) 
      :ARG1 (c2 / construct-01 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "GFP")) 
            :domain-of (o2 / or 
                  :ARG2-of (e2 / express-01 
                        :ARG0 (l / line 
                              :ARG1-of (s2 / stable-03) 
                              :mod (c4 / cell)) 
                        :ARG1 (v / vector) 
                        :location (a3 / alone)) 
                  :op1 (a2 / AQP2) 
                  :op2 (t3 / thing 
                        :name (n2 / name 
                              :op1 "AQP2-F204V")) 
                  :op3 (f / form-01 
                        :ARG1 (j / junction 
                              :ARG1-of (t / tight-05) 
                              :op1-of (u / until 
                                    :time-of (g / grow-03 
                                          :ARG1 (c / coverslip 
                                                :mod (f2 / fibronectin-coat))))))) 
            :op1-of (a / and)) 
      :mod (t2 / transiently))

# ::snt Cells were treated with or without 150 M forskolin for 90 min , and fixed in methanol at  20 C .
# ::tok Cells were treated with or without 150 M forskolin for 90 min , and fixed in methanol at  20 C .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:47.781
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Subsequently , cells were washed and permeabilized in 0.2 % Triton X-100 for 5 min , and sequentially probed for AQP2 and organelle markers for either the PM or the ER .
# ::tok Subsequently , cells were washed and permeabilized in 0.2 % Triton X-100 for 5 min , and sequentially probed for AQP2 and organelle markers for either the PM or the ER .
# ::alignments 30-31|0.0.1.2 28-29|0.0.1 27-28|0.0.1.1 25-26|0.0.1.0 23-24|0.3 22-23|0.2 21-22|0 20-21|0.1 18-19|0.0 17-18|0.0.2 16-17|0.0.4 14-15|0.0.4.1 13-14|0.0.3.0.0 10-12|0.0.4.0.1.1+0.0.4.0.1.0+0.0.4.0.1+0.0.4.0 9-10|0.0.4.0.0 8-9|0.0.4.0.0.0 5-6|0.0.3 4-5|0.0.3.0 2-3|0.0.0 0-1|0.0.3.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:48.510
(a / and 
      :ARG2-of (p2 / probe-01 
            :ARG1 (c / cell) 
            :location (o / or 
                  :mod (e2 / either) 
                  :op1 (p / pm) 
                  :op2 (e / e)) 
            :manner (s / sequentially) 
            :op2-of (a4 / and 
                  :op1 (w / wash-01 
                        :ARG0 5 
                        :time (s2 / subsequent))) 
            :op3-of (a3 / and 
                  :op1 (p3 / person 
                        :mod (p4 / percentage-entity 
                              :value 0.2) 
                        :name (n / name 
                              :op1 "Triton" 
                              :op2 "X-100")) 
                  :op2 (m2 / min))) 
      :op1 (a2 / AQP2) 
      :op2 (o2 / organelle) 
      :op3 (m / marker))

# ::snt AQP2 was detected using goat anti-AQP2 ( 1:100 ; Santa Cruz Biotechnology ; #sc -9882 ) and a 1:200 dilution of AlexaFluor 488-conjugated donkey anti-goat secondary antibody .
# ::tok AQP2 was detected using goat anti-AQP2 ( 1:100 ; Santa Cruz Biotechnology ; #sc -9882 ) and a 1:200 dilution of AlexaFluor 488-conjugated donkey anti-goat secondary antibody .
# ::alignments 26-27|0.0.1.0.1.0.0 25-26|0.0.1.0.0 23-24|0.0.1.0.1.0 22-23|0.0.1.0.1.0.0.0 21-22|0.0.1.0.1.0.0.1.0.0+0.0.1.0.1.0.0.1.0+0.0.1.0.1.0.0.1 19-20|0.0.1.1 16-17|0.0.1 9-12|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 8-9|0 4-5|0.0.1.0.0.0 3-4|0.0.1.0 2-3|0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:48.800
(a3 / and 
      :op1 (o / organization 
            :name (n2 / name 
                  :op1 "Santa" 
                  :op2 "Cruz" 
                  :op3 "Biotechnology") 
            :op1-of (a2 / and 
                  :ARG1-of (u / use-01 
                        :ARG0 (s / secondary 
                              :mod (g / goat)) 
                        :ARG1-of (d3 / detect-01 
                              :ARG0 (d / donkey 
                                    :mod-of (a / antibody 
                                          :mod 488-conjugat 
                                          :mod (t / thing 
                                                :name (n / name 
                                                      :op1 "AlexaFluor")))))) 
                  :op2 (d2 / dilution))))

# ::snt The PM and ER were probed using mouse anti-Na + / K + - ATPase ( Upstate , Waltham , Massachusetts , United States ) or rabbit anti-calnexin ( Stressgen Biotechnology , Victoria , British Columbia , Canada ) antibodies and the secondary antibodies , Cy3-conjugated goat anti-mouse ( 1:200 ; Jackson ImmunoResearch , West Grove , Pennsylvania , United States ) or AlexaFluor 594-conjugated chicken anti-rabbit ( 1:200 ) respectively .
# ::tok The PM and ER were probed using mouse anti-Na + / K + - ATPase ( Upstate , Waltham , Massachusetts , United States ) or rabbit anti-calnexin ( Stressgen Biotechnology , Victoria , British Columbia , Canada ) antibodies and the secondary antibodies , Cy3-conjugated goat anti-mouse ( 1:200 ; Jackson ImmunoResearch , West Grove , Pennsylvania , United States ) or AlexaFluor 594-conjugated chicken anti-rabbit ( 1:200 ) respectively .
# ::alignments 70-71|0.0 65-66|0.3 64-65|0.1.3.1.1.4.0 63-64|0.1.3.1.1.4.2.0.0+0.1.3.1.1.4.2.0+0.1.3.1.1.4.2 62-63|0.1.3.1.1.4 59-61|0.1.3.1.0.4.1+0.1.3.1.0.4.0.1+0.1.3.1.0.4.0.0+0.1.3.1.0.4.0+0.1.3.1.0.4 57-58|0.1.3.1.0.3.0.0+0.1.3.1.0.3.0+0.1.3.1.0.3 54-56|0.2.0.1+0.2.0.0+0.2.0+0.2 51-53|0.1.1.1+0.1.1.0+0.1.1+0.1 50-51|0 46-47|0.1.3.1.1.4.1.0 45-46|0.1.3.1.1.4.1.1.0+0.1.3.1.1.4.1.1+0.1.3.1.1.4.1 43-44|0.1.3.1.1.3 42-43|0.1.3.1.1.1.1.0 40-41|0.1.3.1.0 39-40|0.1.3.1.1.2 37-38|0.1.3.3.1+0.1.3.3.0.0+0.1.3.3.0+0.1.3.3 34-36|0.1.3.2.0.1+0.1.3.2.0.0+0.1.3.2.0+0.1.3.2 32-33|0.1.3.1.2.0.1+0.1.3.1.2.0.0.0+0.1.3.1.2.0.0+0.1.3.1.2.0 29-31|0.1.3.1.0.2.0.1+0.1.3.1.0.2.0.0+0.1.3.1.0.2.0+0.1.3.1.0.2 26-27|0.1.3.1.1.1 25-26|0.1.3.1.1 22-24|0.1.0.1+0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 20-21|0.1.3.1.1.1.1.2+0.1.3.1.1.1.1.1.0+0.1.3.1.1.1.1.1+0.1.3.1.1.1.1 18-19|0.1.3.1.0.1.0.0+0.1.3.1.0.1.0+0.1.3.1.0.1 16-17|0.1.3.1.0.0.0.0+0.1.3.1.0.0.0+0.1.3.1.0.0 11-12|0.1.3.1.1.1.0 10-11|0.1.2 7-8|0.1.3.1.1.0 6-7|0.1.3.1 5-6|0.1.3.1.2 3-4|0.1.3.0 2-3|0.1.3 1-2|0.1.3.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:55.904
(a / and 
      :mod (r / respective) 
      :op1 (p / person 
            :mod (c7 / country 
                  :name (n11 / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States") 
            :name (n5 / name 
                  :op1 "Jackson" 
                  :op2 "ImmunoResearch") 
            :op1-of (s4 / slash) 
            :op5-of (a5 / and 
                  :op1 (e / e) 
                  :op2 (u / use-01 
                        :ARG0 (a3 / and 
                              :op1 (o4 / organization 
                                    :name (n14 / name 
                                          :op1 "Upstate")) 
                              :op2 (c8 / country 
                                    :name (n13 / name 
                                          :op1 "Waltham")) 
                              :op3 (o2 / organization 
                                    :name (n10 / name 
                                          :op1 "Stressgen" 
                                          :op2 "Biotechnology")) 
                              :op4 (c3 / country 
                                    :name (n3 / name 
                                          :op1 "Pennsylvania")) 
                              :op5 (c2 / country 
                                    :name (n2 / name 
                                          :op1 "United" 
                                          :op2 "States") 
                                    :wiki "United_States")) 
                        :ARG1 (o3 / or 
                              :op1 (m / mouse) 
                              :op2 (r2 / rabbit-01 
                                    :ARG0 (k / k) 
                                    :ARG1 (s3 / state 
                                          :mod-of (s / secondary) 
                                          :name (n12 / name 
                                                :op1 "Massachusetts") 
                                          :wiki "Massachusetts")) 
                              :op3 (a4 / antibodi) 
                              :op4 (a2 / antibodi) 
                              :op5 (o / or 
                                    :mod 594-conjugat 
                                    :op1 (t2 / thing 
                                          :mod-of (g / goat) 
                                          :name (n6 / name 
                                                :op1 "Cy3-conjugated")) 
                                    :op2 (t / thing 
                                          :name (n / name 
                                                :op1 "AlexaFluor")))) 
                        :ARG1-of (p2 / probe-01 
                              :ARG0 (s2 / state 
                                    :name (n9 / name 
                                          :op1 "Victoria") 
                                    :wiki "Victoria_(Australia)")) 
                        :ARG2 (p3 / pm)) 
                  :op3 (c6 / country 
                        :name (n8 / name 
                              :op1 "British" 
                              :op2 "Columbia")) 
                  :op4 (c5 / country 
                        :name (n7 / name 
                              :op1 "Canada") 
                        :wiki "Canada"))) 
      :op2 (c4 / country 
            :name (n4 / name 
                  :op1 "West" 
                  :op2 "Grove")) 
      :op3 (c / chicken))

# ::snt Cells were washed in PBS , counterstained with DAPI , and mounted in Vectashield .
# ::tok Cells were washed in PBS , counterstained with DAPI , and mounted in Vectashield .
# ::alignments 11-12|0.1 10-11|0 8-9|0.0.0.0.0+0.0.0.0+0.0.0 4-5|0.0.1 2-3|0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:55.965
(a / and 
      :ARG2-of (w / wash-01 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "DAPI")) 
            :location (p / pb)) 
      :op1 (m / mount-01 
            :ARG1 (c / cell)))

# ::snt In experiments in which GFP fusions were used , AQP2 was probed using the antibody combination used for kidney immunohistochemistry in order to detect the AQP2 at 594 nm , to distinguish between the GFP fusion proteins .
# ::tok In experiments in which GFP fusions were used , AQP2 was probed using the antibody combination used for kidney immunohistochemistry in order to detect the AQP2 at 594 nm , to distinguish between the GFP fusion proteins .
# ::alignments 36-37|0 35-36|0.1 31-32|0.0.1.2.1 28-29|0.0.1.2.0 23-24|0.0.1.2 19-20|0.0.2.0 18-19|0.0.2.0.0 16-17|0.0.2 15-16|0.0 14-15|0.0.0 12-13|0.0.1 11-12|0.0.1.1 7-8|0.0.1.0.0.0 5-6|0.0.1.0.0 4-5|0.0.1.0.1.0+0.0.1.0.1+0.0.1.0 1-2|0.0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:56.795
(p / protein 
      :ARG0-of (c / combine-01 
            :ARG1 (a / antibody) 
            :ARG1-of (u2 / use-01 
                  :ARG0 (o / organization 
                        :mod-of (f2 / fusion 
                              :ARG1-of (u3 / use-01 
                                    :ARG2 (e / experiment-01))) 
                        :name (n2 / name 
                              :op1 "GFP")) 
                  :ARG1-of (p2 / probe-01) 
                  :purpose (d2 / detect-01 
                        :ARG2 (n / nm) 
                        :purpose (d / distinguish-01))) 
            :ARG1-of (u / use-01 
                  :ARG2 (i / immunohistochemistry 
                        :mod (k / kidney)))) 
      :mod (f / fusion))

# ::snt Confocal microscopy .
# ::tok Confocal microscopy .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:56.800
(m / microscopy 
      :mod (c / Confocal))

# ::snt Optical z-section images were collected on a BioRad ( Hercules , California , United States ) Rainbow Radiance 2100 Laser Scanning Confocal Microscope .
# ::tok Optical z-section images were collected on a BioRad ( Hercules , California , United States ) Rainbow Radiance 2100 Laser Scanning Confocal Microscope .
# ::alignments 19-23|0.0.2.3+0.0.2.2+0.0.2.1+0.0.2.0+0.0.2+0.0 18-19|0.0.0.0+0.0.0 16-18|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 13-15|0.3.1+0.3.0.1+0.3.0.0+0.3.0+0.3 11-12|0.1.0.1.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 9-10|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 7-8|0.2.0.0+0.2.0+0.2 4-5|0 2-3|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:57.426
(c2 / collect-01 
      :ARG0 (o / organization 
            :mod (d / date-entity 
                  :year 2100) 
            :mod (t / thing 
                  :name (n2 / name 
                        :op1 (r / Rainbow) 
                        :op2 (r2 / Radiance))) 
            :name (n / name 
                  :op1 "Laser" 
                  :op2 "Scanning" 
                  :op3 "Confocal" 
                  :op4 "Microscope")) 
      :ARG1 (i / image 
            :mod (o4 / optical 
                  :mod (o2 / organization 
                        :name (n5 / name 
                              :op1 "Hercules")) 
                  :poss (s / state 
                        :name (n4 / name 
                              :op1 "California") 
                        :wiki "California"))) 
      :ARG2 (o3 / organization 
            :name (n6 / name 
                  :op1 "BioRad")) 
      :op1-of (c / country 
            :name (n3 / name 
                  :op1 "United" 
                  :op2 "States") 
            :wiki "United_States"))

# ::snt Image stacks were flattened , or sectioned along the z-axis , then further processed using BioRad Laser Sharp 2000 software and Image J software ( v. 1.32 ; National Institutes of Health ) .
# ::tok Image stacks were flattened , or sectioned along the z-axis , then further processed using BioRad Laser Sharp 2000 software and Image J software ( v. 1.32 ; National Institutes of Health ) .
# ::alignments 28-32|0.1.0.0.1.0.0.0.0.3+0.1.0.0.1.0.0.0.0.2+0.1.0.0.1.0.0.0.0.1+0.1.0.0.1.0.0.0.0.0+0.1.0.0.1.0.0.0.0+0.1.0.0.1.0.0.0 27-28|0.1.0.0.1.0.0 23-24|0.1 22-23|0.1.0.2+0.1.0.1.0+0.1.0.1+0.1.0 20-21|0 19-20|0.0.0 18-19|0.0.0.1.0+0.0.0.1 15-18|0.0.0.0.0.2+0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 14-15|0.0 13-14|0.0.1 12-13|0.0.1.0 11-12|0.1.0.0.1.1 9-10|0.1.0.0.1.0.1.0 7-8|0.1.0.0.1.0.1 6-7|0.1.0.0.1 5-6|0.1.0.0.1.0 3-4|0.1.0.0.0 1-2|0.1.0.0 0-1|0.1.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:59.410
(a3 / and 
      :ARG0-of (u / use-01 
            :ARG1 (s2 / software 
                  :mod (o2 / organization 
                        :name (n3 / name 
                              :op1 "BioRad" 
                              :op2 "Laser" 
                              :op3 "Sharp")) 
                  :time (d / date-entity 
                        :year 2000)) 
            :ARG1-of (p / process-01 
                  :ARG0 (f / further))) 
      :op1 (s / software 
            :mod (a2 / aircraft-type 
                  :ARG1-of (s4 / stack-01 
                        :ARG1-of (f2 / flatten-01) 
                        :ARG1-of (s3 / section-01 
                              :op1-of (o3 / or 
                                    :op2 (a / and 
                                          :op1 (o / organization 
                                                :name (n / name 
                                                      :op1 "National" 
                                                      :op2 "Institutes" 
                                                      :op3 "of" 
                                                      :op4 "Health"))) 
                                    :time (a4 / along 
                                          :op1 (z / z-axi))) 
                              :time (t / then)) 
                        :mod (i / image)) 
                  :name (n2 / name 
                        :op1 "J-10") 
                  :wiki "Chengdu_J-10")))

# ::snt Colocalization was performed using the overlay coefficient of Image J software .
# ::tok Colocalization was performed using the overlay coefficient of Image J software .
# ::alignments 10-11|0.0.0.0.0 9-10|0.0.0.0.2+0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 8-9|0.0.0.0.0.0 6-7|0.0 5-6|0.0.0 3-4|0 2-3|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:59.483
(u / use-01 
      :ARG1 (c / coefficient 
            :ARG1-of (o / overlay-01 
                  :ARG0 (a / aircraft-type 
                        :mod-of (s / software 
                              :mod (i / image)) 
                        :name (n / name 
                              :op1 "J-10") 
                        :wiki "Chengdu_J-10"))) 
      :ARG1-of (p / perform-02))

# ::snt The GenBank ( http://www.ncbi.nlm.nih.gov/ ) accession number of Aqp2 is NM_009699 .
# ::tok The GenBank ( http://www.ncbi.nlm.nih.gov/ ) accession number of Aqp2 is NM_009699 .
# ::alignments 10-11|0 8-9|0.0.2.1+0.0.2+0.0.2.0 6-7|0.0 5-6|0.0.0 1-2|0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:59.525
(n / nm_009699 
      :domain (n3 / number 
            :mod (a / accession) 
            :mod (p / person 
                  :name (n4 / name 
                        :op1 "GenBank")) 
            :quant-of (n2 / name 
                  :name-of (c / country) 
                  :op1 "Aqp2")))

# ::snt The IMAGE ( http://image.llnl.gov ) accession number of AQP2 is 4222942 .
# ::tok The IMAGE ( http://image.llnl.gov ) accession number of AQP2 is 4222942 .
# ::alignments 10-11|0.3+0.2+0.0+0 6-7|0.1.0 5-6|0.1 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:40:59.557
(d / date-entity 
      :day 42 
      :domain-of (a / accession 
            :mod-of (n / number 
                  :mod (i / image))) 
      :month 29 
      :year 422)

# ::snt We thank Debby Stradley for all genotyping , Lacey Kischassey for breeding and care of mice , Karina Ayala and Sandy Bohan for phenotyping the study mice , Miah Gilmore for performing endoglycosidase H experiments , James Watson for sectioning tissue , and Dr. William Kiossis for collecting confocal images .
# ::tok We thank Debby Stradley for all genotyping , Lacey Kischassey for breeding and care of mice , Karina Ayala and Sandy Bohan for phenotyping the study mice , Miah Gilmore for performing endoglycosidase H experiments , James Watson for sectioning tissue , and Dr. William Kiossis for collecting confocal images .
# ::alignments 49-50|0.0.4.0.2.0.0.0 47-48|0.0.4.0.2.0.0 44-46|0.2.0.1.1.0.1+0.2.0.1.1.0.0+0.2.0.1.1.0+0.2.0.1.1 43-44|0.0.4.0.2.0.0.1 42-43|0.2.0.1 40-41|0.0.1 39-40|0.0.1.0 36-38|0.2.0.1.0.0.1+0.2.0.1.0.0.0+0.2.0.1.0.0+0.2.0.1.0 34-35|0 33-34|0.1 31-32|0.2 28-30|0.2.0.0.1+0.2.0.0.0+0.2.0.0+0.2.0 26-27|0.0.4.0.2.0 25-26|0.0.4.0.2 20-22|0.0.4.0.1.0.1+0.0.4.0.1.0.0+0.0.4.0.1.0+0.0.4.0.1 19-20|0.0.4.0 17-19|0.0.4.0.0.0.1+0.0.4.0.0.0.0+0.0.4.0.0.0+0.0.4.0.0 15-16|0.0.3.0 13-14|0.0.4 12-13|0.0 11-12|0.0.3 8-10|0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 6-7|0.0.0.2 5-6|0.0.0.2.0 2-4|0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:01.474
(e / experiment-01 
      :ARG0 (a3 / and 
            :ARG3-of (t2 / thank-01 
                  :ARG0 (w / we) 
                  :ARG1 (p8 / person 
                        :name (n7 / name 
                              :op1 "Debby" 
                              :op2 "Stradley")) 
                  :ARG2 (g / genotyp 
                        :quant (a4 / all))) 
            :mod-of (t / tissue 
                  :ARG1-of (s / section-01)) 
            :op1 (p7 / person 
                  :name (n6 / name 
                        :op1 "Lacey" 
                        :op2 "Kischassey")) 
            :op2 (b / breed-01 
                  :ARG1 (m2 / mouse)) 
            :op3 (c2 / care-03 
                  :ARG1 (a2 / and 
                        :op1 (p6 / person 
                              :name (n5 / name 
                                    :op1 "Karina" 
                                    :op2 "Ayala")) 
                        :op2 (p5 / person 
                              :name (n4 / name 
                                    :op1 "Sandy" 
                                    :op2 "Bohan")) 
                        :op3 (s2 / study-01 
                              :ARG0 (m / mouse 
                                    :ARG0-of (c / collect-01 
                                          :ARG1 (i / image) 
                                          :manner (d / dr.))))))) 
      :ARG1 (h / h) 
      :ARG1-of (p3 / perform-02 
            :ARG0 (p4 / person 
                  :name (n3 / name 
                        :op1 "Miah" 
                        :op2 "Gilmore") 
                  :op1-of (a / and 
                        :op2 (p2 / person 
                              :name (n2 / name 
                                    :op1 "James" 
                                    :op2 "Watson")) 
                        :op3 (p / person 
                              :name (n / name 
                                    :op1 "William" 
                                    :op2 "Kiossis"))))))

# ::snt AVPR2 - AVP type 2 receptor .
# ::tok AVPR2 - AVP type 2 receptor .
# ::alignments 5-6|0.0.0 4-5|0.0.0.0 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:01.486
(a / AVPR2 
      :mod (t / type 
            :mod-of (r / receptor 
                  :quant 2)))

# ::snt AVP - arginine vasopressin .
# ::tok AVP - arginine vasopressin .
# ::alignments 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:01.498
(v / vasopressin 
      :mod (a / arginine))

# ::snt dDAVP - 1-deamino-8-D-arginine vasopressin .
# ::tok dDAVP - 1-deamino-8-D-arginine vasopressin .
# ::alignments 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:01.508
(d / dDAVP 
      :mod (v / vasopressin))

# ::snt ER - endoplasmic reticulum .
# ::tok ER - endoplasmic reticulum .
# ::alignments 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:01.516
(e / e 
      :poss-of (r / reticulum))

# ::snt MDCK - Madin-Darby canine kidney .
# ::tok MDCK - Madin-Darby canine kidney .
# ::alignments 4-5|0.0.0 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:01.528
(m / MDCK 
      :degree-of (c / canine 
            :mod-of (k / kidney)))

# ::snt NDI - nephrogenic diabetes insipidus .
# ::tok NDI - nephrogenic diabetes insipidus .
# ::alignments 4-5|0.0.0 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:01.538
(n / NDI 
      :poss-of (d / diabetes 
            :mod-of (i / insipidu)))

# ::snt PM - plasma membrane .
# ::tok PM - plasma membrane .
# ::alignments 3-4|0.0.0 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:01.549
(p2 / pm 
      :mod-of (p / plasma 
            :mod-of (m / membrane)))

# ::snt Analysis of Aqp2 Sequence and Phenotype in Mutant Mice .
# ::tok Analysis of Aqp2 Sequence and Phenotype in Mutant Mice .
# ::alignments 8-9|0.2.0 7-8|0.2 4-5|0 2-4|0.1.0.1+0.1.0.0+0.1.0+0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:01.576
(a / and 
      :op1 (a2 / analysi) 
      :op2 (t / thing 
            :name (n / name 
                  :op1 "Aqp2" 
                  :op2 "Sequence")) 
      :op3 (m2 / mutant 
            :mod-of (m / mouse)))

# ::snt ( A ) Chromatographic traces of Aqp2 F204V mutation .
# ::tok ( A ) Chromatographic traces of Aqp2 F204V mutation .
# ::alignments 8-9|0.0 6-8|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 4-5|0 3-4|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:01.596
(t2 / trace 
      :consist-of (m / mutation 
            :purpose (t / thing 
                  :name (n / name 
                        :op1 "Aqp2" 
                        :op2 "F204V"))) 
      :op1 (c / chromatographic))

# ::snt The box shows the mutated codon , TTC ( Phe ) to GTC ( Val ) at position 204 .
# ::tok The box shows the mutated codon , TTC ( Phe ) to GTC ( Val ) at position 204 .
# ::alignments 17-18|0.2 14-15|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 12-13|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 7-8|0.2.0.0.0+0.2.0.0+0.2.0 5-6|0.1 4-5|0.1.0 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:01.881
(s / show-01 
      :ARG0 (b / box) 
      :ARG1 (c / codon 
            :ARG1-of (m / mutate-01 
                  :ARG0 (o2 / organization 
                        :name (n2 / name 
                              :op1 "GTC") 
                        :part (o / organization 
                              :name (n / name 
                                    :op1 "Val"))))) 
      :time (p / position 
            :op1-of (o3 / organization 
                  :name (n3 / name 
                        :op1 "TTC"))))

# ::snt WT , wild type ; Mut , mutant .
# ::tok WT , wild type ; Mut , mutant .
# ::alignments 7-8|0.0.0.0 4-5|0 3-4|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:01.895
(a / and 
      :op1 (t / type 
            :mod (w / wild 
                  :op1-of (m / mutant))))

# ::snt ( B ) Amino acid conservation of mouse AQP2 ( residues 194 -- 214 ) .
# ::tok ( B ) Amino acid conservation of mouse AQP2 ( residues 194 -- 214 ) .
# ::alignments 10-11|0.1.0 8-9|0.0.0 7-8|0.0.0.0 5-6|0.0 4-5|0.0.1 3-4|0 1-2|0.1.2+0.1.1.0+0.1.1+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:01.994
(a3 / amino 
      :mod-of (c / conserve-01 
            :ARG1 (a / AQP2 
                  :mod (m / mouse)) 
            :mod (a2 / acid)) 
      :mod-of (l / location 
            :mod-of (r / residu) 
            :name (n / name 
                  :op1 "B") 
            :wiki -))

# ::snt The boxed residue indicates phenylalanine at position 204 .
# ::tok The boxed residue indicates phenylalanine at position 204 .
# ::alignments 6-7|0.2 4-5|0.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:02.026
(i / indicate-01 
      :ARG0 (r / residue 
            :ARG1-of (b / box-01)) 
      :ARG1 (p2 / phenylalanine) 
      :ARG2 (p / position))

# ::snt hAQP2 , human AQP2 ; mAQP1 , mouse AQP1 ; mAQP2 , mouse AQP2 ; rAQP2 , rat AQP2 ; xAQP2 , Xenopus AQP2 .
# ::tok hAQP2 , human AQP2 ; mAQP1 , mouse AQP1 ; mAQP2 , mouse AQP2 ; rAQP2 , rat AQP2 ; xAQP2 , Xenopus AQP2 .
# ::alignments 22-24|0.0.1.1+0.0.1.0+0.0.1+0.0 20-21|0.0.0.1.0 17-18|0.0.0.1 12-13|0 10-11|0.0.0.1.0.0.2 8-9|0.0.0.0 7-8|0.0.0 5-6|0.0.0.1.0.0.1 4-5|0.0.0.1.0.0 3-4|0.0.0.1.0.0.0 2-3|0.0.0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:02.105
(m / mouse 
      :mod-of (p / person 
            :mod (m3 / mouse 
                  :mod-of (a / AQP1) 
                  :mod-of (r / rat 
                        :mod (x / xAQP2 
                              :op4-of (a2 / and 
                                    :op1 (a3 / AQP2 
                                          :mod (h / human)) 
                                    :op2 (m4 / mAQP1) 
                                    :op3 (m2 / mAQP2))))) 
            :name (n / name 
                  :op1 "Xenopus" 
                  :op2 "AQP2")))

# ::snt ( C ) Urine production ( ml ) and water consumption ( ml ) of 58 F2 mice over a 24-h period ( both sexes , aged 10 -- 22 wk ) .
# ::tok ( C ) Urine production ( ml ) and water consumption ( ml ) of 58 F2 mice over a 24-h period ( both sexes , aged 10 -- 22 wk ) .
# ::alignments 29-30|0.0.0.0.0 27-28|0.0.0.0.2 26-27|0 24-25|0.0.0 23-24|0.0 21-22|0.0.0.0.3.1.1.0 17-18|0.0.0.0.3.1.1 15-16|0.0.0.0.3.1.2 10-11|0.0.0.0.3.1 9-10|0.0.0.0.3.1.0 8-9|0.0.0.0.3 6-7|0.1 4-5|0.0.0.0 3-4|0.0.0.0.1 1-2|0.0.0.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:02.402
(a / age-01 
      :ARG1 (b / both 
            :mod-of (s / sex 
                  :ARG0-of (p2 / produce-01 
                        :ARG2 22 
                        :mod (u / urine) 
                        :op1-of 10 
                        :op2-of (a2 / and 
                              :op1 (c2 / C) 
                              :op3 (c / consume-01 
                                    :ARG0 (w / water) 
                                    :ARG1 (m / mouse 
                                          :topic (p / period)) 
                                    :ARG2 58))))) 
      :op1-of (m2 / ml))

# ::snt Mutant mice ( black squares ) exhibit overt polyuria and polydipsia compared to littermate wild-type ( white triangles ) and heterozygous ( grey circles ) mice .
# ::tok Mutant mice ( black squares ) exhibit overt polyuria and polydipsia compared to littermate wild-type ( white triangles ) and heterozygous ( grey circles ) mice .
# ::alignments 25-26|0.0.0.0 23-24|0.0.3.2 22-23|0.0.3.2.0 20-21|0.0.3.1 19-20|0.0.3 17-18|0.0.3.0 16-17|0.0.3.0.0 11-12|0.0.0 10-11|0.0.2 9-10|0.0 8-9|0.1 7-8|0.0.2.0 6-7|0 4-5|0.0.1 3-4|0.0.1.0 1-2|0.0.3.2.0.0 0-1|0.0.3.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:03.264
(e / exhibit-01 
      :ARG1 (a2 / and 
            :ARG1-of (c2 / compare-01 
                  :ARG2 (m / mouse)) 
            :op1 (s / square-01 
                  :ARG1-of (b / black-04)) 
            :op2 (p / polydipsia 
                  :mod (o / overt)) 
            :op3 (a / and 
                  :op1 (t / triangl 
                        :mod (w / white)) 
                  :op2 (h / heterozygou) 
                  :op3 (c / circle 
                        :mod (g / grey 
                              :mod-of (m2 / mouse 
                                    :mod (m3 / mutant)))))) 
      :ARG2 (p2 / polyuria))

# ::snt ( D ) Urine osmolality and concentrating ability in Aqp2 mutant and their littermates ( 10 -- 22 wk , both sexes ) , before ( white bars ) and after ( black bars ) dDAVP treatment .
# ::tok ( D ) Urine osmolality and concentrating ability in Aqp2 mutant and their littermates ( 10 -- 22 wk , both sexes ) , before ( white bars ) and after ( black bars ) dDAVP treatment .
# ::alignments 36-37|0.0.1 33-34|0.0.0 32-33|0.0.0.0 30-31|0.0 29-30|0 27-28|0.1.0.0.1.2.0 26-27|0.1.0.0.1.2 24-25|0.0.1.0 21-22|0.1.0.0.1.0.0 20-21|0.1.0.0.1.0 17-18|0.0.0.0.0 15-16|0.0.1.1 13-14|0.1.0 11-12|0.1 10-11|0.1.0.0 9-10|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 7-8|0.1.0.0.1.1.1 6-7|0.1.0.0.1.1 5-6|0.1.0.0.1 1-2|0.1.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:03.760
(a2 / and 
      :op1 (a / after 
            :op1 (b / bar 
                  :ARG1-of (b2 / black-04 
                        :ARG2 22)) 
            :op2 (t / treat-03 
                  :ARG0 (b4 / before) 
                  :ARG2 10)) 
      :op2-of (a3 / and 
            :op1 (l / littermat 
                  :poss (m / mutant 
                        :mod (c / country 
                              :name (n / name 
                                    :op1 "Aqp2")) 
                        :poss-of (a5 / and 
                              :mod (b5 / both 
                                    :mod-of (s / sex)) 
                              :op1 (c2 / concentrate-01 
                                    :ARG0 (d / D) 
                                    :ARG1 (a4 / ability)) 
                              :op2 (w / white 
                                    :mod-of (b3 / bar)))))))

# ::snt Wild type ( WT ; n = 12 ) ; heterozygote ( Het ; n = 20 ) ; mutant ( Mut ; n = 9 ) .
# ::tok Wild type ( WT ; n = 12 ) ; heterozygote ( Het ; n = 20 ) ; mutant ( Mut ; n = 9 ) .
# ::alignments 25-26|0.0.0 19-20|0.0.3 16-17|0.0.1.1 12-13|0.0.0.1 10-11|0.0.2 7-8|0.0.0.0 5-6|0 4-5|0.0 1-2|0.0.1.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:03.821
(n / n 
      :op2-of (a / and 
            :mod (9 / 9 
                  :poss 12 
                  :poss (h / het)) 
            :op1 (w / wild 
                  :mod-of (t / type) 
                  :mod-of 20) 
            :op3 (h2 / heterozygote) 
            :op4 (m / mutant)))

# ::snt Data represent averages  standard error of the mean , ** p < 0.01 ; *** p < 0.001 .
# ::tok Data represent averages  standard error of the mean , ** p < 0.01 ; *** p < 0.001 .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:03.823
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Anatomy and Histology of Mouse Kidneys .
# ::tok Anatomy and Histology of Mouse Kidneys .
# ::alignments 4-6|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 2-3|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:03.842
(a / and 
      :op1 (a2 / anatomy) 
      :op2 (h / histology 
            :poss (p / person 
                  :name (n / name 
                        :op1 "Mouse" 
                        :op2 "Kidneys"))))

# ::snt ( A ) Gross anatomy of an affected mouse ( 8-mo-old male ) .
# ::tok ( A ) Gross anatomy of an affected mouse ( 8-mo-old male ) .
# ::alignments 11-12|0.0 8-9|0.1 7-8|0 4-5|0.1.0 3-4|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:03.865
(a / affect-01 
      :ARG0 (m / male) 
      :ARG1 (m2 / mouse 
            :poss-of (a2 / anatomy 
                  :ARG0-of (g / gross-03))))

# ::snt This shows the enlargement and cystic dilatation of the renal pelvis .
# ::tok This shows the enlargement and cystic dilatation of the renal pelvis .
# ::alignments 10-11|0.1.1.1 9-10|0.1.1.1.0 6-7|0.1.1 5-6|0.1.1.0 4-5|0.1 3-4|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:04.029
(s / show-01 
      :ARG0 (t / this) 
      :ARG1 (a / and 
            :op1 (e / enlargement) 
            :op2 (d / dilatation 
                  :mod (c / cystic) 
                  :poss (p / pelvi 
                        :mod (r / renal)))))

# ::snt There is thinning of the overlying renal parenchyma imparting a translucent appearance to portions of the kidney and collecting system .
# ::tok There is thinning of the overlying renal parenchyma imparting a translucent appearance to portions of the kidney and collecting system .
# ::alignments 19-20|0.2 18-19|0.1 17-18|0 16-17|0.0 13-14|0.2.0 11-12|0.2.0.0 10-11|0.2.0.0.1 8-9|0.2.0.0.0 7-8|0.2.0.0.0.0 6-7|0.2.0.0.0.0.0 2-3|0.2.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:04.178
(a / and 
      :op1 (k / kidney) 
      :op2 (c / collect-01) 
      :purpose-of (s / system 
            :mod (p / portion 
                  :ARG1-of (a2 / appear-01 
                        :ARG1-of (i / impart-01 
                              :ARG0 (p2 / parenchyma 
                                    :mod (r / renal)) 
                              :ARG1-of (t2 / thin-01)) 
                        :manner (t / translucent)))))

# ::snt The bladder is also dilated .
# ::tok The bladder is also dilated .
# ::alignments 4-5|0.0 3-4|0.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:04.187
(b / bladd 
      :ARG0-of (d / dilate-01 
            :mod (a / also)))

# ::snt ( B ) Left kidney from mutant mouse ( right ) shown in ( A ) compared to a kidney from an age-sex matched unaffected littermate ( left ) .
# ::tok ( B ) Left kidney from mutant mouse ( right ) shown in ( A ) compared to a kidney from an age-sex matched unaffected littermate ( left ) .
# ::alignments 27-28|0.1.0 25-26|0.1 24-25|0.2+0 23-24|0.1.1 19-20|0.0.2.0.1.0 16-17|0.0.2.0.1 11-12|0.0.2.0 9-10|0.0.2.0.0 7-8|0.0.2 6-7|0.0.2.1 4-5|0.0.1 3-4|0.0 1-2|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:04.466
(a / affect-01 
      :ARG1 (l3 / leave-01 
            :ARG0 (l4 / location 
                  :name (n / name 
                        :op1 "B") 
                  :wiki -) 
            :ARG1 (k2 / kidney) 
            :ARG2 (m2 / mouse 
                  :ARG0-of (s / show-01 
                        :ARG1 (r / right) 
                        :ARG1-of (c / compare-01 
                              :ARG2 (k / kidney))) 
                  :mod (m3 / mutant))) 
      :mod-of (l2 / littermate 
            :ARG1-of (l / leave-11) 
            :ARG1-of (m / match-01)) 
      :polarity -)

# ::snt ( C ) Hematoxylin and eosin stained section of ureter from a mutant mouse , showing normal histology despite bloating of the kidney .
# ::tok ( C ) Hematoxylin and eosin stained section of ureter from a mutant mouse , showing normal histology despite bloating of the kidney .
# ::alignments 22-23|0.0.2.1.1 19-20|0.0.2.1 17-18|0.0.2.0 16-17|0.0.2.0.0 15-16|0.0.2 13-14|0.0.1 12-13|0.0.1.0 9-10|0.0.0.0 7-8|0.0.0 6-7|0.0 5-6|0.1 4-5|0 1-2|0.0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:04.769
(a / and 
      :ARG0-of (s3 / stain-01 
            :ARG1 (s2 / section 
                  :part-of (u / uret)) 
            :ARG2 (m / mouse 
                  :mod (m2 / mutant)) 
            :purpose (s / show-01 
                  :ARG1 (h / histology 
                        :ARG1-of (n / normal-02)) 
                  :concession (b / bloat-01 
                        :ARG0 (c / C) 
                        :ARG1 (k / kidney)))) 
      :op1 (e / eosin))

# ::snt ( D ) Hematoxylin and eosin stained histologic section of a kidney from a 4-wk-old female mutant mouse .
# ::tok ( D ) Hematoxylin and eosin stained histologic section of a kidney from a 4-wk-old female mutant mouse .
# ::alignments 17-18|0.3 16-17|0.3.1 15-16|0.3.0 11-12|0.0.0.1 8-9|0.0.0 7-8|0.0.0.0 6-7|0.0 5-6|0.2 4-5|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:04.944
(a / and 
      :ARG0-of (s2 / stain-01 
            :ARG1 (s / section 
                  :mod (h / histologic) 
                  :part-of (k / kidney))) 
      :op1 (d / D) 
      :op2 (e / eosin) 
      :op3 (m / mouse 
            :mod (f / female) 
            :mod (m2 / mutant)))

# ::snt The mutant kidney shows marked dilatation of the renal pelvis with blunting of the papilla .
# ::tok The mutant kidney shows marked dilatation of the renal pelvis with blunting of the papilla .
# ::alignments 14-15|0.1.0.0 11-12|0.1.0 9-10|0.1.1 8-9|0.1.1.0 5-6|0.1 4-5|0 3-4|0.0 2-3|0.0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:05.081
(m / mark-01 
      :ARG0 (s / show-01 
            :ARG1 (k / kidney) 
            :mod (m2 / mutant)) 
      :ARG1 (d / dilatation 
            :ARG0-of (b / blunt-01 
                  :ARG1 (p / papilla)) 
            :poss (p2 / pelvi 
                  :mod (r / renal))))

# ::snt There is preservation of the cortex and medulla .
# ::tok There is preservation of the cortex and medulla .
# ::alignments 7-8|0.2 6-7|0 5-6|0.1 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:05.097
(a / and 
      :op1 (p / preservation) 
      :op2 (c / cortex) 
      :op3 (m / medulla))

# ::snt Immunoblot Analyses of AQP2 from Mouse Kidneys .
# ::tok Immunoblot Analyses of AQP2 from Mouse Kidneys .
# ::alignments 5-7|0.1.0.1+0.1.0.0+0.1.0+0.1 0-4|0.0.3+0.0.2+0.0.1+0.0.0+0.0+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:05.115
(o / organization 
      :name (n2 / name 
            :op1 "Immunoblot" 
            :op2 "Analyses" 
            :op3 "of" 
            :op4 "AQP2") 
      :source (p / person 
            :name (n / name 
                  :op1 "Mouse" 
                  :op2 "Kidneys")))

# ::snt ( A ) Western blot analyses of total kidney membranes from littermate mice .
# ::tok ( A ) Western blot analyses of total kidney membranes from littermate mice .
# ::alignments 12-13|0.2 9-10|0.1.0 8-9|0.1.0.0 7-8|0.2.0 5-6|0.1 4-5|0 3-4|0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:05.223
(b / blot-01 
      :ARG0 (w / world-region 
            :name (n / name 
                  :op1 "West") 
            :wiki "Western_world") 
      :ARG1 (a / analysis 
            :mod (m2 / membran 
                  :mod (k / kidney))) 
      :ARG2 (m / mouse 
            :ARG2-of (t / total-01)))

# ::snt An intermediate form of AQP2 at 31 kDa was identified in kidney membranes from a mutant mouse ( Mut ) and partially in a heterozygous mouse ( Het ) .
# ::tok An intermediate form of AQP2 at 31 kDa was identified in kidney membranes from a mutant mouse ( Mut ) and partially in a heterozygous mouse ( Het ) .
# ::alignments 27-28|0.0.0.1.0.0 25-26|0.1 24-25|0 21-22|0.1.0 20-21|0.0.0.0 16-17|0.0.0.2 15-16|0.0.0.2.0 12-13|0.0.0.3 11-12|0.0.0.3.0 9-10|0.0.0 7-8|0.0.0.1 6-7|0.0.0.1.0 2-3|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:05.560
(h2 / heterozygou 
      :mod (f / form 
            :ARG2-of (i / identify-01 
                  :ARG0 (a / and) 
                  :ARG1 (k2 / kDa 
                        :quant (3 / 31 
                              :mod (h / het))) 
                  :source (m2 / mouse 
                        :mod (m3 / mutant)) 
                  :time (m4 / membran 
                        :mod (k / kidney))) 
            :mod (i2 / intermediate)) 
      :mod-of (m / mouse 
            :mod (p / partial)))

# ::snt ( B ) Total kidney membranes were subjected to endoglycosidase H treatment ( Endo H ) prior to Western blotting .
# ::tok ( B ) Total kidney membranes were subjected to endoglycosidase H treatment ( Endo H ) prior to Western blotting .
# ::alignments 19-20|0.1.1 18-19|0.1.1.1.1+0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 16-17|0.1.0.0.0 13-15|0.1.1.0.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 11-12|0.1 10-11|0.1.2 7-8|0 5-6|0.1.0 4-5|0.1.0.1 3-4|0.1.0.0 1-2|0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:05.891
(s / subject-01 
      :ARG1 (l / location 
            :name (n3 / name 
                  :op1 "B") 
            :wiki -) 
      :ARG2 (t / treat-03 
            :ARG0 (m / membran 
                  :ARG1-of (t2 / total-01 
                        :ARG0 (p / prior)) 
                  :mod (k / kidney)) 
            :ARG1 (b / blot-01 
                  :ARG1 (c / country 
                        :name (n2 / name 
                              :op1 "Endo" 
                              :op2 "H")) 
                  :mod (w / world-region 
                        :name (n / name 
                              :op1 "West") 
                        :wiki "Western_world")) 
            :ARG2 (h / h)))

# ::snt High-mannose ( h.m. ) glycosylated proteins that have not exited the ER are sensitive to endoglycosidase H digestion .
# ::tok High-mannose ( h.m. ) glycosylated proteins that have not exited the ER are sensitive to endoglycosidase H digestion .
# ::alignments 17-18|0.0.0.2 16-17|0.0.0.2.0 13-14|0.0.0.0 11-12|0 9-10|0.0 8-9|0.0.2 5-6|0.0.0 4-5|0.0.0.1 0-1|0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:06.140
(e / e 
      :ARG1-of (e2 / exit-01 
            :ARG0 (p / protein 
                  :ARG1-of (s / sensitive-03) 
                  :mod (g / glycosylat) 
                  :poss-of (d / digestion 
                        :mod (h / h))) 
            :ARG2 (p2 / person 
                  :name (n / name 
                        :op1 "High-mannose")) 
            :polarity -))

# ::snt AQP2 Subcellular Localization and Translocation in Mouse Kidney Collecting Ducts and MDCK Cell Lines .
# ::tok AQP2 Subcellular Localization and Translocation in Mouse Kidney Collecting Ducts and MDCK Cell Lines .
# ::alignments 11-14|0.2.0.2+0.2.0.1+0.2.0.0+0.2.0+0.2 10-11|0.2.1 6-10|0.2.1.0.0.3+0.2.1.0.0.2+0.2.1.0.0.1+0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 4-5|0.1 3-4|0 1-3|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:06.212
(a2 / and 
      :op1 (t2 / thing 
            :name (n3 / name 
                  :op1 (s / Subcellular) 
                  :op2 (l / Localization))) 
      :op2 (t / translocation) 
      :op3 (o / organization 
            :name (n / name 
                  :op1 "MDCK" 
                  :op2 "Cell" 
                  :op3 "Lines") 
            :op2-of (a / and 
                  :op1 (c / country 
                        :name (n2 / name 
                              :op1 "Mouse" 
                              :op2 "Kidney" 
                              :op3 "Collecting" 
                              :op4 "Ducts")))))

# ::snt ( A ) Immunohistochemistry on collecting ducts in kidney sections from an AQP2-F204V mutant ( Mut ) mouse and an age-sex matched wild-type ( WT ) littermate .
# ::tok ( A ) Immunohistochemistry on collecting ducts in kidney sections from an AQP2-F204V mutant ( Mut ) mouse and an age-sex matched wild-type ( WT ) littermate .
# ::alignments 21-22|0.1.0 18-19|0 17-18|0.1 13-14|0.1.0.0 12-13|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 9-10|0.0.1 8-9|0.0.1.0 6-7|0.0.0 5-6|0.0 3-4|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:06.441
(a / and 
      :ARG0-of (c / collect-01 
            :ARG1 (d / duct 
                  :location (t / thing 
                        :name (n / name 
                              :op1 "AQP2-F204V"))) 
            :ARG2 (s / section 
                  :mod (k / kidney)) 
            :topic-of (i / immunohistochemistry)) 
      :op1 (m2 / mouse 
            :ARG1-of (m / match-01 
                  :ARG0 (m3 / mutant))))

# ::snt Mice were injected intraperitoneally with PBS ( NT ) or dDAVP before sacrificing and fixation of the kidneys .
# ::tok Mice were injected intraperitoneally with PBS ( NT ) or dDAVP before sacrificing and fixation of the kidneys .
# ::alignments 17-18|0.0.1 14-15|0.1 13-14|0 12-13|0.0 11-12|0.0.2 10-11|0.0.2.0.0.1 9-10|0.0.2.0.0 7-8|0.0.0 5-6|0.0.2.0.0.0 2-3|0.0.2.0 0-1|0.0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:06.556
(a / and 
      :op1 (s / sacrifice-01 
            :ARG0 - 
            :ARG1 (k / kidney) 
            :op1-of (b / before 
                  :time-of (i / inject-01 
                        :ARG1 (o / or 
                              :op1 (p / pb) 
                              :op2 (d / dDAVP)) 
                        :ARG2 (m / mouse)))) 
      :op2 (f / fixation))

# ::snt Kidneys sections were immunostained for AQP2 ( red ) and the basolateral marker AQP3 ( green ) .
# ::tok Kidneys sections were immunostained for AQP2 ( red ) and the basolateral marker AQP3 ( green ) .
# ::alignments 15-16|0 13-14|0.0.1.0+0.0.1+0.0 12-13|0.0.0 9-10|0.0.2 7-8|0.0.2.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:06.605
(g / green-02 
      :ARG1 (p / person 
            :ARG0-of (m / mark-01 
                  :ARG1 (s / section 
                        :mod (k / kidney))) 
            :name (n / name 
                  :op1 "AQP3") 
            :op2-of (a / and 
                  :op1 (r / red))))

# ::snt The images were merged and an area of the cytoplasm was magnified ( zoom ) .
# ::tok The images were merged and an area of the cytoplasm was magnified ( zoom ) .
# ::alignments 13-14|0.2 11-12|0.1 9-10|0.1.0.0 6-7|0.1.0 4-5|0 3-4|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:06.686
(a2 / and 
      :op1 (m2 / merge-01 
            :ARG1 (i / image)) 
      :op2 (m / magnify-01 
            :ARG1 (a / area 
                  :mod (c / cytoplasm))) 
      :op3 (z / zoom-01))

# ::snt Note that mutant AQP2 is not properly localized to the subapical compartment , nor does it respond to dDAVP .
# ::tok Note that mutant AQP2 is not properly localized to the subapical compartment , nor does it respond to dDAVP .
# ::alignments 18-19|0.0.0.0.0 16-17|0.0.0.0 11-12|0.0.1 7-8|0.0 6-7|0.0.2 5-6|0.0.3 2-4|0.0.0.1.1+0.0.0.1.0+0.0.0.1+0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:06.899
(n2 / note-01 
      :ARG1 (l / localize-01 
            :ARG1 (t / thing 
                  :ARG0-of (r / respond-01 
                        :ARG1 (d / dDAVP)) 
                  :name (n / name 
                        :op1 (m / mutant) 
                        :op2 (a / AQP2))) 
            :ARG2 (c / compartment) 
            :manner (p / proper) 
            :polarity -))

# ::snt ( B ) MDCK cell lines , stably transfected with constructs encoding mouse WT or AQP2-F204V , were treated with and without 150 M forskolin for 90 min , after which cells were fixed , permeabilized , and subjected to immunocytochemistry .
# ::tok ( B ) MDCK cell lines , stably transfected with constructs encoding mouse WT or AQP2-F204V , were treated with and without 150 M forskolin for 90 min , after which cells were fixed , permeabilized , and subjected to immunocytochemistry .
# ::alignments 40-41|0.2 38-39|0 37-38|0.3 33-34|0.3.3 31-32|0.3.3.0 29-30|0.3.3.2 27-28|0.1 26-27|0.3.1.0 24-25|0.1.0.1 23-24|0.1.0.1.0.2+0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 22-23|0.1.0.1.0.1 20-21|0.1.0.0 18-19|0.1.0 15-16|0.3.2.0.1.0+0.3.2.0.1+0.3.2.0 14-15|0.3.2 12-13|0.3.3.1 11-12|0.3.2.0.0 10-11|0.3.1 7-8|0.0 5-6|0.3.1.1.0 4-5|0.3.1.1 1-2|0.3.0.1+0.3.0.0.0+0.3.0.0+0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:07.921
(s / subject-01 
      :ARG0 (s2 / stably) 
      :ARG1 (m / min 
            :purpose-of (t / treat-01 
                  :ARG1 (a3 / and) 
                  :ARG2 (f2 / forskolin 
                        :mod (v / vehicle 
                              :name (n / name 
                                    :op1 "M1") 
                              :quant 150 
                              :wiki "M1_Abrams")))) 
      :ARG2 (i / immunocytochemistry) 
      :op4-of (a / and 
            :op1 (l2 / location 
                  :name (n3 / name 
                        :op1 "B") 
                  :wiki -) 
            :op2 (c2 / construct-01 
                  :ARG0 90 
                  :ARG1 (c3 / cell 
                        :mod-of (l / line))) 
            :op2-of (o / or 
                  :op1 (t2 / thing 
                        :ARG1-of (e / encode-01) 
                        :name (n2 / name 
                              :op1 "AQP2-F204V"))) 
            :op3 (f / fix-03 
                  :ARG1 (c / cell) 
                  :ARG2 (m2 / mouse) 
                  :time (a2 / after))))

# ::snt AQP2 is shown in green , and the basolateral marker Na + / K + - ATPase is shown in red , alongside the nuclear stain DAPI .
# ::tok AQP2 is shown in green , and the basolateral marker Na + / K + - ATPase is shown in red , alongside the nuclear stain DAPI .
# ::alignments 25-27|0.1.1.1.0.0.1.1+0.1.1.1.0.0.1.0+0.1.1.1.0.0.1+0.1.1.1.0.0 24-25|0.1.1.1.0.0.0 22-23|0.1.1.1.0.0.2 20-21|0.1.1.1.0.1 18-19|0.1.1.1.0 13-14|0.1.1.0 12-13|0.1.0 10-11|0.0 9-10|0 6-7|0.1.1.1 4-5|0.1 2-3|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:08.144
(m / mark-01 
      :ARG0 (n3 / na) 
      :ARG1 (g / green-02 
            :ARG1 (s3 / slash) 
            :ARG2-of (s4 / show-01 
                  :ARG0 (k / k) 
                  :ARG1 (a2 / and 
                        :op1 (s2 / show-01 
                              :ARG0 (t / thing 
                                    :mod (n2 / nucleus) 
                                    :name (n / name 
                                          :op1 (s / stain) 
                                          :op2 (d / DAPI)) 
                                    :op1-of (a / alongside)) 
                              :ARG1 (r / red))))))

# ::snt The z-profile images were reconstructed from multiple z-sections , along the dotted line .
# ::tok The z-profile images were reconstructed from multiple z-sections , along the dotted line .
# ::alignments 12-13|0.2.0 11-12|0.2 9-10|0.2.0.0 7-8|0.1 6-7|0.1.0 4-5|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:08.208
(r / reconstruct-01 
      :ARG1 (i / image) 
      :ARG2 (z / z-section 
            :quant (m / multiple)) 
      :ARG2-of (d / dot-01 
            :ARG1 (l / line 
                  :op1-of (a / along))))

# ::snt Mutant AQP2 fails to localize to the cell surface upon forskolin stimulation .
# ::tok Mutant AQP2 fails to localize to the cell surface upon forskolin stimulation .
# ::alignments 11-12|0.1.0 10-11|0.1.0.0 8-9|0.1.1 7-8|0.1.1.0 4-5|0.1 2-3|0 0-2|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:08.253
(f2 / fail-01 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 (m / Mutant) 
                  :op2 (a / AQP2))) 
      :ARG2 (l / localize-01 
            :ARG1 (s / stimulation 
                  :mod (f / forskolin)) 
            :ARG2 (s2 / surface 
                  :mod (c / cell))))

# ::snt Rather , the perinuclear staining is consistent with an ER localization of mutant AQP2 .
# ::tok Rather , the perinuclear staining is consistent with an ER localization of mutant AQP2 .
# ::alignments 12-14|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 10-11|0.1 9-10|0.1.0 6-7|0 4-5|0.0 3-4|0.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:08.353
(c / consistent-01 
      :ARG1 (s / stain-01 
            :ARG1 (p / perinuclear)) 
      :ARG2 (l / localization 
            :mod (e / e) 
            :poss (t / thing 
                  :name (n / name 
                        :op1 (m / mutant) 
                        :op2 (a / AQP2)))) 
      :manner (r / rather))

# ::snt ( C ) The MDCK cell line expressing AQP2-F204V was grown on fibronectin-coated coverslips until tight junctions formed , at which point the cells were treated with 150 M forskolin for 90 min .
# ::tok ( C ) The MDCK cell line expressing AQP2-F204V was grown on fibronectin-coated coverslips until tight junctions formed , at which point the cells were treated with 150 M forskolin for 90 min .
# ::alignments 32-33|0.0.0.2.0.1.1.2 31-32|0.0.0.0 29-30|0.0.0.2.0.1.1.1 28-29|0.0.0.2.0.1.1.1.0.2+0.0.0.2.0.1.1.1.0.0.0+0.0.0.2.0.1.1.1.0.0+0.0.0.2.0.1.1.1.0 27-28|0.0.0.2.0.1.1.1.0.1 25-26|0.0.0.2.0.1.1 23-24|0.0.0.2.0.1.1.0 21-22|0.0.0.2.0.1.1.3 17-18|0.0.0.2.0.1 16-17|0.0.0.2.0 15-16|0.0.0.2.0.0 14-15|0.0.0.2 13-14|0.0.0.1 12-13|0.0.0.1.0 10-11|0.0.0 8-9|0.1.0.0+0.1.0+0.1 7-8|0 6-7|0.0 5-6|0.0.1 4-5|0.0.2.0.0+0.0.2.0+0.0.2 1-2|0.0.0.2.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:09.719
(e / express-01 
      :ARG0 (l / line 
            :ARG1-of (g / grow-03 
                  :ARG0 90 
                  :ARG2 (c2 / coverslip 
                        :mod (f3 / fibronectin-coat)) 
                  :time (u / until 
                        :op1 (j / junction 
                              :ARG1-of (t2 / tight-05) 
                              :ARG1-of (f2 / form-01 
                                    :ARG0 (c4 / C) 
                                    :purpose-of (t / treat-01 
                                          :ARG1 (c / cell) 
                                          :ARG2 (f / forskolin 
                                                :mod (v / vehicle 
                                                      :name (n / name 
                                                            :op1 "M1") 
                                                      :quant 150 
                                                      :wiki "M1_Abrams")) 
                                          :duration (m / min) 
                                          :time (p / point)))))) 
            :mod (c3 / cell) 
            :mod (o / organization 
                  :name (n3 / name 
                        :op1 "MDCK"))) 
      :ARG1 (t3 / thing 
            :name (n2 / name 
                  :op1 "AQP2-F204V")))

# ::snt Cells were fixed , permeabilized , and sequentially immunoblotted for AQP2 ( green ) and calnexin ( red ) , an ER marker .
# ::tok Cells were fixed , permeabilized , and sequentially immunoblotted for AQP2 ( green ) and calnexin ( red ) , an ER marker .
# ::alignments 22-23|0.1 21-22|0.1.1 17-18|0.1.0 15-16|0.0.1.1 14-15|0.0.1 12-13|0.0.1.0 7-8|0.0.1.0.0 6-7|0 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:09.865
(a2 / and 
      :op1 (f / fix-03 
            :ARG1 (c2 / cell) 
            :ARG4 (a / and 
                  :op1 (g / green-02 
                        :ARG1 (s / sequentially)) 
                  :op2 (c / calnexin))) 
      :op2 (m / mark-01 
            :ARG0 (r / red) 
            :ARG1 (e / e)))

# ::snt The merged image shows that AQP2-F204V colocalizes with the endoplasmic reticulum marker .
# ::tok The merged image shows that AQP2-F204V colocalizes with the endoplasmic reticulum marker .
# ::alignments 11-12|0.0.0.0 10-11|0.0.0.0.0 5-6|0.1.0.0+0.1.0+0.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:09.898
(s / show-01 
      :ARG0 (i / image 
            :ARG1-of (m2 / merge-01 
                  :ARG0 (m / mark-01 
                        :ARG1 (r / reticulum)))) 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 "AQP2-F204V")))

# ::snt Scale bar refers to 10 m .
# ::tok Scale bar refers to 10 m .
# ::alignments 5-6|0.1 4-5|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:09.914
(r / refer-01 
      :ARG0 (b / bar-01 
            :ARG1 (s / scale)) 
      :ARG1 (m / m 
            :quant 10))

# ::snt AQP2-F204V Rescue in Heterozygous Mouse Collecting Ducts and in Cotransfected MDCK Cells .
# ::tok AQP2-F204V Rescue in Heterozygous Mouse Collecting Ducts and in Cotransfected MDCK Cells .
# ::alignments 10-12|0.1.1.1+0.1.1.0+0.1.1+0.1 9-10|0.1.0 7-8|0 5-7|0.0.1.1+0.0.1.0+0.0.1+0.0 3-5|0.0.1.0.0.0.1+0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:09.985
(a / and 
      :op1 (t2 / thing 
            :ARG2-of (r / rescue-01) 
            :name (n2 / name 
                  :op1 (c2 / Collecting 
                        :mod (t3 / thing 
                              :name (n3 / name 
                                    :op1 (h / Heterozygous) 
                                    :op2 (m / Mouse)))) 
                  :op2 (d / Ducts))) 
      :op2 (t / thing 
            :mod (c / cotransfect) 
            :name (n / name 
                  :op1 "MDCK" 
                  :op2 "Cells")))

# ::snt ( A ) In heterozygous animals , AQP2 localizes and responds to dDAVP normally .
# ::tok ( A ) In heterozygous animals , AQP2 localizes and responds to dDAVP normally .
# ::alignments 13-14|0.1.0 10-11|0.1 9-10|0 8-9|0.0 5-6|0.1.0.0 4-5|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:10.015
(a / and 
      :op1 (l / localize-01) 
      :op2 (r / respond-01 
            :ARG0-of (n / normal-02 
                  :ARG1 (a2 / animal 
                        :mod (h / heterozygou)))))

# ::snt Immunohistochemistry was carried out on kidney sections from an Aqp2F204V / + mouse , after injection with dDAVP .
# ::tok Immunohistochemistry was carried out on kidney sections from an Aqp2F204V / + mouse , after injection with dDAVP .
# ::alignments 17-18|0.0.0 15-16|0.0 14-15|0.0.2 12-13|0 10-11|0.0.1.1 9-10|0.0.1.0 6-7|0.0.1.2 5-6|0.0.1.2.0 2-3|0.0.1 0-1|0.0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:10.135
(m / mouse 
      :ARG0-of (i / inject-01 
            :ARG1 (d / dDAVP) 
            :ARG2 (c / carry-out-03 
                  :ARG0 (a2 / Aqp2F204V) 
                  :ARG1 (s / slash) 
                  :ARG2 (s2 / section 
                        :mod (k / kidney)) 
                  :time (i2 / immunohistochemistry)) 
            :op1-of (a / after)))

# ::snt Kidney sections were sequentially immunostained for AQP2 ( red ) and the basolateral marker AQP3 ( green ) .
# ::tok Kidney sections were sequentially immunostained for AQP2 ( red ) and the basolateral marker AQP3 ( green ) .
# ::alignments 16-17|0.0.0 14-15|0.0.1.0+0.0.1+0.0 13-14|0 10-11|0.0.2 8-9|0.0.2.1 4-5|0.0.2.0 3-4|0.0.2.0.1 1-2|0.0.2.0.0 0-1|0.0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:10.194
(m / mark-01 
      :ARG0 (p / person 
            :ARG1-of (g / green-02) 
            :name (n / name 
                  :op1 "AQP3") 
            :op3-of (a / and 
                  :op1 (i / immunostain 
                        :domain (s2 / section 
                              :mod (k / kidney)) 
                        :mod (s / sequentially)) 
                  :op2 (r / red))))

# ::snt ( B ) Mutant and wild-type AQP2 physically interact .
# ::tok ( B ) Mutant and wild-type AQP2 physically interact .
# ::alignments 8-9|0.0 7-8|0.0.0 4-5|0 3-4|0.2 1-2|0.1.1+0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:10.216
(a / and 
      :ARG1-of (i / interact-01 
            :manner (p / physical)) 
      :op1 (l / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -) 
      :op2 (m / mutant))

# ::snt MDCK cells stably expressing wild-type AQP2 were transiently transfected with GFP tagged wild-type AQP2 , AQP2-F204V , or GFP alone .
# ::tok MDCK cells stably expressing wild-type AQP2 were transiently transfected with GFP tagged wild-type AQP2 , AQP2-F204V , or GFP alone .
# ::alignments 19-20|0.0.1 17-18|0 15-16|0.2.0.0+0.2.0+0.2 11-12|0.0 10-11|0.0.0.0.0+0.0.0.0+0.0.0 8-9|0.1.0.0.0 7-8|0.1.0.0.0.0 5-6|0.1 3-4|0.1.0 2-3|0.1.0.1 1-2|0.1.0.0 0-1|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:10.691
(o / or 
      :ARG1-of (t2 / tag-01 
            :ARG0 (o2 / organization 
                  :name (n2 / name 
                        :op1 "GFP")) 
            :manner (a / alone)) 
      :op1 (a2 / AQP2 
            :ARG1-of (e / express-01 
                  :ARG0 (c / cell 
                        :domain-of (t3 / transfect 
                              :mod (t4 / transiently)) 
                        :location (o3 / organization 
                              :name (n3 / name 
                                    :op1 "MDCK"))) 
                  :mod (s / stably))) 
      :op2 (t / thing 
            :name (n / name 
                  :op1 "AQP2-F204V")))

# ::snt Solubilized membranes were immunoprecipitated with a GFP antibody .
# ::tok Solubilized membranes were immunoprecipitated with a GFP antibody .
# ::alignments 7-8|0.1.0 6-7|0.1.1.0+0.1.1+0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:10.718
(i / immunoprecipitat 
      :domain (m / membran 
            :mod (s / solubiliz)) 
      :location (o / organization 
            :mod-of (a / antibody) 
            :name (n / name 
                  :op1 "GFP")))

# ::snt Total membranes and immunoprecipitates ( GFP-IP ) were Western blotted using an antibody against AQP2 ( arrow ) or AQP2-GFP fusions ( arrowhead ) .
# ::tok Total membranes and immunoprecipitates ( GFP-IP ) were Western blotted using an antibody against AQP2 ( arrow ) or AQP2-GFP fusions ( arrowhead ) .
# ::alignments 20-21|0.0.2.1 19-20|0.0.2.1.0.0.0+0.0.2.1.0.0+0.0.2.1.0 18-19|0.0.2 16-17|0.0.2.0 12-13|0.0.1 10-11|0.0 9-10|0 8-9|0.1.1+0.1.0.0+0.1.0+0.1 3-4|0.0.0.1 2-3|0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:11.472
(b / blot-01 
      :ARG0 (u / use-01 
            :ARG0 (a3 / and 
                  :op1 (m / membran 
                        :ARG1-of (t / total-01)) 
                  :op2 (i / immunoprecipitat)) 
            :ARG1 (a2 / antibody) 
            :ARG2 (o2 / or 
                  :op1 (a / arrow) 
                  :op2 (f / fusion 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "AQP2-GFP"))))) 
      :ARG1 (w / world-region 
            :name (n2 / name 
                  :op1 "West") 
            :wiki "Western_world"))

# ::snt ( C ) Wild-type AQP2 rescues the localization defect of mutant AQP2 .
# ::tok ( C ) Wild-type AQP2 rescues the localization defect of mutant AQP2 .
# ::alignments 10-12|0.0.0.1+0.0.0.0+0.0.0+0.0 8-9|0 7-8|0.2 5-6|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:11.521
(d / defect-01 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 (m / mutant) 
                  :op2 (a / AQP2))) 
      :ARG1-of (r / rescue-01 
            :ARG0 (c / C)) 
      :mod (l / localization))

# ::snt GFP fusions of either wild-type AQP2 ( WT-GFP , top photomicrographs ) or F204V AQP2 ( F204V-GFP , bottom photomicrographs ) were expressed in polarized MDCK stable cell lines expressing vector alone ( vector , left photomicrographs ) or AQP2-WT ( right photomicrographs ) .
# ::tok GFP fusions of either wild-type AQP2 ( WT-GFP , top photomicrographs ) or F204V AQP2 ( F204V-GFP , bottom photomicrographs ) were expressed in polarized MDCK stable cell lines expressing vector alone ( vector , left photomicrographs ) or AQP2-WT ( right photomicrographs ) .
# ::alignments 42-43|0.1.1.1.0 41-42|0.1.1.1 39-40|0.3.2.2.0.0+0.3.2.2.0+0.3.2.2 38-39|0.3.2 36-37|0.0.0 35-36|0.0 33-34|0.3.2.1 31-32|0.3.3 30-31|0.3.1 29-30|0.3 28-29|0.2 27-28|0.2.1 26-27|0.2.0 25-26|0.2.2.0.0+0.2.2.0+0.2.2 24-25|0.2.0.1 22-23|0 19-20|0.2.0.1.0 18-19|0.2.0.1.0.0 16-17|0.3.2.0.0.0+0.3.2.0.0+0.3.2.0 13-15|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 12-13|0.1 10-11|0.2.0.0.0 9-10|0.2.0.0 5-6|0.1.0 3-4|0.1.0.0 1-2|0.3.0 0-1|0.3.0.0.0.0+0.3.0.0.0+0.3.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:13.877
(e2 / express-01 
      :ARG1 (l / left 
            :mod-of (p3 / photomicrograph)) 
      :example (o4 / or 
            :op1 (a2 / AQP2 
                  :mod (e3 / either)) 
            :op2 (p6 / person 
                  :name (n4 / name 
                        :op1 "F204V" 
                        :op2 "AQP2") 
                  :poss-of (r / right 
                        :mod-of (p / photomicrograph)))) 
      :manner (l2 / line 
            :ARG1-of (s / stable-03 
                  :ARG0 (t / top 
                        :mod-of (p7 / photomicrograph)) 
                  :ARG2 (p4 / polarize-01 
                        :ARG1 (p5 / photomicrograph 
                              :mod (b / bottom)))) 
            :mod (c / cell) 
            :mod (o2 / organization 
                  :name (n2 / name 
                        :op1 "MDCK"))) 
      :purpose (e / express-01 
            :ARG0 (f / fusion 
                  :mod (o5 / organization 
                        :name (n5 / name 
                              :op1 "GFP"))) 
            :ARG1 (v2 / vector) 
            :ARG2 (o / or 
                  :mod-of (o3 / organization 
                        :name (n3 / name 
                              :op1 "F204V-GFP")) 
                  :op1 (v / vector) 
                  :op2 (p2 / person 
                        :name (n / name 
                              :op1 "AQP2-WT"))) 
            :location (a / alone)))

# ::snt Cells were stimulated with forskolin , processed for immunocytochemistry , and used to generate z-sectional images .
# ::tok Cells were stimulated with forskolin , processed for immunocytochemistry , and used to generate z-sectional images .
# ::alignments 15-16|0.0.0.0.0.0.0 13-14|0.0.0.0.0.0 11-12|0.0.0.0.0 10-11|0.0.0.0 6-7|0.0.0 4-5|0.1 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:13.963
(s / stimulate-01 
      :ARG1 (c / cell 
            :ARG1-of (p / process-01 
                  :op1-of (a / and 
                        :ARG1-of (u / use-01 
                              :ARG2 (g / generate-01 
                                    :ARG1 (i / image)))))) 
      :ARG2 (f / forskolin))

# ::snt ( D ) Mutant AQP2 is present at the cell surface in cells coexpressing wild-type AQP2 ( AQP2-WT ) .
# ::tok ( D ) Mutant AQP2 is present at the cell surface in cells coexpressing wild-type AQP2 ( AQP2-WT ) .
# ::alignments 17-18|0.1.0+0.1+0 12-13|0.0.1 10-11|0.0.1.0 9-10|0.0.1.0.0 6-7|0.0.0 3-5|0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:14.023
(p / person 
      :mod (d / D 
            :domain-of (p2 / present 
                  :domain (t / thing 
                        :name (n2 / name 
                              :op1 (m / Mutant) 
                              :op2 (a / AQP2)))) 
            :poss-of (c / cell 
                  :location-of (s / surface 
                        :mod (c2 / cell)))) 
      :name (n / name 
            :op1 "AQP2-WT"))

# ::snt GFP fused to AQP2-F204V was expressed in MDCK cells expressing wild-type AQP2 or vector alone .
# ::tok GFP fused to AQP2-F204V was expressed in MDCK cells expressing wild-type AQP2 or vector alone .
# ::alignments 14-15|0.1.0.2 13-14|0.1.0.1.0 12-13|0.1.0.1 11-12|0.1.0.0 9-10|0.1.0 8-9|0.1 7-8|0.1.1.0.0+0.1.1.0+0.1.1 5-6|0 3-4|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.0.0 0-1|0.0.1.0+0.0.1+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:14.754
(e2 / express-01 
      :ARG1 (o3 / organization 
            :ARG0-of (f / fuse-01 
                  :ARG1 (t / thing 
                        :name (n2 / name 
                              :op1 "AQP2-F204V"))) 
            :name (n3 / name 
                  :op1 "GFP")) 
      :source (c / cell 
            :ARG0-of (e / express-01 
                  :ARG1 (a2 / AQP2) 
                  :ARG2 (o / or 
                        :op1 (v / vector)) 
                  :manner (a / alone)) 
            :location (o2 / organization 
                  :name (n / name 
                        :op1 "MDCK"))))

# ::snt Cells were stimulated with forskolin , and cell surface biotinylated proteins were precipitated then analyzed for the presence of wild-type AQP2 ( arrow ) and AQP2-F204V ( arrowhead ) by Western blot .
# ::tok Cells were stimulated with forskolin , and cell surface biotinylated proteins were precipitated then analyzed for the presence of wild-type AQP2 ( arrow ) and AQP2-F204V ( arrowhead ) by Western blot .
# ::alignments 31-32|0.0.0.0.0 30-31|0.0.0.0.0.1.1+0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 25-26|0.0.0.1.2.0.0.0+0.0.0.1.2.0.0+0.0.0.1.2.0 24-25|0.0.0.1.2 22-23|0.0.0.0.0.0 20-21|0.0.0.1.0.0 17-18|0.0.0.1.0 14-15|0.0.0.1 13-14|0.0.0.1.1 12-13|0.0.0 10-11|0.0.0.0 8-9|0.2.0 7-8|0.2.0.0 6-7|0.2 4-5|0.1 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:15.596
(s2 / stimulate-01 
      :ARG1 (c2 / cell 
            :ARG0-of (p2 / precipitate-01 
                  :ARG1 (p3 / protein 
                        :ARG0-of (b / blot-01 
                              :ARG1 (a2 / arrow) 
                              :mod (w / world-region 
                                    :name (n / name 
                                          :op1 "West") 
                                    :wiki "Western_world"))) 
                  :manner (a4 / analyze-01 
                        :ARG1 (p / presence 
                              :mod (a3 / AQP2)) 
                        :mod (t2 / then) 
                        :op1-of (a / and 
                              :op2 (t / thing 
                                    :name (n2 / name 
                                          :op1 "AQP2-F204V")))))) 
      :ARG2 (f / forskolin) 
      :op1-of (a5 / and 
            :op2 (s / surface 
                  :mod (c / cell))))

# ::snt Competing interests .
# ::tok Competing interests .
# ::alignments 1-2|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:15.601
(c / compete-01 
      :topic-of (i / interest))

# ::snt The authors have declared that no competing interests exist .
# ::tok The authors have declared that no competing interests exist .
# ::alignments 8-9|0.1 7-8|0.1.0 6-7|0.1.0.0 5-6|0.1.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:15.648
(d / declare-01 
      :ARG0 (a / author-01) 
      :ARG1 (e / exist-01 
            :ARG1 (i / interest 
                  :ARG1-of (c / compete-02)) 
            :polarity -))

# ::snt Author contributions .
# ::tok Author contributions .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:15.653
(c / contribute-01 
      :ARG1-of (a / author-01))

# ::snt DJL and NG conceived and designed the experiments .
# ::tok DJL and NG conceived and designed the experiments .
# ::alignments 7-8|0.1.1 5-6|0.1 4-5|0 3-4|0.1.2.0 2-3|0.0.0.0+0.0.0+0.0 1-2|0.1.2 0-1|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:15.736
(a / and 
      :op1 (o / organization 
            :name (n / name 
                  :op1 "NG")) 
      :op2 (d / design-01 
            :ARG0 (o2 / organization 
                  :name (n2 / name 
                        :op1 "DJL")) 
            :ARG1 (e / experiment-01) 
            :op1-of (a2 / and 
                  :ARG0-of (c / conceive-01))))

# ::snt DJL performed the experiments .
# ::tok DJL performed the experiments .
# ::alignments 3-4|0 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:15.747
(e / experiment-01 
      :ARG1-of (p / perform-02 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "DJL"))))

# ::snt DJL , FWH , and NG analyzed the data .
# ::tok DJL , FWH , and NG analyzed the data .
# ::alignments 8-9|0.1 6-7|0 5-6|0.0.2.0.0+0.0.2.0+0.0.2 4-5|0.0 2-3|0.0.1.0.0+0.0.1.0+0.0.1 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:15.793
(a / analyze-01 
      :ARG0 (a2 / and 
            :op1 (o3 / organization 
                  :name (n3 / name 
                        :op1 "DJL")) 
            :op2 (o2 / organization 
                  :name (n2 / name 
                        :op1 "FWH")) 
            :op3 (o / organization 
                  :name (n / name 
                        :op1 "NG"))) 
      :ARG1 (d / data))

# ::snt DJL and LMT contributed reagents/materials/analysis tools .
# ::tok DJL and LMT contributed reagents/materials/analysis tools .
# ::alignments 5-6|0.1 4-5|0.1.0 3-4|0 2-3|0.0.1.0.0+0.0.1.0+0.0.1 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:15.830
(c / contribute-01 
      :ARG0 (a / and 
            :op1 (o2 / organization 
                  :name (n2 / name 
                        :op1 "DJL")) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "LMT"))) 
      :ARG1 (t / tool 
            :purpose (r / reagents/materials/analysi)))

# ::snt DJL and NG wrote the paper .
# ::tok DJL and NG wrote the paper .
# ::alignments 5-6|0.1 3-4|0 2-3|0.0.1.0.0+0.0.1.0+0.0.1 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:16.013
(w / write-01 
      :ARG0 (a / and 
            :op1 (o2 / organization 
                  :name (n2 / name 
                        :op1 "DJL")) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "NG"))) 
      :ARG1 (p / paper))

# ::snt Citation : Lloyd DJ , Hall FW , Tarantino LM , Gekakis N ( 2005 ) Diabetes insipidus in mice with a mutation in aquaporin-2 .
# ::tok Citation : Lloyd DJ , Hall FW , Tarantino LM , Gekakis N ( 2005 ) Diabetes insipidus in mice with a mutation in aquaporin-2 .
# ::alignments 22-23|0.0.0 19-20|0.0.0.1 16-17|0 14-15|0.0.1+0.0 12-13|0.0.0.2 8-10|0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 5-7|0.0.0.3.0.1+0.0.0.3.0.0+0.0.0.3.0+0.0.0.3 2-4|0.0.0.4.0.0.1+0.0.0.4.0.0.0+0.0.0.4.0.0+0.0.0.4.0 0-1|0.0.0.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:16.110
(d / diabet 
      :li (d2 / date-entity 
            :mod (m / mutation 
                  :domain (p / person 
                        :name (n2 / name 
                              :op1 "Tarantino" 
                              :op2 "LM")) 
                  :location-of (m2 / mouse) 
                  :mod-of (n / N) 
                  :op1 (c / country 
                        :name (n3 / name 
                              :op1 "Hall" 
                              :op2 "FW")) 
                  :quant (c2 / citation 
                        :mod-of (o / organization 
                              :name (n4 / name 
                                    :op1 "Lloyd" 
                                    :op2 "DJ")))) 
            :year 2005))

# ::snt PLoS Genet 1 ( 2 ) : e20 .
# ::tok PLoS Genet 1 ( 2 ) : e20 .
# ::alignments 7-8|0 4-5|0.0 2-3|0.0.0.0 0-2|0.0.0.1.1+0.0.0.1.0+0.0.0.1+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:41:16.130
(e / e20 
      :quant (2 / 2 
            :op1-of (o / organization 
                  :mod 1 
                  :name (n / name 
                        :op1 "PLoS" 
                        :op2 "Genet"))))

